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ABSTRACT 
 
Porcine reproductive and respiratory syndrome (PRRS), which is characterized by 
respiratory distress and reproductive problem in pigs, have been endemic throughout the 
world since the first outbreaks decades ago.  Enormous efforts have failed to deter the disease 
outbreaks, and highly genetic or/and antigenic variation of PRRSV is believed to have taken 
major responsibility for the failure.   Therefore, it has been required to define evolutionary 
features of PRRSV to provide fundamental information for preventing the disease outbreaks 
in swine industry.  
In this study, PRRSV evolution was explored by analyzing genetic (ORFs 2-7 
sequence) or/and antigenic changes of viruses isolated during in vivo replication in pigs or 
field isolates from clinical samples.  Sequential pig-to-pig passages of a single strain 
introduced continuous mutation on the structural protein gene, while the mutation rates and 
number of mutants were diverse among individual structural protein genes.  It was noted that 
a single virus underwent independent evolution among hosts, creating distinct viral 
population.  Importantly, the generation of diversity led to modification of immunological 
property and inefficacy of a diagnostic method (RFLP).  Pigs were subjected to concurrent 
infection of two different strains, being followed by sequential pig-to-pig passages.  
Emergence of recombinants was observed in all animals under the dual infection.  
Recombination occurred between two strains or among viral subpopulation, producing 
multiple types of recombinants during the passages.  Random cross-over points were 
unevenly observed throughout structural protein genes.  Recombination analysis 
(Phylogenetic analysis and cBrother) of field isolates resulted in discovery of 44.7% of 
 v 
recombinants among tested field isolates, indicating high frequency of recombination in the 
field, while the recombination occurred with regional preference.  Conclusively, PRRSV 
continued to evolve during in vivo replication in pigs through diverse evolutionary 
mechanisms (e.g. random point mutation, recombination etc).   
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CHAPTER 1. GENERAL INTRODUCTION 
 
 
Introduction 
 
Porcine reproductive and respiratory syndrome (PRRS) first appeared in the United 
States as ‘Mystery Swine Disease’ in mid 1980’s.  Since then, this catastrophic, 
uncontrollable and clinical disease continues to be a plaque in swine industry throughout the 
world. Infection of porcine reproductive and respiratory syndrome virus (PRRSV), the 
causative agent, induces subclinical to severe respiratory distress in pigs of all ages and 
reproductive problem such as mid to late-term abortion or premature farrowing in breeding 
animals, leading to significant economic losses. 
PRRSV belongs to the family Arteriviridae along with equine arteritis virus (EAV), 
lactate dehydrogenase elevating virus (LDV) of mice, and simian hemorrhagic fever virus 
(SHFV) in the order of Nidovirales. PRRSV is divided into two genotypes, such as type I 
(Eurpean genotype) and type II (North American genotype), showing a high degree of 
antigenic and genetic diversity between them.  
As expected for RNA viruses, PRRSV has been shown to continuously evolve during 
infection in pigs.  This feature is believed to be responsible for endemic outbreaks of the 
disease throughout the world, despite the current efforts to control the disease.  Genetic 
diversity of PRRSV in the field among type I or type II has been well documented.  
Continuous genetic changes have resulted in emergence of novel strains in swine population, 
leading to expanding genetic variability, and existence of multiple strains in the same farm, 
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and raising concerns about vaccine efficacy in swine farms. Therefore, it is important to 
define evolutionary features of PRRSV for control and prevention of the outbreaks. 
Understanding of evolutionary features will become essential information in developing 
intervention strategies using diverse approaches such as vaccines and diagnostics.  Besides, 
the information will be useful when epidemiological and ecological studies are conducted.  
In these studies, we assessed and characterized molecular evolution of all PRRS viral 
structural protein genes during continuous in vivo replication through sequential pig-to-pig 
passages under a single or dual infection of PRRSV.  In addition, we investigated occurrence 
of recombination on structural proteins of field isolates.   
 
Dissertation Organization 
 
This dissertation begins with an abstract and is followed by 7 Chapters.  Chapter 1 
contains a general introduction.  Chapter 2 contains a literature review.  Chapter 3 through 6 
each (except for Chapter 4) contains a manuscript to be submitted to the Journal of Virology.  
Chapter 4 was published in the Journal of Clinical Microbiology.  The doctoral candidate is 
the first author for all four papers.  The dissertation concludes with a general discussion 
(Chapter 7), references and acknowledgements. 
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CHAPTER 2. A LITERATURE REVIEW OF EVOLUTIONARY BIOLOGY OF 
PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS  
 
Introduction 
 
 Evolution is an essential part of RNA viruses to expand host range and survival 
in infected host.  During replication of RNA virus, low fidelity of RNA-dependent RNA 
polymerase (RdRp) due to the lack of proof reading, genetic exchange (i.e. recombination, 
genetic reassortment) among viruses and other possible mechanisms including RNA editing 
are involved in generation and maintenance of genetic diversity in a virus population.  These 
mechanisms create genetically related viral populations (quasispecies) of a RNA virus, which 
contain various genetic type as well as phenotype of subpopulations.  The high fluctuation in 
RNA viral population may contribute to the emergence of new diseases, such as human 
immunodeficiency virus (HIV), severe acute respiratory syndrome (SARS), avian influenza 
and Nipah etc in recent days by adapting to new environment.  The distinguished features of 
these viruses are high degree of genetic and antigenic variation, continuous evolution and the 
capability of escaping from immune protection, which impose importance on better 
understanding of evolutionary dynamics of the viruses in prevention and control. 
Porcine reproductive and respiratory syndrome (PRRS) is a plague causing significant 
economic loss (approximately 600 million dollars a year in USA) to pig production 
throughout the world (Neumann et al., 2005).  The causative agent, PRRS virus, is a RNA 
virus belonging to the family Arteriviridae and has shown several outstanding characteristics 
that have been strong impediments to effective control of PRRS.  Among them, a high degree 
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of genetic and antigenic heterogeneity among PRRS viruses has thwarted huge efforts on 
behalf of many scientists and producers to control and eradicate the disease, leading to 
consistent circulation and expansion of viral diversity in swine population throughout the 
world.  Therefore, understanding the evolutionary dynamics of PRRSV is a crucial part for 
increasing productivity and eliminating the virus from swine population.  Additionally, extra 
attention to evolution of other arteriviruses may help disclose and characterize the 
unidentified evolutionary features of PRRSV.  This review will have major focus on the 
current understanding and knowledge of genetic and antigenic variability, evolution and 
biological implication, including the potential genetic mechanisms that are responsible for 
PRRSV evolution  
 
Potential genetic mechanisms for diversity of arteriviruses 
 
 General mechanisms proposed for RNA viruses that produce RNA and protein 
diversity are results of random point mutation, recombination, genetic reassortment, and 
RNA editing (a.k.a. post-transcription changes).  Random point mutation and recombination 
are well known for mutation and generation of viral diversity in most of RNA viruses.  
Meanwhile, the others are specific events to some RNA viruses.  RNA editing occurs in 
hepatitis delta virus (Polson et al., 1996), mumps virus (Paterson and Lamb, 1990) and 
ebolavirus (Volchkov et al., 2001) to create diversity of mRNA and proteins involved in viral 
replication and pathogenesis.  However, the full impact of RNA editing on genetic diversity 
of viruses remains to be determined.  Genetic reassortment is common event among viruses 
with segmented genome, such as influenza viruses (Nelson and Holmes, 2007) and 
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reoviruses (Liu et al, 2003).  Like other RNA viruses with non-segmented genome, random 
point mutation and recombination has been demonstrated or suggested to be largely 
responsible for generation of diversity and evolution of arteriviruses.   
 
Genetic variation mechanism of individual virus 
Random point mutation  
  Low fidelity of RdRp of RNA viruses that have a small and compacted genome 
(approximately 3-32kb) tends to introduce random mutations into their genome during 
replication.  While the mutational change rate of DNA viruses has been estimated at 10-7- 
10-11mutations/site/replication (Beckman and Loeb, 1993; Calcagnile et al., 1996; Drake, 
1991), RNA viruses have shown the mutational change rate of 10-3 - 10-
6
mutations/site/replication (Drake, 1993; Hubner et al., 1992; Drake and Holland, 1999).  
Meanwhile, Hanada et al. (2004) reported that PRRSV has the highest synonymous 
substitution rate (6.2×10-2/site/year) among RNA viruses (6.2×10-2- 1.35×10-7/site/year) and 
harbors the replication error rate (3.7×10-5/site/replication) similar to that of other positive-
stranded single-stranded RNA viruses, negative single-stranded RNA viruses and 
retroviruses.  
 Random point mutation is generated on structural as well as non-structural genes of 
RNA virus genome.  However, mutation is introduced with preference among and/or within 
functional genes.  Escarmis et al. (2002) reported that distribution of mutations appeared not 
even throughout FMDV genome, and focused on some regions creating clusters (i.e., hot 
spots).  The fact that mutation rate in gag was higher than that of env during repeated 
bottleneck in HIV-1 (Yuste et al., 2000) was supportive of the mutational preference.   
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Recombination 
 Most of recombination in RNA viruses occurs in compliance with “copy-choice 
model”, which was proposed with poliovirus study (Cooper et al., 1968).  The copy-choice 
model results from template switching of RdRp-nacent strand complex from donor (one 
template) to acceptor (another template) without strand breaks.  Although some viruses 
showed breakage-induced template switching mechanism (White and Morris, 1995; Coffin, 
1979), and breakage and ligation mechanism (Lazzarini et al., 1981), the popularity of the 
replicase driven-template switching mechanism has been supported by a number of studies 
(Nagy and Bujarski, 1995; Nagy and Simon, 1997).  Template switching occurs based on 
homologous sequence or non-homologous sequence between donor and acceptor.  
Homologous recombination occurs with different efficiency based on sequence similarity 
between donor and acceptor sequence.  Homologous recombination has been observed in 
poliovirus (Kirkegaard and Baltimore, 1986), coronavirus (Koetzner et al., 1992), alphavirus 
(Raju et al., 1995; Walling et al., 1997), rotavirus (Suzuki et al, 1998), and hantavirus (Sibold 
et al., 1999).  It is induced by sequence similarity, by which frequency of the event is greatly 
affected (Nagy and Bujarski, 1996).  Non-homologous recombination in Brome mosaic virus 
(BMV) (Alejska et al., 2005) and reteroviruses (Yin et al., 1997) is affected not by the 
sequence similiarity but by secondary structure elements or heteroduplex formation (Nagy 
and Bujarski, 1993; Nagy et al., 1995).  Some viruses may use a mechanism combining the 
features of homologous and non-homologous recombination (Nagy and Simon, 1997).  
 Recombination occurs in structural genes as well as non-structural genes and makes a 
significant contribution to the generation and maintenance of viral diversity (Gorbalenya et 
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al., 1989; Lukashev et al., 2005; Woo et al., 2006; Moutouh et al., 1996; Rambaut et al., 
2004; Kitrinos et al., 2005; Charpentier et al., 2006; Simmonds and Welch, 2006).  
Recombination frequency varies among species of virus within the same genus and regions 
of viral genome (Simmonds and Welch, 2006).  In human enteroviruses, coxackie type 
(serotype) B were demonstrated to have recombinants with much higher frequency 
(approximately 40-100%) than type A (approximately 11-29%) between variants isolated 
over times.  It was also found that recombination occurred more extensively in non-structural 
protein regions (2A-3D) than structural protein (VP2-VP3-VP1), showing regional 
preference of recombination.   
 
Quasispecies dynamics and diversification 
Lack of proof-reading mechanism of RdRp and recombination within quasispecies 
can end up with deleterious mutation or generation of new viral population.  The new viral 
population is composed of various subpopulations of viruses with different fitness and 
various tropisms (Doming and Holland, 1997; Domingo et al., 2003).  A cloud of 
subpopulations is defined as “quasispecies”, which is composed of viruses that have close 
genetic relatedness in their genome.   The mutant spectrum is defined as “an ensemble of 
mutant genomes that compose a quaispecies”.  Genomic diversity within a RNA viral 
population refers to mutant spectrum.  Change in the size and complexity of mutant spectrum 
(or quasispecies) of FMDV was demonstrated during continuous replication in cell culture 
(Domingo et al., 2005).   
Mutant spectrum is determined by mutation frequency (defined as “the proportion of 
mutants in a population of genome”) and Shannon entropy (defined as “the proportion of 
 8 
different nucleotide sequences in a mutant spectrum), and change of mutant spectrum is 
reflected on quasispecies evolution and selection leading to emergence and dominance of 
mutants with distinct genetic and phenotypic features (Domingo et al., 1998).  There are 
some contributors to generation of diversity of viral quasispecies.  One, high viral replication 
frequency may render viral genome to have better chance of random point mutation.  Hanada 
et al. (2004) reported that RNA viruses possess various synonymous substitution rate, and 
replication frequency is mostly associated with the synonymous substitution rates under the 
similar replication error rate.  Two, replication error rate of RdRP has a close relationship 
with mutation level at every synthesis of new RNA viral genome.  Vignuzzi et al. (2006) 
demonstrated that a poliovirus phenotypic mutant (G64S within the finger domain of the 
viral polymerase) had high fidelity of RNA polymerase, and had more homogenous 
populations with low level of mutation in their genome, when compared to wild type.  Three, 
the level of mutation depends on the type of host (e.g. cell culture versus natural host) for 
replication. FMDV replication in different host even within cells or natural host produced 
diverse populations of viruses (Tami et al., 2003), indicating difference in the mutation rate 
and mutant spectrum among hosts.  Four, unknown host factors affect on the emergence of 
new viral population, through enhanced genetic mutation.  Gay et al (2006) reported that an 
avirulent strain of coxsackievirus B3 became pathogenic after passed once in old host, while 
the virus passed in adult host was not.  Sequence analysis of the viral genome showed 13 
specific nucleotide changes matched with sequence of virulent strain, which were responsible 
for the increased pathogenicity.  On the other hand, the virus passed in adult host showed 
only one nucleotide change.  Five, Specific environment during replication (e.g. plaque-to-
plaque passage, drug treatment and immune selection) induces population bottleneck.  
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Population bottleneck is an event that asexual or highly homologous subpopulation is 
selected or significant population is eliminated or prevented from propagating.  Repeated 
bottleneck restricts complexity of mutant spectrum, leading to loss of fitness and extinction 
of virus, while mutation is accumulated and accelerated.  Also, the population bottleneck 
positively selects a population to maintain infection in cells.  Since the theory about the 
fitness loss in Muller’s racket involving the plaque-to-plaque passages was proposed (Muller, 
1964), the first experimental evidence was obtained by Chao (1990).  Chao (1990) showed 
that plaque-to-plaque passages of RNA bacteriophage Φ6 resulted in loss of fitness, due to 
deleterious mutations during asexual replication.  Yuste et al. (2000) demonstrated bottleneck 
phenomenon during plaque-to-plaque passages of HIV-1 in which fitness loss appeared 
remarkable.  Bottleneck event may be also created by anti-viral drug treatment, inducing 
restricted diversification of viral population as shown with HIV-1 (Charpentier et al., 2006; 
Kitrinos et al., 2005).  In comparison, replication of FMDV with antiviral drug produced 
unexpected mutants which could not be observed in natural population of FMDV (Sierra et 
al., 2000).  The presence of other antiviral component such as immune pressure influences 
virus evolution.  During serial passage of FMDV in the presence of polyclonal antibodies 
against VP1, mutant population emerged and became a dominant population.  Crucial amino 
acid changes for escaping were observed on VP1 of the mutants, while not the viruses passed 
without the antibodies (Borrego et al., 1993).  Six, recombination within quasispecies have 
also great impact on generation of new viral population.  Recombination generated and 
expanded quasispeices diversity, in which emergence of mutants (i.e. drug-resistant mutant) 
were expedited (Moutouh et al., 1996; Rambaut et al., 2004; Kitrinos et al., 2005; 
Charpentier et al., 2006). 
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PRRSV evolution 
 
Genomic replication and transcription of arterivirus 
Genomic replication and transcription of arteriviruses involve RdRp, “strand-
transfer” mechanism, and the synthesis of subgenomic RNAs, which are potentially utilized 
to generate and increase complexity of the viral population.  
The genus Arterivirus is the group of small enveloped viruses with single-stranded, 
positive-sense RNA genome, belonging to the family Arteriviridae in the order Nidovirale 
that also contains the family Coronaviridae, Toroviridae and Roniviridae (Snijder et al., 
2005; Gonzalez et al., 2003).  The members of Arteriviridae have smaller-sized RNA 
genome (approximately 13-15kb) than members of other families in Nidovirale 
(approximately 26-32kb), not to mention that arteriviruses have the virion morphology 
distinct from other viruses of the Nidovirale.  Nonetheless, all nidoviruses share the 
similarity in genomic organization and gene expression strategies.  The genus Arterivirus is 
composed of Equine Arteritis Virus (EAV), Lactate Dehydrogenase-elevating Virus (LDV) 
of mice, Simian Hemorrhagic Fever Virus (SHFV), and Porcine Reproductive and 
Respiratory Syndrome Virus (PRRSV).    
Arterivirus infects various primary cells or cell lines, including 
monocyte/macrophage lineage cells which are common and preferential target cells of 
arteriviruses.  In vitro, PRRSV replicates in established cell lines, such as African green 
monkey (Cercopithecus aethiops) kidney cell line (MA104) and its clone (i.e., MARC-145), 
and CRL11171 (Collins et al., 1992; Conzelmann et al., 1993; Kim et al., 1993; Meng et al., 
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1994, 1996).  Primary cells that are permissive to PRRSV include monocyte/macrophage 
lineage cells, such as porcine alveolar macrophages (PAMs), peripheral blood monocytes, 
and pulmonary intravascular macrophages (PIMs) (Christianson and Joo, 1994; Meng et al., 
1996;  Molitor et al., 1992; Rossow et al., 1996).  In addition, porcine testicular germ cells, 
such as spermatids and spermatocids have been shown to have limited permissiveness (Sur et 
al., 1997).  PAMs are the most susceptible primary cell where PRRSV have demonstrated 
preferential replication (Bautista et al., 1993, Mardassi et al., 1994, Duan et al., 1998).  
MARC-145 cells have been shown to be more susceptible to PRRSV than MA104, 
producing high titer (up to 10 8.5 TCID50/0.1ml) (Kim et al., 1993).  
Entry to target cells has been confirmed to be achieved through receptor-mediated 
endocytosis.  Since heparin treatment with virus or heparinase treatment with erythrocytes 
reduced EAV-induced agglutination of erythrocytes, it was suggested that EAV may use 
heparin-like molecules on the cell surface for attachment (Sano et al, 1998).  In the case of 
PRRSV, it has been reported that the entry into the target cell was induced through clathrin-
dependent endocytosis mediated by interaction between cellular receptors and PRRSV 
(Nauwynck et al., 1999).  As of cellular receptors, viral matrix (M) protein or glycoprotein 
(GP) 5-M complex was demonstrated to interact with heparan sulfate of target cells (Delputte 
et al., 2002), which is present on most types of cells.  In addition, porcine alveolar 
macrophage-derived protein, sialoadhesin, also was shown to play a role in mediating 
internalization of type I or type II PRRSV (Vanderheijden et al., 2003).   Analysis of the two 
putative receptors (Delputte et al., 2005) showed that PRRSV attachment to target cells 
involved both of heparan sulfate and sialoadhesin, while sialoadhesin showed greater 
propensity for attachment and internalization of virus as compared to heparan sulfate that 
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was involved only in attachment of the virus at the low level.  Following internalization, low 
pH in the endosome was proven to be crucial for uncoating (Kreutz and Ackermann, 1996; 
Nauwynck et al., 1999).   Cellular factors may be essential for viral replication, since not all 
of cells expressing the cellular receptors were capable of supporting viral replication 
(Vanderheijden et al, 2003; Delputte et al, 2005).  Kim et al. (2006) demonstrated that one of 
cytoskeletal filaments, Vimentin, served as the part of receptor for PRRSV on the cell surface, 
and was involved in transportation of the virus inside cell by forming a complex with other 
cytoskeletal filaments.   
Following attachment, entry, uncoating and transportation inside of cell, genomic 
replication and transcription of arterivirus are initiated in the cytoplasm as expected for RNA 
viruses.  The processes induces production of plus strand progeny viral RNA, continuous 
minus strand RNAs, minus subgenomic RNA and subgenomic mRNA.   Open reading frame 
(ORF) 1, which comprises two-thirds of the genome, encodes the viral replicase complex 
(Conzelmann et al., 1993; Meulenberg et al., 1993).  Plus strand genomic RNA can serve as 
mRNA to be translated, which produces a total of 12-13 final products (Ziebuhr et al., 2000) 
and many intermediates from ORF 1 region, using the ribosomal frameshift mechanism (den 
Boon et al., 1991).  Two polypeptide, ORFs 1a and 1ab, are cleaved by a series of digestion 
of main (3C-like serine proteinase) or accessory (nsp1 papain-like proteinase and nsp2 
cystein proteinase) proteinases (Ziebuhr et al., 2000).  Transcription for expression of 
structural proteins produces 3’ co-terminal nested set of 6-9 subgenomic mRNAs 
(Conzelmann et al., 1993; Meng et al., 1996; Meulenberg et al., 1993; den Boon et al., 1991; 
Snijder and Meulenberg, 1998).  EAV and PRRSV produces 7 subgenomic mRNAs from 
ORFs 2 to 7, which are postulated or demonstrated to encode structural proteins: 
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glycoprotein (GP) 2a, 2b (E), GP3, GP4, GP5, Matrix (M) protein, and nucleocapsid (N) 
protein (Meulenberg et al., 1995; Snijder and Meulenberg, 1998; Wu et al., 2001; de Vris et 
al., 1992).  Currently, expression of most of structural proteins of other two viruses (LDV 
and SHFV) remains to be demonstrated from the subgenomic mRNAs.   
Typical genomic replication and transcription mechanisms of arterivirus are believed 
to be similar to those of coronaviruses.  Transcription may take advantage of two different 
mechanisms: a) discontinuous plus-strand RNA synthesis and b) discontinuous minus-strand 
RNA synthesis.  Both mechanisms require interaction between sense transcription-regulating 
sequence (TRS) in the leader sequence of the genome and anti-sense TRSs located in the 
body of the genome by “strand-transfer” process.  The first mechanism was proposed by Lai 
et al. (1982), because coronavirus infection could not demonstrate existence of minus strand 
subgenomic RNAs.  However, the detection of the negative strand subgenomic RNAs in cells 
infected with coronaviruses (Sethna et al., 1989) and arteriviruses (Conzelmann et al., 1993; 
Meulengberg et al., 1993; den Boon et al., 1996) supported the second mechanism, which 
was also demonstrated in transcription of recombinant EAV (de Vries et al., 2001) and 
investigation of leader-body junction sites in EAV (Pasternak et al., 2001).  Figure 1 
illustrates the process of plus or minus subgenomic RNA synthesis.   Viral genomic minus-
strand RNA, which is synthesized from 3’end of plus strand of viral genome, can be found as 
continuous strand for copy of progeny viral genome or discontinuous strand (subgenomic 
minus strand RNA) for synthesis of viral proteins (Sawicki and Sawicki, 1995; Pasternak et 
al., 2006).  For the synthesis of subgenomic minus strand RNA, the transcription initiated 
from 3’end of viral genome attenuates at different body TRS regions, which act as an 
attenuation signal, of the genomic template.  Through strand-transfer mechanism, the nascent 
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subgenomic minus strand that has anti-sense TRS relocates to the 5’end of the plus strand of 
genomic templates and interacts with leader TRS, and terminate the transcription to produce 
complete minus strand subgenomic RNA.  The minus strand subgenomic RNA become a 
template to generate subgenomic mRNA (subgenomic positive strand RNA), leading to 
translation of viral proteins (Pasternak et al., 2006).   
Leader TRS is highly conserved among members of each genus in the family 
Arteriviridae: UCAAC for EAV (den Boon et al., 1996), UAUAACC for LDV (Cheng et al., 
1993) and UUAACC for SHFV (Godeny, 1998).  For PRRSV, leader TRS appears to be 
UUAACC regardless of genotypes (Tan et al., 2001; Meulenberg et al., 1993).  In contrast, 
body TRSs have been shown to be diverse: [U/A/G][U/A/G][A/C][A/G][C/U]C among 
North American genotype, and U[A/U/C][A/G][A/C]CC among European genotype 
(Faaberg et al., 1998; Nelsen et al., 1999; Meng et al., 1996; Meulenberg et al., 1993).  The 
number and position of TRSs vary among body segments in North American strains.  In 
other words, multiple TRSs were identified at different sites on upstream of the start codon of 
some ORFs: ORF 3 (2; 83 and ) (Meng et al., 1996), ORF4 (2; 4 and 56) (Nelsen et al., 1999), 
ORF 5 (2; 40 and 111) (Nelsen et al., 1999) and ORF 7 (4; 9, 23, 127and 226) (Nelsen et al., 
1999; Lin et al., 2002), where numbers in the parenthesis indicates the number of TRS and 
site on upstream of the start codon of each body.  Body TRS of EAV was shown to be 
conserved (UCAAC) for 7 subgenomic mRNA.  Like PRRSV, EAV also had multiple 
numbers of TRS at different position: 3 for ORF 3, 3 for ORF3; 2 for ORF 4; 2 for ORF 5, 2 
for ORF 7 (den Boon et al, 1996; Pasternak et al., 2000).  The different species of 
subgenomic RNA may be involved in production of proteins in different sizes with various 
functions, since each ORF region contains multiple start codons, dependent upon time of 
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infection.  Further studies are needed to prove any relationship between existence of different 
species of subgenomic RNA and genetic variation of viral genome.  
 
Origin and divergence of PRRSV 
There have been a few controversial studies about the origin of PRRSV and 
divergence time (start date for independent evolution of the two genotypes from the most 
recent common ancestor) in swine.  The controversy is originated from data contents (test 
region, viral strains etc) and methodology used in those studies.  In general, divergence time 
in evolutionary study is estimated based on (overall) nucleotide substitution rate including 
non-synonymous substitution or synonymous substitution rate.  Synonymous substitution 
rate, in particular, is believed to represent mutation rate, because natural selection is less 
influential to fixation probability of synonymous substitution (Hanada et al., 2004, Miyata 
and Yasunaga, 1980; Nei, 1986).   
Kapur et al. (1996) investigated molecular diversity of 10 PRRS virus isolates of type 
II from USA in 1989-1992 and reported that ORF 6 is highly conserved and divergence time 
of PRRS viruses was estimated at the mid of 1980’s based on assumption that ORF 6 of 
PRRSV had a similar synonymous substitutions rate to influenza viruses (1.4×10-3 in 
hemagglutinin, 9×10-3 in neuraminidase) (Hayashida et al., 1985) in ORF 6.  Forsberg et al 
(2001) compared ORF 3 sequences of 44 PRRSV field isolates of type I obtained between 
1991 and 1999 from Denmark (30), UK (8), Italy (5), Netherland (1) and estimated that the 
rate of nucleotide substitution was 5.8×10-3 (95% confidence interval 4.8-6.9×10-3) per site 
per year.  The investigators suggested usefulness of ORF 3 as a molecular clock, which dated 
the most recent common ancestor to 1979. 
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Plagemann et al. (2003) proposed his hypothesis about the origin of PRRSV by 
comparing amino acid sequence of the GP5 ectodomains and N proteins of VR-2332 (type II 
prototype), Lelystad (type I prototype) and LDV.  The results of comparison suggested that 
PRRSV should have been derived from LDV, leading to the hypothesis that LDV was 
transmitted to wild boars in Europe and some wild boars harboring the virus were introduced 
to the United States in 1912.  From that time, independent evolution may have generated two 
distinct genotypes.  Meanwhile, Hanada et al. (2005) estimated divergence time of PRRSV at 
approximately 1980, using ORFs 3-5 sequences of 12 isolates of type II, one isolate of type I 
and one LDV, which were all isolated before 1995 excluding vaccine like isolates.  
Divergence time was calculated based on the rate of synonymous substitution which was 
examined by the distance-based (7.7±2.1×10-2) and maximum likelihood (4.74±0.3×10-2) 
methods.  However, this study was challenged by Forsberg (2005) who used different 
methodologies with the same isolates used by Hanada et al. and estimated overall rate of 
nucleotide substitution at 1.8×10-3 per site per year with wide confidence intervals.  This 
study concluded that common ancestor of two genotypes dated back to around 1880, which 
was largely in agreement with divergence time suggested in the hypothesis by Plagemann 
(2003).  
Origin and divergence time of PRRSV still remain to be elucidated by further study.  
However, when we consider the time gap between initiation of PRRS outbreak in the field 
and divergence time, long-term adaptation of PRRSV to pigs might have been a necessary 
step prior to PRRSV being a recognizable pathogen to pigs.   
 
Evolutionary change of viral population of PRRSV 
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Generally, viruses inducing acute and persistent infection showed significantly higher 
synonymous substitution rate than viruses inducing only acute or persistent or latent infection.  
This tendency was determined by replication frequency since those viruses had a similar 
replication error rate (Hanada et al., 2004).  PRRS virus has the synonymous substitution rate 
of 4.71-9.8 ×10-2 per year, which is significantly higher than the synonymous substitution 
rate of other RNA viruses, FMDV (8.2×10-3), Measles virus (2.3×10-3), influenza virus 
(7.0×10-3), vesicular stomatitis virus (7.0×10-5) and other 40 viruses (Hanada et al., 2004; 
Hanada et al., 2005).  When it comes to replication error rate, PRRS virus (3.7×10-5/ 
site/replication) (Hanada et al., 2004) is equivalent to other RNA viruses, such as foot and 
mouth disease virus (FMDV), influenza viruses, and vesicular stomatitis virus.  Therefore, 
PRRSV were shown to have high replication frequency, because it had similar replication 
error rate to other 4 RNA viruses (Hanada et al., 2005), but, the highest synonymous 
substitution error rate among compared 49 RNA viruses (Hanada et al., 2004; Hanada et al., 
2005).  The basic feature of evolution at the highest rate in PRRSV may have provided a 
higher chance for genetic change, and have been reflected on the current highly diversity in 
the field.  
 
Continuous change of viral population 
Several studies demonstrated that viral population of PRRSV changes during in vivo 
or in vitro replication.  Chang et al. (2002) studied the continuous change of viral populations 
during in vivo replication and estimated mutation rate during sequential pig-to-pig passages.  
Pigs were inoculated with a plaque cloned virus (CC-01) originated from VR-2332, and sera 
at 7 DPI were used for virus isolation by plaque cloning.  The sequential infections continued 
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up to 7th passage and all plaque-cloned virus isolates were sequenced for part of ORF 1b, 
ORF 5 and ORF 7.  The study showed different rate of mutational changes among different 
genes and emergence of a new predominant viral population at each passage through 
negative selection.  The mutation rate increased as mutational changes were cumulative over 
time, which was prominent in ORF 5.     
Sequential passages of PRRSV in cell culture was also shown to induce genetic 
change on Nsp 2, ORF 3, ORF 5 and ORF 6 of PRRSV genome, leading to the generation of 
diverse viral populations (or mutant spectrum) (Schommer and Kleiboeker et al., 2006).  
Mutant spectrum was the most in Nsp 2 but the least in ORF6.  Interestingly, although 
continuous cell passages of the virus were associated with increasing diversity of mutant 
spectrum, there was no change in the master sequence (both nucleotides and amino acids) of 
viruses isolated after the first or the third passage.  The results were somewhat contradictory 
to the observation from in vivo replication (Chang et al., 2002), in which no viral population 
contained sequence of ORF 5 of the original virus (CC-01) after the first passage.  These 
results suggested that PRRSV mutation may be influenced by host type and that PRRSV is 
genetically stable during in vitro replication.   Even if simple features of PRRSV about 
evolution was demonstrated by the previous studies, evolution on other structural protein 
genes (e.g. ORF 2, 2b, 3, 4, 6) need to be shown by further studies.  Functional and genetic 
features of those regions has been proposed: high variability of ORFs 2 and 3 (Forsberg et al., 
2002; Cha et al., 2006), neutralizing activity of ORF 4 (Weiland et al., 1999) and virulence or 
neutralization relevant to ORF 6 (Jiang et al., 2006; Madsen et al., 1998).  Therefore, 
exploration of evolution on those regions would provide interesting observation and 
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fundamental information about generation of mutants that has modified phenotypes.  
Moreover, combined comparison of ORFs 2-7 sequence may give us unexpected outcome.  
 Congenital infection of PRRSV can result in change of viral populations.  Rowland 
et al (1999) showed the emergence of a new viral population from piglet born to dam 
infected with VR-2332.  The new population had amino acid change (D34N) in ectodomain 
of ORF 5.  However, whether the change was specific to piglet was not shown.  Goldberg et 
al. (2003) investigated ORF 5 sequences of viruses isolated from two farms naturally infected 
with PRRSV in Illinois and found co-existence of multiple genetic variants within farms and 
individual pigs as described previously (Dee et al., 2001, Larochelle et al., 2003) and 
reported that the genetic variability within individuals (3.22%) were similar to that within 
each of the farms studied (3.84%).  Larochelle et al. (2003) showed that swine farms 
experienced with introduction of new strains (2-8) periodically.  Farms with persistent single 
strain infection for up to 3.5 years showed less than 2% of genetic variation. 
 
Emergence of new populations by recombination 
Kapur et al. (1996) compared ORFs 2-7 sequences of 10 field isolates of type II 
obtained from lung tissues.  Statistical analysis suggested intra-genotypic recombination in 
the ORFs 2-7 sequence except for ORF 6.  In vitro demonstration of recombination among 
PRRS viruses was made by inoculating two different vaccine strains of type II (i.e., 
RespPRRS® and PrimePac®PRRS) in MA-104 (Yuan et al., 1999).  The recombination event 
was investigated in regions encompassing ORFs 3 and 4 by differential RT-PCR and 
sequence analysis.  The results revealed recombination during in vitro replication.  The 
investigators also identified recombination in ORF 5 region of a field strains isolated from a 
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clinical case.  Type I PRRS viruses also showed recombination when those were infected 
into Marc-145 cells (van Vugt et al., 2001).  The recombination was observed mainly in ORF 
5 and also in ORF 4.  Interestingly, a molecular clone had some deletions in ORF 4, 
suggesting that diverse mechanisms may be involved in the recombination of PRRSV.  The 
recombination frequency among PRRS viruses had been estimated to be 2-10% in 1182 bp 
fragment (ORFs 3-4) (Yuan et al., 1999) and 0.1-2.5% in 621bp fragment (ORFs 4-5) (van 
Vugt et al., 2001), suggesting that the overall rate may vary depending upon the length of 
sequences to compare.   
However, the current recombination data cannot be direct evidence of recombination 
during in vivo replication.  First, the studies demonstrated the event during in vitro 
replication (cell culture).  Like as shown in the mutation pattern, recombination may appear 
differently in terms of occurrence, frequency, and regional preference, etc with regard to host 
type.  Second, the previous studies used molecular clones to examine recombination and 
failed to demonstrate the potential that recombinants would circulate as field isolates in 
swine farms.  Third, currently there is no information about field isolates of recombinants 
circulating in swine farms.  This information is tremendously important to understand 
generation of highly genetic diversity of PRRSV and to set up better efficient control 
measure (e.g. vaccine) and diagnostic methodology.  In addition, recombination between 
type I and type II PRRS viruses is another topic to be explored, since increasing co-existence 
of the two genotypes in the same region (Indik et al, 2005; Fang et al., 2007; ISU/VDL) has 
enhanced the possibility of recombinants among them. 
  
Genetic diversity among field isolates of PRRSV 
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 PRRSV has undergone independent evolution in type I and type II in North American 
and European countries, respectively, since PRRSV were adapted to pigs and separated to 
two different genotypes.  Field isolates of PRRSV are shown to be genetically distinct 
corresponding to geographical origin (Forsberg et al., 2002) and chronology of virus isolation 
(Pesch et al., 2005).  Molecular investigation of PRRSV field isolates has been fulfilled in the 
field mainly by examining ORFs 5 and 7 regions.  Nucleotide or amino acid sequence 
alignment, comparison, RFLP and phylogenetic analysis have been major tools to 
characterize genetic structures, identify the evolutionary point of viruses by classification, 
and predict antigenic distinctness.  Major genetic mechanisms, such as random mutation and 
recombination, are shown to be involved in generating the diversity of PRRSV (Chang et al., 
2002; Yuan et al., 1999; van Vugt et al., 2001).  Genetic divergence between type I and type 
II PRRS viruses ranged approximately from 55% to 70% (Forsberg et al., 2002; Key et al, 
2001; Cha et al., 2006) in full-length genome or ORF 5 nucleotide or amino acid sequences.  
It has been suggested that genetic variation in PRRSV is accumulative leading to the 
emergence of isolates genetically distinct from the current or past strains over time.  In type 
II PRRSV, direct evidence was shown with type II PRRSV in Europe.  Indik et al. (2005) 
demonstrated by partial sequence analysis that ORF5 of recent field isolates of North 
America genotype in Austria had 96.4-99.7 % nucleotide similarity to that of RespPRRS® 
vaccine virus while showing 95.5-99 % nucleotide similarity to Danish isolates whose ORFs 
2-7 harbored 99-99.3 % nucleotide similarity to the RespPRRS® vaccine virus (Madsen et al., 
1998), indicating further genetic deviation of field isolates of type II within Europe.  Besides, 
genetic distance of field isolate from North Amercia or other countries has been increased 
from VR-2332 or other isolates of early period of PRRS outbreaks, chronologically (Table 1).      
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Regarding type I PRRSV, genetic deviation among type I field isolates has been 
demonstrated to be more dramatic.  As examples, Pesch et al. (2005) compared ORF 5 
sequences of 66 European field isolates between 1991 and 2001, and demonstrated that 
nucleotide and amino acid sequence similarity of viruses (1998-2001) was 80.8-95.1 % and 
85.1-94.5 % to Lelystad, respectively, whereas that of 15 isolates (1991) was 93.9-99.7% and 
92-99.5% to Lelystad virus.  The 25 field isolates (1998-2001) showed 78.7-96.5 % and 
82.3-96.1% similarity in nucleotide and amino acid sequence, respectively, among them.  
These results revealed increase in the genetic distance among field isolates over time.  Mateu 
et al. (2006) compared ORF 5 sequence of 18 strains (1991-1995) and 46 field isolates 
(2000-2005) from Spain.   Sequence comparison showed that viruses collected between 1991 
and 1995 had 87.2-99.1 % of nucleotide sequence similarity to Lelystad, while the later 
isolates (i.e., 2000-2005) showed 81.7-94.9 %.  This study also echoed the dynamics of 
genetic changes among PRRS viruses over time even in the same geographic location.  
Further studies that supported on-going genetic variation of type I field isolates were 
summarized in Table 1  
The continuous evolution of field isolates was emphasized by recent studies on the 
genetic diversity of European strains proposing the potential to divide the genotype into 
subtypes.  Recently, many studies on the genetic variability of European PRRS viruses 
disclosed exceptionally diverse strains in Lithuania and Poland (Stadejek et al, 2002; 2006), 
Belarus (Stadejek et al., 2006) and Denmark and Italy (Forsberg et al., 2002), which were 
classified distinctively into independent clades in different ways from that field isolates from 
other countries, such as UK, France, the Netherlands, Germany and Spain, were classified 
(Le Gall et al., 1998; Forsberg et al., 2002; Stadejek et al., 2002; Mateu et al., 2006).  In 
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particular, the viruses from Lithuania, Poland and Belarus were proposed to be classified as 
subtypes within type I PRRSV (Stadejek et al., 2006).  As a matter of fact, the viruses 
genetically distant from Lelystad strain already were identified in Czech (v501, v503), which 
was isolated in 1996 and showed 88.1-88.9 % of ORF 5 nucleotide sequence similarity (Indik 
et al., 2000), and in Italy (PRRSV 2156) which was isolated in 1992 and classified with the 
Czech isolates (v501 and v503) or other Italian strains differently from Lelystad or Lelystad-
like viruses (Suarez et al, 1996; Forsberg et al., 2002; Indik et al., 2000).  
The above studies indicate that type I PRRS virus may have undergone faster 
evolution process than type II PRRS virus, producing genetic groups highly deviated from 
the past strains.  Two speculations may explain the exceptional diversity of European strains.  
First, based on the hypothesis by Plagemann (2003), type II PRRSV was originated from 
wild boars infected with PRRSV, which was initially emerged from European continent and 
became type I PRRSV.  Therefore, type I PRRSV might have more time to spread and evolve 
in pigs than type II PRRSV.  On the other hand, alternative speculation may account for the 
present unbalanced pattern of diversity in PRRSV.  In different ways from North America, 
European continent is composed of many countries that have their own borders, various laws 
or policies from production to consumption of livestock products, which would have 
restricted movement of live pigs or semen among countries.  In the end, distinct evolution of 
field isolates has been preserved with the geographical advantage.  However, recent 
globalization in trade and unification of European countries have presumably broken national 
borders and enhanced trade of live animal or semen substantially, which also has increased 
the possibility of digging-up of novel strains with distinct genetic elements in restricted area 
during transmission among pigs.  Based on both speculations, the fast branching-off of type I 
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PRRSV are attributed to an accidental discovery of highly diverse PRRSV circulating in 
isolated area for prolonged period.  
Genetic differences among field viruses tend to be associated with their geographic 
origins (Forsberg et al., 2002; Cha et al., 2006; Stadejek et al., 2006).  In contrast, Pesch et al. 
(2005), who observed increase in genetic distances between early and recent strains based on 
ORF 5 sequence analysis of 66 European isolates from 1991 to 2002, raised a view different 
from the previous studies about the relationship between the degree of genetic relatedness 
and the geographical origin of samples.  This study suggested that recent isolates broke 
geographical border line and the genetic relatedness progressively had lost close association 
with geographical origin.  In the same context, Goldberg et al. (2000) suggested that genetic 
variation among isolates from local area (Illinois and east Iowa) was similar to that from 
broader range of areas, maybe due to long-distance transportation of live animals or semen.  
Therefore, it is suggested that observation of field isolates without geographical distinctness 
may not be unusual and that current genetic diversity should be assessed using field isolates 
from the same region.   
Continuous introduction of new strains to farms would expedite the genetic diversity 
of PRRSV with the farms. Goldberg et al. (2000) reported that drastic genetic distance 
among field isolates from a farm was developed as a result of introduction of new strains by 
live animals or semen.  In contrast, Pesente et al (2006) suggested that that single strain 
infection did not make significant progress in genetic diversity over time.  Larochelle et al. 
(2003) demonstrated circulation of single strain in farms which showed less than 2% of 
genetic variation in ORF 5.  Collectively, genetic diversity of PRRSV is believed to be 
expedited through interaction of multiple strains.   
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Vaccination may have been additional source for the increase in genetic diversity and 
emergence of novel strains in the field.  This suspicion was supported by identification of 
field viruses that were highly close to vaccine strains (Indik et al, 2005; Cha et al., 2006; 
Thanawongnuwech et al., 2004; Madsen et al., 1998).  Artificial cutting-in of vaccine stain 
into the natural evolution of field PRRS viruses may disrupt geographical uniqueness and 
evolutionary line of PRRSV genetic profile, resulting in frequent identification of field 
isolates with close genetic relatedness with the vaccine or parental strains throughout the 
world. 
Co-infection of the two genotypes, European and North American genotypes, has 
been observed in the USA (European-like viruses that are typically classified into European 
genotype) (Fang et al., 2004; Ropp et al., 2004), Austria (Indik et al., 2005), Denmark 
(Madsen et al, 1998), China (http://www.ncbi.nlm.nih.gov/entrez/) and Thailand 
(Thanawongnuwech et al., 2004).  The gradual spread of European PRRSV in USA resulted 
in the increased detection frequency of the both genotypes in the same farm (ISU/VDL).  
Substantial difference in phenotypic features including antigenicity between the two 
genotypes may render difficulty in controlling PRRS particularly in swine farms with dual 
infection.  At the same time, simultaneous existence of multiple strains at any given time is 
not uncommon in swine operations due to introduction of new strains or continuous mutation 
of single viral population (Pesente et al., 2006; Dee et al., 2001; Yoon et al., 2001; Larochelle 
et al., 2003).  On-going genetic diversity of PRRSV in the field under the mixed infection 
may cause problem by resulting in the antigenic change of the highly diverse strains (Yoon et 
al., 1997), and low vaccine efficacy (Key et al., 2001; Labarque et al., 2004). 
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Evolution of other members of the genus Arterivirus 
Equine arteritis virus 
EAV has only one serotype and is divided into European and North American groups 
based on geographical origin.  EAVs from the two groups are genetically distinct, showing 
around 85% nucleotide sequence similarity in ORFs 3 or 5 (Balasuriya et al., 1995; Lepage et 
al., 1996; Archambault et al., 1997; Balasuriya et al., 1995) as well as full length genomic 
sequence (Balasuriya et al., 2004).  Analysis of partial regions of ORF5 and replicase gene of 
43 field isolates from Europe and the United States in 1953-1997 classified the isolates 
largely into two groups, group I and II.  Group I and II were mainly composed of viruses 
isolated from North America and Europe, respectively.  The groups can be further divided 
into subgroups (I.A and I.B or II.A, II.B and II.C), although some field isolates were 
categorized into different groups (CH1 and S1) which do not belong to either of group I and 
II (Stadejek et al., 1999).  Hornyak et al. (2005) attempted to classify 20 field isolates from 
Hungary and Austria (1997-2003) and 20 foreign strains into further subgroups, resulting in 2 
North American subgroups (I.A & I.B), and 4 European subgroups (II.A, II.B, II.C and II.D), 
based on ORFs 5 and 7 sequences.  Hungarian isolates (after 2000) belonged to North 
American groups (I.A and I.B) and European groups (II.A and II.B), while Hungarian 
isolates before 2000 and one Austrian strain was classified into II.D.  The most recent study 
(Mittelholzer et al., 2006) showed genetic diversity of partial ORF5 sequence among 120 
field isolates and proposed a new classification.  Accordingly, the isolates were classified 
into three large genetic groups (EAV-1 (II.A), 2 (I.A and I.B) and 3 (II.B)) and unclassified 
viruses.  EAV-1 and -2 were composed of European isolates and American isolates, 
respectively, while EAV-3 contained viruses isolated from both regions.  American viruses 
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of EAV-3 included isolate from a stallion which was imported from Europe as described in 
the previous study (Balasuriya et al., 1999).   Importantly, this study emphasized that 
classification of EAV should be based on the three major groups instead of the current two 
groups (European and American groups) in future.    
Glycosylated protein genes have been shown to be highly variable among structural 
protein genes of EAV, while ORFs 3 and 5 shows higher variability than other protein genes 
in most cases (Balasuriya et al., 1995; Balasuriya et al., 1999; 2001; Hedges et al., 2001).  
ORF3 sequences of several field isolates of European and American origins demonstrated 
genetic similarity of (85.3%-98.8%) (Lepage et al., 1996; Archambault et al., 1997).  Viruses 
(CW96 and CW01) isolated in 1996 and 2001 from stallions imported to North America 
from Europe showed approximately 88.0 % in nucleotide sequence similarity with EAV030 
(a prototype virus of EAV) in ORF3 or ORF5, respectively (Balasuriya et al., 2004).  
Interestingly, ORF4 showed the highest variability in the study by approximately 85% of 
nucleotide sequence similarity to EVA030.  GP3 and GP5 were marked by non-synonymous 
substitutions, indicating being under strong selective pressure during persistent infection 
(Balasuriya et a., 1999; Hedges et al., 1999, 2001).  In contrast, ORFs 6 and 7 were more 
conserved (Balasuriya et al., 2001).  Genetic variation was also observed in ORFs 6 and 7 of 
10 viral isolates from various countries (USA, Norway, Switzerland, Austria and Poland) in 
1953-1989 (Chirnside et al., 1994).  M and N proteins genes showed 91-99 % (96-100 %) 
and 95-99 % (97-100 %) similarity of nucleotide (amino acid) sequence with EAV030, 
respectively.  ORF6 sequence analysis also revealed geographic distinction among EAV 
isolates from Europe and USA as shown by sequence analyses for ORF5 and ORF3 (Sugita 
et al., 1994).  Sequence of ORFs 6 and 7 of isolates 5 years apart from stallions showed the 
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least nucleotide sequence similarity to EAV030 of approximately 92 % and 97 %, 
respectively (Balasuriya et al, 2004).    
Additionally, nsp 2 of isolates (CW96 and CW01) from stallions had been shown to 
be the highest variable region (87 % of nucleotide sequence similarity to EAV030) among 
non-structural protein genes (87 % - 98 % of nucleotide sequence similarity to EAV030) with 
insertion of a proline residue at position 407 (Balasuriya et al., 2004). 
Recombination in EAV was proposed by incongruent topology in phylogenetic 
analysis of ORFs 6 and 7 of the 10 viral isolates (Chirnside et al., 1994).  The event was also 
demonstrated during in vitro replication with higher frequency in the 3’ proximal region of 
the genome (Molenkamp et al, 2000).  Replication mechanisms of arteriviruses 
(discontinuous subgenomic mRNA transcription and strand transfer involving attenuation of 
minus-strand RNA synthesis at leader-body junction or TRS) may be involved in the 
predilection. 
Asymptomatic stallions can play a major role as a principal reservoir of EAV, 
transmitting the virus to mares during breeding season.  The virus can be shed and detected 
in semen for prolonged period of time since the virus establishes a persistent infection 
(Timoney et al., 1986; Patton et al., 1999; Hedges et al., 1999).  Genetic variation of 
structural protein genes of EAV, particularly ORF5, and changes in neutralization have been 
observed during persistent infection (Balasuriya et al., 1995; Glaser et al., 1995; St-Laurent 
et al., 1997).  Balasuriya et al. (1999) demonstrated high genetic stability (>99.9% of 
sequence similarity) among EAV during outbreak of equine viral arteritis (EVA) by 
analyzing ORFs 2-7 sequences (2822 bp) directly amplified from tissue samples (lung, 
spleen, lymph node and placenta) of affected foals.  In contrast, viruses from semen after 12 
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months of the initial infection became genetically distant (98.4%) from original virus that 
initiated the EVA outbreak, which was in agreement with research results reported by 
Hedges et al. (1999).  Field viruses that infected different individuals developed independent 
evolution, forming their own genetic group in a phylogenetic analysis.  Hedges et al. (1999) 
investigated sequence change of viruses isolated from semen of stallions that was infected 
with EAV in 1984.  Sequence analysis for ORFs 2-7 revealed that viruses shed yearly from 
the same stallions had a close genetic relatedness, and some of regions of ORFs 3 and 5 were 
shown to be highly variable sites.  The nucleotide sequence variation of ORFs 2-7 was 
estimated at approximately 0.9% and 1.3% on average per year for two stallions.  
Comparison of viral populations from 1984 and 1994 in the same stallion showed that viral 
population had been totally changed.  Nucleotide variation during persistent infection 
accompanies variability of neutralization sites, particularly in the V1 region, one of three 
distinct variable regions (V1-V3) of GL (GP5) protein (Balasuriya et al., 1999; Hedges et al., 
1999), leading to resistance to neutralization followed by modification of antigenic 
phenotype (Balasuriya et al., 1997; Hedges et al., 1999).  It was suggested then that EAV 
quasispecies changes during persistent infection, leading to the emergence of a novel 
genotypic and corresponding phenotypic variants.   
 
Lactate dehydrogenase-elevating virus 
LDV generally establishes long-term persistent infection without apparent symptoms.  
Virus infection has been prevalent in wild house mouse population (Mus musculis 
domesticus) in USA, Australia, Germany and UK (Rowson and Mashy, 1975; Li et al., 2000), 
as well as Asian Ricefield mouse (Mus caroli) (Rowson, 1980).  The well known strains, 
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such as LDV-P, LDV-vx, LDV-C and LDV-p, were originally isolated from laboratory mice 
such as M.musculus (Rowson and Mahy; 1975; Plagemann and Moennig, 1992; Chen and 
Plagemann, 1997).  Plagemann et al. (2001) and Chen et al. (1997) demonstrated coexistence 
of the different subpopulations that had different tissue tropism in host body.  LDV-C and –v, 
which were isolated from brain, had less replication activity in hosts and high susceptibility 
to the immune response when compared to LDV-P and –vx that has typical feature of LDV, 
such as extraneuronal tissue tropism, persistent infection, life-long viremia and asymptomatic 
infections in mice (Plagemann et al., 2001).   
Li et al (2000) isolated 4 LDV viruses from tissues of 243 wild mouse caught in 
America during 1984-1994.  Those viruses were very similar to LDV-P and-vx as for 
pathogenicity and immunological responses to peptide VP-3P ectodomains of LDV-P or 
LDV-C.  Analysis of GP5 (VP-3P) and GP2, expressed from ORF 5 and ORF 2, respectively, 
showed conservation in N-glycosylation sites (GP5 or GP2) and endodomains (GP5), 
indicating similar antigenic structure between the four viruses and LDV-P and/or –vx.   The 
four viruses shared 1.5-6.0% and 2.2-15.4% in ORF 5 and ORF 2 amino acid sequence 
similarities among them, respectively.  LDV-P or –vx shared 2.5-7.0% and 8.0-15.8% in 
ORF 5 and ORF 2 amino acid sequence similarities with the four viruses, respectively.   Most 
of divergences in amino acid sequence were shown in signal sequence.  Meanwile, the 
viruses showed highly genetic relatedness according geographical origin, suggesting 
independent evolutions of wild type of LDVs. 
 
Simian hemorrhagic fever virus 
Little has been studied about genetic variation and evolution of SHFV.   
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Impact of PRRSV evolution 
 
Biological implication  
 
Genetic diversity created by the two major mechanisms can results in extinction of a 
viral population or leads to the emergence of a minor population with genetically and 
phenotypically modified features within viral quaispecies.  The minor population may 
become a major population as selection mechanism (e.g., increased fitness, constraints like 
immune pressure or antiviral drugs, etc) comes into the equation or may remain as a 
dominant population in a restricted area within the host body.   
The transformed phenotypes due to molecular evolution can be seen in modification 
of pathogenicity or pathogenesis (Meyers et al., 1989; Harvala et al., 2005; Woo et al., 2006; 
Chen et al., 1997; Vignuzzi et al., 2006), cell tropism (Baranowski et al., 1998; Rieder et al., 
1994), escaping from host immune defense (Taboga et al., 1997; Tami et al., 2003; Weiner et 
al., 1995; Smirnov et al., 2004), resistance against anti-viral drugs (Charpentier et al., 2006; 
Moutouch et al., 1996; Rambaut et al., 2004), expansion of host range (Vignuzzi et al., 2006; 
Gay et al., 2006) or crossing species barrier (Van Reeth, 2007; Li et al., 2005) and creation of 
novel viruses in the genus (Holmes and Rambaut, 2004) or diseases (Kawaoka and Webster, 
1985).  
 Even if detailed mechanisms are not available for PRRSV, some studies provide clues 
to the potential impact of the genetic diversity particularly regarding biological features of 
the virus (e.g. virulence, replication, persistence in host, etc) and immunological response 
(e.g. innate or adaptive immune response) to the virus as genetic diversity of PRRSV is 
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generated and expanded over time.  There is evidence to support the argument that mutation 
may make an avirulent PRRSV be a virulent virus.  Danish PRRS outbreaks with type II 
PRRSV in 1997 was considered as an outcome of the reversion of the vaccine virus to 
virulence (Botner et al., 1997; Madsen et al., 1998).  Combined with epidemiological 
investigation, sequence comparison and phylogenetic analysis indicated that the viruses, 
which were responsible for the outbreaks, were closely related to the RespPRRS® vaccine 
virus.  Grebennikova et al. (2004) demonstrated that even single passage of an attenuated 
virus may recover phenotypes of the wild-type parental virus including virulence.  A virulent 
isolate, NADC-8 (2), was passed 251 times in MARC-145 producing NADC-8 (251).   The 
NADC-8 (251) was then back-passed in a pig once and examined the recovered virus (251P) 
for changes in full-length sequences at the level of nucleotide and amino acid as well as 
recovery of virulence in pigs.  NADC-8 (251P) induced viremia, even if the level is much 
lower than NADC-8 (2).  Pigs infected with NADC-8 (251) did not show viremia in the 
study.  Since the duration and level of viremia appears to be the most important criteria for 
determining the virulence of PRRSV besides pathological lesions and clinical signs (e.g. 
abortion) (Kwon et al, 2006), the virema could be considered to be reversion to virulence.  
Three amino acid changes in ORF 1a, ORF 1b and ORF 6 were shown to be responsible for 
the reversion, based on the deduced amino acid sequence of full-length genome.  Similarly, 
Chang et al (2002) reported that a virus (CC-01), which was passaged numerous times in cell 
culture (MARC-145 cells), showed different in vivo replication pattern after passage once in 
pigs.  While viremia at the first passage peaked at 28 DPI, that during the second passages 
reached the highest titer at 7-14DPI, as expected for most of virulent field isolates.  The 
reversion of attenuated or vaccine viruses to virulence has been studied in other viruses, such 
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as HIV (Berkhout et al., 1999), Poliovirus (Ogra et al., 1991).  Meanwhile, the reversion may 
appear differently depending upon host.  In the study performed by Gay et al (2006), when 
coxsackievirus B3, avirulent strain, was passed once in an old host (mouse), it became 
pathogenic, whereas the virus passed in adult host was not.  Genetic exchange mechanism 
would make great contribution to trade of viral virulence determinants among PRRS viruses, 
leading to virulence reversion.  Therefore, the use of a live virus vaccine may rather become 
an entangler than the most useful regime for control or eradication of the disease in a long-
standing view. 
 Establishment of persistent infection may require the involvement of various 
mechanisms, such as cell type (e.g. lymphocytes or macrophages) and infection site (e.g. 
central nervous systems, tonsils, etc), host immune response (e.g. ineffective innate or 
adaptive immune response), and biological characteristics of virus (e.g. mutation rates).  HIV 
and cytomegalovirus infects lymphocytes and macrophage to modulate host immune 
response to the virus avoiding their clearance by the host immunity.  Measles virus, rubella 
virus and herpesvirus protect themselves from attacking of host immune cells by infecting 
privileged sites such as central nervous systems.  Poliovirus and respiratory syncytial virus 
induce ineffective adaptive immune response by inhibiting presentation of MHC class I 
molecule on cellular surface.  Antigenic alteration during replication in single animal renders 
resistance against clearance by neutralizing antibodies of the host, resulting in persistent 
infection.  Failure of CD8 T cells is associated with persistent infection of HCV (Gruener et 
al., 2001, Kimura et al., 2005).  Escape mutants selected in the presence of neutralizing 
antibody in the host led to persistent infection of LCMV (Ciurea et al., 2000).  Persistent 
infection of PRRSV may use some of these common mechanisms, such as infection sites, 
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modulation of host immune response and high mutation frequency leading to generation of 
escaping mutants, even if how those mechanisms work on PRRSV has not been 
demonstrated.  Generation of specific mutation may induce advantageous outcome for 
persistent infection, which was demonstrated in EAV (Balasuriya et al., 1997; Hedges et al., 
1999).  In PRRSV, Rowland et al. (1999) recognized specific amino acid change (D to N) at 
residue 34 of GP 5 in PRRSV isolated from persistently infected pigs but failed to 
demonstrate the contribution of the change to the viral persistence. 
Continuous evolution of PRRSV during pig-to-pig passages in swine herd may result 
in phenotypes (e.g. antigenicity and biological features) of viruses.  Chang et al (2002) failed 
to show antigenic change of viruses obtained from seven sequential pig-to-pig passages using 
monoclonal antibodies and porcine polyclonal antibodies (against CC-01).  Further studies 
remains to be done to investigate the affection of sequential passages on antigenic as well 
biological changes. 
Antigenic diversity among field isolates has been predicted by analyzing deduced 
amino acid sequences of glycoprotein (GP) 5 (major envelope protein) among field isolates 
of type I and type II.  Commonly, most of variations were concentrated on N- and C-terminus 
of ectodomain (Plagemann et al., 2002), linear B cell epitope (Rodriguez et al., 2001; 
Ostrowski et al., 2002) and signal sequence (Pesch et al., 2005; Mateu et al., 2006; Stadejek 
et al., 2002, 2006; Cha et al., 2006; Andreyev et al., 1996; Key et al., 2001).  The most 
outstanding change was addition or deletion of N-glycosylation sites around the ectodomain 
(Key et al., 2001; Stadejek et al., 2006; Indik et al., 2000).  N-glycosylation may affect on 
protein structure, accessibility of antibody and immunogenicity of proteins, which are 
important for viral infection to, replication in and immune response of the host (Ansari et al., 
 35 
2006; Wissink et al., 2004).  The variability of amino acid sequence (particularly on 
ectodomain(s) containing neutralizing epitope and B cell epitope(s)) has the great potential to 
modify antigenic structure or reaction between antigen and antibody. 
 Adverse effect of genetic diversity on antigen-antibody reaction was investigated 
using a panel of monoclonal or polyclonal antibodies, being induced by antigenic diversity 
among field isolates.  Yoon et al. (1997) demonstrated difference in the susceptibility to 
neutralizing antibody among field isolates by performing a one-way serum-virus 
neutralization test with hyperimmune polyclonal porcine antibody monospecific for ISU-P 
against 17 field isolates of North American genotype.  Immunofluorescence microscopy with 
monoclonal antibodies showed different reactivity with viruses or viral proteins between type 
II and type I PRRSV or among field isolates of each genotype (Nelson et al., 1993; Drew et 
al., 1995; Yoon et al., 1995; Yang et al., 2000).  The aberration shown in antigen-antibody 
reaction and the adaptive immune responses become a stem of concern for the vaccine 
efficacy and may explain co-existence of extraneously introduced viruses in a farm.  Lager et 
al (1999) described that protection conferred by previous exposures was only effective 
against challenge of the homologous strain.  Subsequently, Lager et al. (2003) reported that 
gilts vaccinated with RespPRRS® developed little or no viremia following challenge of 20 
different field strains but underwent reproductive failure, indicating incomplete protection.  
Mengeling et al. (2003) demonstrated that pigs vaccinated with one of three attenuated 
strains (NADC-8, 9 and 14) of North American genotype, which share approximately 93-
97 % nucleotide sequence similarity, were protected only from viremia of homologous 
virulent strains, providing evidence of strain specificity in protective mechanism.  In the 
study performed by Labarque et al. (2004), pigs were vaccinated with vaccine strain DV 
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(porcilis® PRRS) and challenged with Lelystad or an Italian strain, which have 97% and 87% 
identity with the vaccine strain at amino acid level of ORF 5, respectively.  The vaccination 
resulted in elimination of Lelystad virus in BAL fluid and serum of the pigs, but not the 
Italian strain, suggesting the adverse affect of genetic variability on the vaccine efficacy.  
These results suggested that diversity of PRRSV can pose a potential obstacle in vaccine 
efficacy. 
 
Diagnostic implication 
Besides general PRRS clinical symptoms and pathological lesions as outcomes of 
PRRSV infection, there are various molecular diagnostic methods to define PRRSV 
infection: RT-PCR, sequencing, phylogenetic analysis, multiple alignment & sequence 
comparison.  RT-PCR is the fastest as well as the most sensitive method to detect viral 
genome, being widely used in the diagnosis of PRRSV from serum, feces, semen, tissue and 
organs, at present.  Sequencing will provide direct information of the viral genome.  Other 
analytic methods following sequencing, such as multiple alignment or phylogenetic analysis, 
lead to elucidation of genetic relatedness among field isolates and final conclusion of the 
origin of the isolates.  The molecular diagnostic methods have been conducted for diverse 
purposes: genetic typing and diversity of field isolates (Mengeling et al., 1997; Mateu et al., 
2003; Pesch et al., 2005), evolution study (Chang et al, 2002; Pesch et al, 2005; Hanada et al., 
2005; Forsberg, 2005), epidemiological study (Forsberg et al., 2002; Stadejek et al., 2006; 
Dee et al., 2001; Pesente et al., 2006).  Most of studies have been performed with ORFs 5 
or/and 7 sequence. 
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Accuracy of the molecular studies has been threatened by evolutionary features of 
PRRSV.  Many studies that have explored genome of PRRSV and genetic relationship 
among isolates have disclosed some characteristics regarding PRRSV evolution, which may 
lead to diagnostic failure.  Continuous mutation on PRRSV genome may lead to generation 
of multiple strains (Chang et al., 2002).  Presence of multiple strains in a farm (Pesente et al., 
2006; Dee et al., 2001; Yoon et al., 2001; Larochelle et al., 2003) is believed to be an 
aftermath of mutation of a single virus during circulation in a farm or external introduction of 
new strains.  Unfortunately, if the genetic difference is not dramatic, it is difficult to define 
the source of diverse strains by genetic variation and phylogenetic analysis.  Information on 
how far extraneous strains are different from viruses from natural evolution of single strain is 
not available.  Interestingly, mutation rate per year obtained by Larochelle et al. (2003) 
where there was no evidence of extraneous introduction of new strains resulted in less than 
2% of genetic variation in ORF5.  However, the estimation in the study may be irrelevant to 
the field because it was a descriptive study that has less control over variables (exact number 
of strain in the farm, management condition etc).  Experimental estimation of genetic 
variation by natural evolution in the field may not be possible due to lots of variables (e.g. 
management, disease history etc) in farms that affect on the result.  Nevertheless, it is sure 
that even approximate estimation about buildup of the genetic variation in the field under 
experimental single strain infection or multiple strains infection may become greatly useful 
information to keep track of viral origin in farms being affected by PRRS.  Meanwhile, 
molecular diagnosis may require test region to be expanded beyond only ORF5 or/and ORF7.  
Since regional preference and host dependence of mutation rate were shown in the previous 
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studies (Chang et al., 2002), size of test region may positively correlate with probability of 
correct diagnosis.   
Restriction fragment length polymorphism (RFLP) pattern of PRRSV was proposed 
to be used to differentiate vaccine or VR-2332 like viruses (2-5-2) from other isolates by 
digesting amplified PCR products of ORF5 with three different restriction enzymes (i.e. MluI, 
HincII and SacII) or analysis of ORF5 sequence (Wesley et al., 1998).  Since then, the 
differential method had been being used in numerous epidemiological studies (Cai et al., 
2002; Cheon et al., 2000; Itou et al., 2001; Umthun et al., 1999).  However, when the 
outstanding feature of highly genetic variability in PRRSV is taken into consideration, the 
RFLP might not be a stable method since even a single synonymous change would modify 
the pattern.  In many cases, diagnosis (ISU/VDL) of PRRSV recognized large number of 
cases showing viruses that had high nucleotide sequence similarity to vaccine virus 
(RespPRRS®), while having different RFLP pattern from the virus.  Therefore, the 
uncertainty of the method needs to be demonstrated experimentally.  
Recombination is most responsible for destruction of molecular clock, and may result 
in false description about origin of viruses because even a small level of recombination may 
hamper estimation of evolutionary point (Schierup and Hein, 2000).  Based on currently 
published data, neither direct evidence of recombination during in vivo replication nor 
information regarding occurrence and frequency of recombination in the field is at hand.  
However, recombinants from in vitro replication or clinical samples (Yuan et al., 1999; van 
Vugt et al, 2001) may imply the circulation of recombinants with mosaic structures 
composed of genetic elements originated from more than two strains.  Due to the propensity 
of recombination at 3’ end of genome in equine arteritis virus (Molenkamp et al., 2000), 
 39 
recombination in structural protein genes of PRRSV is likely to occur with higher frequency 
than non-structural protein genes.  The recombination may lead to unfavorable effect on 
diagnosis of PRRSV currently using ORF5 or/and ORF7.  For example, one extraneous 
strain (B), which is different from an existent virus (A) in a farm in terms of genetic 
relatedness and phenotypic including virulence, is introduced to the farm.  Then, genetic 
exchange encompassing whole ORF5 region would produce novel strains that may harbor 
ORF5 of A strain but maintain phenotypic features of B strain.  If a diagnosis is performed 
with ORF5 sequence of the recombinant, false diagnostic results would be obtained by 
considering the virus to be A strain.   Therefore, to avoid incorrect diagnosis caused by 
recombination may take the test region to be larger or multiple regions to be targeted.  
However, direct evidence of recombination during in vivo replication and assessment of 
frequency of recombination in the field isolates should be provided first as fundamental 
information, which would give us clues about features of PRRSV recombination.  Based on 
the information, we might be able to locate hot-spot as well as unpopular region for cross-
over, which would become useful targets to determine the origin of field isolates.  In fact, 
examination of recombination in many studies has involved multiple regions on the same 
genomic strand, in which incongruent topology in phylogenetic analysis becomes strong 
evidence of recombination (Lindberg et al., 2003; Lukashev et al., 2005; Simonds and Welch, 
2006; Coyne et al., 2006). 
 
Conclusion 
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Collectively, studies about evolution of PRRSV may suggest that 1) basically 
common genetic mechanisms (random point mutation and recombination) have led to 
creation of genetic diversity of PRRSV, and 2) biological features of PRRSV, such as high 
replication frequency, high level of evolution rate (overall nucleotide or synonymous 
substitution rates) and persistent infection by diverse mechanisms (infection site, immune 
escape, immune modulation etc), have expedited evolution of PRRSV.  Currently, even if 
two genotypes have underwent steadily independent evolution in their own regions, spread 
and evolution of alternative genotype in each region have been increased and accelerated 
over time.  Meanwhile, spurred genetic deviation of type I PRRSV in Europe has been shown 
to be manifest in recent days, whose reason remains to be elucidated.   Despite the present 
evolutionary features of PRRSV disclosed by numerous studies, strong evidence 
encompassing detailed pattern or mechanism of PRRSV evolution is required to provide 
basic information for future epidemiological or evolutionary studies and development of new 
control measures. 
PRRSV evolution may be reflected on phenotypic modification, such as protein 
structure, antigen-antibody reaction, immunogenicity, infection pattern, and virulence, which 
need to be answered under well-designed experiments.  Currently, some studies are 
suggesting that continuous genetic changes were attributed to reversion of virulence and 
adverse effect on vaccine efficacy.  Diagnostic efficiency is also greatly affected by the 
evolution.  Knowledge about PRRSV evolution would be essential information to invent and 
implement new diagnostic methods with better efficiency.  In particular, information about 
genetic variation induced by natural evolution in the field may enable us to locate the origin 
of viruses with higher accuracy.   
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Figure 1. The process of discontinuous plus-strand and minus-strand RNA.  This figure was 
adapted from Snijder et al. (2005)  
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Table 1. Genetic variability among filed isolates of type I and type II PRRSV 
 
 
 
 
 
No.of isolates 
 (Isolation Place) 
Isolation 
year 
ORF Sequence similarity 
:nucleotide or amino acid 
Reference 
Type II PRRSV  
9 (USA) 1989-
1992 
ORFs 2-7 
ORF 5 
92.1-97.5 % among isolates 
87.4-94.4 % among isolates  
90.4-95.9 % to VR-2332 
Kapur et al. (1996) 
22 (the US, 
Guatemala, Canada) 
1989-
1994 
ORF 5 91-95 % (89-94 %) to VR2332 Andreyev et al. 
(1997) 
8 (USA) 
 
1998 ORF 5 88-95 % (88-96 %) among isolates 
87-97 % (84-96 %) to other preivous 
isolates 
Key et al (2001) 
8 (Thailand) 
 
2000-
2002 
ORF 5 89.1-100 % among isolates 
83.7-85.2 % (83.5-85.5 %) to VR-2332 
Thanawongnuwech 
et al. (2004) 
250 (Canada) 1998-
2002 
ORF 5 84-100 % (78.5-100 %) among isolates Larochelle et al. 
(2003) 
23 (Korea) 
12 (USA) 
2002-
2003 
ORF 5 (Korean isolates) 
87.6-100 % among isolates 
88.9-99.7 % to VR-2332 
(US isolates) 
83.9-99.8 % among isolates 
85.9-99.5 % to VR-2332 
Cha et al. (2006) 
Type I PRRSV  
14  1991-
1995 
Partial 
ORF 5 
87.1-99.2 % among isolates Suarez et al. (1996) 
22 (Lithuania, Poland) 2000 Partial 
ORF 5  
(97-528) 
~72.2 % among isolates 
~71.5 % to the previous isolates (1997) 
Stadejek et al. 
(2002) 
6 (Thailand) 2001-
2003 
ORF 5 84-100 % among isolates 
87.5-98.5 % (88.3-98.5 %) to Lelystad 
Thanawongnuwech 
et al. (2004) 
66 (European 
countries) 
1991-
2001 
ORF 5 (1991 isolates) 
93.9-99.7 % (92-99.5 %) to Lelystad 
(1998-2002 isolates) 
80.8-95.1 % (85.1-94.5 %) to Lelystad 
78.7-96.5 % (81.1-96.1 %) among 
isolates 
Pesch et al. (2006) 
64 (Spain) 1991-
2005 
ORF 5 (1991-1995 isolates) 
87.2-99.1 % to Lelystad 
(2000-2005 isolates) 
81.7-94.9 % to Lelystad 
Mateu et al. (2006) 
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Abstracts 
 
Field isolates of porcine reproductive and respiratory syndrome virus (PRRSV) have 
demonstrated a high degree of genetic and antigenic variability, which imposes a difficulty in 
controlling the disease.  Our previous study showed that ORF5 (major envelope protein gene) 
of PRRSV continued to mutate during 367-day replication in pigs while polymerase gene 
(ORF1b) and nucleocapsid gene (ORF7) of the virus remained unchanged.  The present study 
maintained pig-to-pig passages of a plaque-cloned virus derived from VR-2332 in 3 
independent lines of in-vivo replication for additional 360 days (i.e., a total of 727 days) and 
assessed genetic and antigenic variation of ORFs 2a, 2b, 3, 4, 5, 6 and 7 encoding for 
structural proteins [i.e., GP2a, 2b, GP3, GP4, GP5, membrane (M) and nucleocapsid (N)] 
over time.  All genes continued to mutate at varying rates throughout the study.  Within 
individual pigs, the dominant variant (on both nucleotide and amino acid sequence basis) 
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differed from one passage to the next, even within the same line of passages.  Non-
synonymous change and transition were main mutational types although synonymous change 
increased over passages.  On average, the nucleotide sequence mutation rates of ORFs 2, 3 
and 5 (0.62-0.78%) were higher than those of ORFs 4 and 6 (0.41-0.45%) per year.  ORF7 
showed the least variability (0.22% per year) among all structural genes.  Mutation rates and 
patterns varied among passage lines, suggesting that host factor(s) may also influence the 
development of RNA quasispecies.  Mutational changes were immunologically important as 
resistance to neutralization was significantly (p<0.0001) increased in plaque-cloned viruses 
from P7 and P13 of line B and P7 of line A.  In conclusion, PRRSV evolves continuously in 
infected pigs, which is attributed to continuous and concurrent mutations in genes for all viral 
structural proteins, leading to antigenic modification.   
 
Introduction 
 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a viral pathogen 
which causes significant economic losses in swine industry (39).  PRRSV infection induces 
subclinical to severe respiratory distress in pigs of all ages and reproductive problem such as 
mid to late-term abortion or increased premature farrowing in breeding sows (7, 19, 21, 48).   
PRRSV is a small enveloped virus with single-stranded positive-sense RNA genome 
(approximately 15kb) which belongs to the family Arteriviridae.  The genome consists of 
nine open reading frames (ORFs) that are expressed through the production of a nested set of 
subgenomic 3’-coterminal mRNAs (9, 34, 35).  ORF1, which comprises approximately two-
thirds of the genome, encodes the viral RNA-dependent RNA polymerase complex and 
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proteinase (9, 35).  ORFs 2 to 7 are postulated to encode seven structural proteins.  GP2a (29-
30 kDa), GP3 (42-50 kDa), GP4 (31-35 kDa) and GP5 (a.k.a. E; 25 kDa) that are encoded by 
ORFs 2a, 3, 4 and 5 respectively are believed to be associated with the viral envelope, where 
GP stands for “glycoprotein” and the number designates the ORF from which it is expressed.  
Products of ORFs 2b, 6 and 7 are 2b, matrix (M) protein and nucleocapsid (N), respectively 
(34, 36, 58).  T cell epitopes (GP2a, GP5 and M) (1), B cell epitopes (GP3, 4 and 5) (40, 47) 
and neutralizing epitopes (GP4, 5 and M) (42, 45, 57) have been found on these structural 
proteins.  Sequences of those epitopes have not been determined except for neutralizing 
epitope on GP5 (45).    
PRRSV has shown numerous outstanding characteristics.  One of those is remarkable 
genetic variability among PRRS viruses in the field as expected for RNA virus.  Accordingly, 
there are 2 distinct genotypes: type 1 (European) and type 2 (North American) which share 
similarity of 55% to 70% (5, 13) in full-length genome or ORF 5 nucleotide sequences.  
Genetic variation among field isolates also has been well documented within each genotype 
by numerous field-based molecular epidemiology (5, 23, 29, 32, 43, 52).  Genetic variation 
obviously corresponds to the antigenic variability among PRRS viruses.  Yoon et al. (1997) 
demonstrated difference in the susceptibility to neutralizing activity of antisera, which were 
raised against a PRRSV strain, among field isolates of type 2 PRRSV.  Analyses using panels 
of monoclonal antibodies further showed different reactivity patterns with viruses or viral 
proteins between North American and European genotype or among field isolates of each 
genotype (12, 38, 59, 62). 
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Under experimental conditions, PRRSV has been shown to evolve continuously during 
replication in pigs (4, 6). Chang et al. (2002) assessed genetic changes in ORF 1b, 5 and 7 
during sequential pig-to-pig passages of a plaque-clone virus (CC-01) and observed that the 
mutational rate was high in ORF5 while ORF1b and ORF7 of the virus remained unchanged 
during 365-day in vivo replication.  Dominant genotype of PRRS viruses recovered at each 
passage were negatively selected, and showed the independence of mutational pattern and 
kinetic in the three independent pig lines.  Cha et al. (2004) maintained pig-to-pig passages 
of the CC-01 in 3 independent lines of in vivo replication for another 360 days (i.e., a total of 
727 days).  Sequence analyses of all descent isolates for ORF5 revealed continuous and 
accumulative mutational changes at a rate of approximately 0.78% per year.  The present 
study was to assess the molecular evolution of all PRRS viral structural protein genes during 
continuous in vivo replication through sequential pig-to-pig passages and its impact on the 
antigenic profile related to cross neutralization.  
 
Materials and Methods 
 
Viruses, cells, and media.     The North American prototype PRRSV ATCC VR-2332 
(American type Culture Collection, Manassas, VA, USA) was propagated on MARC-145 
cells, a highly persmissive clone of the African monkey kidney cell line MA-104 (24).  A 
highly homologous challenge virus (CC-01) was prepared by three rounds of plaque-cloning 
of the VR-2332 strain in MARC-145 cells (6).  The cells were cultured and maintained in 
Dulbecco’s modified Eagle’s medium (DMEM; Sigma Chemical Co., St Louis, MO, USA) 
supplemented with 10% fetal bovine serum (HyClone Laboratories, Inc., Logan, Utah. USA), 
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and gentamicin (Sigma) and amphotericin B (Sigma) at a concentration of 50µg and 0.25µg, 
respectively, per 1 ml of the medium (hereafter DMEM growth medium). 
Animal, inoculation and sampling.     The design of animal passage, as well as animal, 
housing and care, was well described in the previous study (Cha et al, 2004; Chang et al, 
2002).  In brief, the experiment began by inoculating PRRSV-naïve pigs with the highly 
homogeneous CC-01 derived from VR-2332 by 3 rounds of plaque cloning. Three 
independent pig lines (A, B and C) of in vivo virus replication were established and 
monitored over 13 animal passages (P1 to P13) representing a total of 727-day in vivo 
replication.  Pigs in a fourth line (D) served both as mock-infected negative controls and 
environmental sentinels.  All animal care and handling was done according to the 
Institutional Animal Use Committee of the Iowa State University.   
For each passage, pigs (10 to 14 days of age) were purchased from a closed herd 
historically free of PRRSV and housed individually in HEPA-filtered isolation units with 
feeder, water supply and automated flushing system during each passage.  Pigs 1A, 1B and 
1C were inoculated with the CC-01 and P2 to P13 were inoculated with a tissue filtrate from 
the corresponding pig in the previous passage.  Each passage took 60 days.  At each passage, 
serum samples were collected from all pigs periodically and used to monitor viremia and 
antibody response to PRRSV.  At the end of passage, all pigs were necropsied and a variety 
of tissue besides whole blood and serum were collected from each pig.  In addition, 15 viral 
plaque clones (biological clones) were directly isolated from day 7 serum of each pig at each 
passage for genetic characterization of ORFs 2a, 2b, 3, 4, 5, 6 and 7, and assessment of their 
susceptibility to neutralizing activity of antisera (n=3) generated against the CC-01. 
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PCR and sequencing.     A total of 210 plaque-cloned viruses were sequenced for ORFs 
2 to 7 (except for ORF5 of all clones, ORFs 5 and 7 of 15 clones from the CC-01 inoculum, 
and ORF 7 of viruses from P1, P3 and P7), i.e., 15 clones from the CC-01 inoculum, 45 
clones each from P1 (day 7 of in vivo replication), P3 (day 127 of in vivo replication) and P7 
(day 367 of in vivo replication), and 30 clones each from P10 (day 547 of in vivo replication) 
and P13 (day 727 of in vivo replication).  Fifteen plaque-cloned viruses from the CC-01 
inoculum were included in each sequencing reaction to assess the homogeneity of the 
inoculum and any random mutation(s) which could be introduced during reverse 
transcription-polymerase chain reactions (RT-PCRs) or sequencing reactions.  Viral RNA for 
RT-PCR and sequencing was extracted from each plaque-cloned virus with a QIAamp viral 
RNA minikit (Qiagen Inc., Valencia, CA, USA) by following the protocols recommended by 
the manufacturer. Viral RNA was collected and stored at - 80°C until used. 
For PCR amplification of ORFs 2, 3 and 4, RT was performed with 5 µl of extracted 
RNA for 1 hr at 55°C using a primer (PR13863R) 5 pmol in a tube containing reverse 
transcriptase 100U (Superscript® III reverse transcriptase; Invitrogen, Grand Island, NY, 
USA), 0.4mM dNTP, 5X first strand buffer and ribonuclease inhibitor 20U (RNaseOUT®; 
Invitrogen).  After the reverse transcriptase was inactivated at 65°C, 5µl of synthesized 
cDNA was added to a tube containing primers (PR11933F 5 pmol and PR13863R 5 pmol) 
(Table 1), 4 units of rTth DNA polymerase which has proofreading activity, 0.2mM dNTP, 
1X XL PCR buffer, 1.2mM Mg(OAc)2 and water (GeneAmp® XL PCR kit; Applied 
Biosystems, Foster City, CA, USA).  The PCR was performed with a thermocycler 
(GeneAmp PCR system 2400; PE Biosystems, Foster City, CA, USA) at 94°C for 1 min; 
then, 16 cycles of denaturation at 94°C for 15 sec, annealing and extending at 68°C for 3 
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min; and 12 cycles of denaturation at 94°C for 15 sec, annealing and extending at 68°C for 3 
min, increasing 15 sec for annealing and extending time at every cycle.   After the last cycle, 
the extension period was maintained at 72°C for another 10 min, and then all final products 
were stored at 4°C until used. 
ORF6 and ORF7 RT-PCR were performed as described previously (Chang et al., 2002) 
except for the use of a pair of sense (P6F) and antisense (P6R) primers (for ORF6), and a pair 
of sense (P7F) and antisense (P7R) primers (for ORF7) (Table 1), and 55°C (for ORF6) and 
58°C (for ORF7) instead of 50°C for the annealing process. 
To confirm the positive reaction, 2 µl of the final products was separated by 
electrophoresis in a 1% agarose gel (Amresco Inc., Solon, Ohio, USA) containing 0.1% 
ethidium bromide in Tris-borate-EDTA buffer.  The positive products were visualized and 
photographed under UV light, and the remaining products were stored at 4°C until used. 
Sequencing of ORFs 2, 3, 4, 6 and 7 was performed at the Iowa State University Nucleic 
Acid Facility (Ames, IA, USA) by using 30 µg/µl of purified PCR product and 5 pmol of 
each primer.  Primers PR11933F, PR13863R, PR12202F, PR12712F, PR13254F, PR13342R, 
PR12809R, and PR12478R were used for ORFs 2, 3 and 4, and primers P6F and P6R were 
used for ORF6, and P7F and P7R were used for ORF7 (Table 1). 
Virus neutralization assay.  One-way virus neutralization (VN) assay with constant 
antibody (1:8 VN titer) and various virus concentrations (100 to 10-6 dilutions) was 
performed as described previously (6, 59) to compare the relative susceptibilities of pig-
derived plaque-cloned virus isolates to the neutralizing activity of antisera generated against 
the CC-01 and to screen for potential escape mutant viruses.  A total of 135 plaque-cloned 
viruses were examined in the VN assay, i.e., 15 clones from the CC-01 inoculum, 45 clones 
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from P3 (15 clones from each of three pigs), 45 clones from P7 (15 clones from each of three 
pigs) and 30 clones from P13 (15 clones from each of two pigs).  The relative susceptibility 
of plaque-cloned viruses was calculated with the following equation and was expressed as 
the reduction index (RI):  Reduction in titer of each viral clone ÷ Mean reduction in titers of 
15 plaque-cloned viruses derived from CC-01, where reduction in titer means the net 
difference in virus titer (TCID50) in the absence and presence of antiserum.  The smaller RI 
indicated the higher resistance to pig polyclonal antibody against CC-01 virus. 
Virus titration.     A microtitration infectivity assay was performed to assess the titer of 
the viruses used in VN assay, following the procedures described in the previous study (6).  
The cells were monitored daily for cytopathic effects (CPE) for up to 5 days.  The replication 
of PRRSV in the inoculated cells was determined based on the observation of virus-specific 
CPE.  Virus titers were determined by using the method described by Reed and Muench 
(1938) and were expressed as TCID50 per milliliter. 
Analysis of data.     The sequence data of viral clones were analyzed by Lasergene® 
software (DNASTAR Inc., Madison, WI, USA) and compared to CC-01 to evaluate the 
degree and location of mutation over time.  Sequence alignment was done using Clustal W 
method (56).  The mutation rates were calculated as the proportion of substitutions with 
regard to the CC-01 and were expressed as mean percent change from plaque-cloned viruses.  
Frequency of non-synonymous change was calculated as a ratio between the number of 
amino acid variants with changes at the specific position of amino acid sequence and total 
number of amino acid variants of each ORF. 
Data from the VN assay were summarized by using the mean RI for each set of a plaque 
cloned virus isolate and 15 CC-01 plaque-cloned viruses.  Plaque-cloned viral isolates with a 
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RI statistically smaller (p<0.0001) than mean RI of the 15 CC-01 plaque-cloned viruses were 
considered as VN escape mutants.  
For differences in mean mutational change and mean RI of plaque-cloned viruses, linear 
regression curve and regressional coefficient value (r2) were analyzed by two-factor ANOVA 
test (SAS).  
 
Results 
 
A total of 210 viruses (CC-01=15, P1=45, P3=45, P7=45, P10=30 and P13=30) were 
sequenced for ORFs 2-7 including 15 clones from CC-01. Sequences of ORF5 of all clones, 
ORFs 5 and 7 of 15 clones of CC-01 inoculum and ORF 7of viruses from P1, P3 and P7 were 
obtained from the previous study (4, 6) for comparison purpose.  PRRS viruses in Line A 
could not be passed to subsequent pigs after P7 as described previously (4)  
Genetic characterization of CC-01 inoculum.     Sequences of ORFs 2a (771 bp), 2b 
(222 bp), 3 (765 bp), 4 (537 bp), and 6 (525bp) and 7 (372 bp) were obtained for the 15 
plaque-cloned viruses derived from the CC-01 inoculum and were identical among the all 15 
clones.  Nucleotide sequences of ORF5 (603 bp) and ORF7 (372 bp) obtained during 
repeated sequencing attempts in this study were identical as described in the previous study 
(6).  Collectively, this result demonstrated the high homogeneity of the original virus 
inoculum, proving that no random mutation was introduced during PCR and sequencing, and 
provided a baseline for comparing and contrasting virus clones recovered in later passage. 
Relative to VR-2332, the CC-01 had nucleotide substitutions in various ORFs.  The 
ORF2a nucleotide sequence of the CC-01 differed from that of VR-2332 at four positions: 30 
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(G to T), 189 (C to T), 528 (G to T), and 610 (C to A).  These changes resulted in 
substitution of two amino acids at positions 10 (L to F) and 204 (H to R) respectively.  The 
ORF2b nucleotide sequence of the CC-01 had nucleotide substitutions at positions 25 (G to 
T), 184 (C to T), which resulted in substitutions of two amino acid residues at positions 9 (D 
to Y) and 62 (P to S) respectively.  The ORF3 nucleotide sequence of the CC-01 differed 
from VR-2332 at five positions: 190 (A to G), 248 (G to A), 255 (C to T), 280 (A to G), and 
316 (G to A), resulting in amino acid substitutions at positions 64 (T to A), 83 (G to E), 94 (I 
to V) and 106 (G to S).  The ORF4 nucleotide sequences of the CC-01 and VR-2332 were 
identical.  The ORF6 nucleotide sequences of the CC-01 showed nucleotide changes at 
positions 46 (C to G), 361 (C to G) and 363 (G to C), two of which were non-synonymous 
changes resulting in amino acid substitutions at positions 16 (Q to E) and 121 (R to G).  The 
ORF5 and ORF7 sequences of the CC-01 in comparison to those of VR-2332 were described 
in the previous report (6). 
Mutation dynamics of individual ORFs.     Nucleotide and deduced amino acid 
sequence analyses of individual ORF regions revealed that each passage produced novel viral 
genotypes (major or/and minor populations) which were not observed in the corresponding 
animals of the previous passages (Fig. 1), indicating continuous mutation of PRRSV during 
in vivo replication and negative selection of dominant genotype.  Overall, ORFs 2a and 5 
showed continuous emergence of novel genotypes at a relatively higher frequency than other 
ORFs, and some genotypes that disappeared in the previous passage re-emerged in later 
passage.  On the other hand, ORFs 2b, 6, and 7 developed a lower number of novel 
genotypes emerged and a higher rate of recurrence of the same genotypes. 
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Individual ORFs showed different mutation rate over time (Fig. 2).  Overall, ORF7 
showed the least variation among all of structural ORFs at both nucleotide and amino acid 
levels (p<0.0001).  At nucleotide level, ORFs 2a and 5 showed significantly higher mutation 
rate (p<0.001) than other ORFs, while there was no significant difference in mutation rate 
between ORFs 2a and 5.  The nucleotide mutation rates of individual ORFs (2a, 2b, 3, 4, 5, 6 
and 7, respectively) followed: Y2a=0.1106X + 0.0218 (r2=0.83), Y2b=0.1114X + 0.0289 
(r2=0.64), Y3=0.0958X - 0.0052 (r2=0.73), Y4=0.0634X - 0.0079 (r2=0.79), Y5=0.1104X + 
0.0382 (r2=0.92), Y6=0.0688X + 0.0042 (r2=0.63), and Y7=0.0341X + 0.0124 (r2=0.59) 
where X  represents the number of passage for each ORF.  Increase (i.e. slope) in mutation 
rates of nucleotide sequence among all ORFs could be placed in order: 2 = 2b = 5 > 3 > 4 = 6 
> 7 (p<0.005).  
At amino acid level, mutation rates of ORFs 2a and 5 were not significantly different 
from that of ORF3 (p>0.1); however, the mutation rate of ORF2a was significantly higher 
than that of ORF5 (p<0.01).  The amino acid mutation rates of individual ORFs of the CC-01 
over time followed: Y2a=0.1768X + 0.1269 (r2=0.79), Y2b=0.2567X + 0.2843 (r2=0.56), 
Y3=0.1634X + 0.0347 (r2=0.49), Y4=0.0968X - 0.0029 (r2=0.56), Y5=0.1494X + 0.2390 
(r2=0.73), Y6=0.1259X + 0.0402 (r2=0.55), and Y7=0.0391X + 0.0402 (r2=0.19) for ORFs 2, 
2b, 3, 4, 5, 6 and 7, respectively. Increase in mutation rates of amino acid sequence among all 
ORFs could be placed in order: 2b > 2 = 3 or 3 = 5 > 6 > 4 > 7 (p<0.05). 
Mutation of PRRSV appeared to be influenced by host as each pig line showed different 
degrees of mutation at individual ORFs.  For instance, line A showed the highest mutation 
rate in ORF3 and the least mutation rate in ORF5.  Line B disclosed the highest mutation rate 
in ORF2b and the least in ORF6.  Although line C showed the least mutation rate in ORF3, it 
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revealed the highest mutation rate in ORFs 4 and 6 at both nucleotide and amino acid level 
(Fig. 3).  
Mutation type.  Nucleotide substitutions of plaque-cloned viruses in each ORF at 
passage 1, 3, 7, 10 and 13 in comparison to CC-01 were analyzed.  In general, transitions (T 
to C or C to T, and A to G or G to A) were more prevalent than transversions (A to C or C to 
A, and T to G or G to T) throughout the all ORFs of all lines.  Synonymous changes were 
increased over time, while non-synonymous changes were observed mainly at the beginning 
of passage or in lower passages.  The non-synonymous changes still remained as the main 
type of mutation during the study, although synonymous changes surpassed non-synonymous 
changes in some ORFs (i.e., ORF2 of line B, ORF4 of lines A and C, ORF5 of line B, ORF6 
of line B and ORF7 of line C) as summarized in Table 2.  
Characteristic of mutations in individual ORF.     Nucleotide changes were shown in 
different positions of individual ORFs within independent lines, which resulted in change of 
the deduced amino acid sequence (Fig. 4).  Accumulative (from P3 or P7 or P10 to P13) 
substitutions of amino acids were observed in various positions of each ORF over time. 
ORF2a.     Ten nucleotides variants (NVs) at each of the independent lines were 
observed, which resulted in 7, 6 and 10 amino acid variants (AVs) in lines A, B and C, 
respectively, showing the most frequent appearance of variants among 7 ORFs.  Although 
most of nucleotide changes were distributed throughout the gene, accumulative nucleotide 
change at 30 (T to G or C) was shown in all three lines from P3 to P13.  Such change resulted 
in the substitution of amino acid (F to L). Other accumulative nucleotide changes from the 
previous passage to the last one were shown in all plaque-cloned viruses from each line, 
leading to amino acid change at position 237 (I to M) in line A, and 7 (K to R), 188 (N to D), 
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191 (F to S), 223 (A to T) and 237 (I to M) in line B, and 98 (L to F) and 204 (N to H) in line 
C. 
ORF2b.     Four, 3 and 4 NVs in lines A, B and C, respectively, appeared, corresponding 
to 2, 3 and 4 AVs, respectively. The common nucleotide change (T to C or G) of all lines was 
shown at position 25, resulting in substitution of Y with D or H at amino acid position 9. 
Other consistent nucleotide changes were observed and the resultant amino acid changes 
were found at position 7 (L to I) and 30 (I to T) only in line B. 
ORF3.     Seven, 10 and 14 NVs which resulted in 3, 6 and 8 AVs were observed in Line 
A, B and C, respectively, during the study. There was no common change of nucleotide or 
amino acid change in the all three lines. Accumulative nucleotide changes led to amino acid 
changes at 2 and 6 different positions in line A and B, respectively: 30 (T to A) and 208 (V to 
A) in line A; 3 (N to D), 15 (S to N), 30 (T to A), 87 (H to Q), 93 (M to V) and 253 (R to L) 
in line B. 
ORF4.     Four, 12 and 10 NVs each of which corresponded to 3, 6 and 8 AVs were 
identified. There was no common nucleotide or amino acid change in all lines. Accumulative 
nucleotide changes led to amino acid changes at 2 and 6 different positions in line A and B, 
respectively: 30 (T to A) and 208 (V to A) in line A; 3 (N to D), 15 (S to N), 30 (T to A), 87 
(H to Q), 93 (M to V) and 253 (R to L) in line B. 
ORF5.     Sequence analyses of ORF5 gene revealed 10, 13 and 15 NVs, which resulted 
in 5, 8 and 9 AVs in lines A, B and C, respectively. Any of nucleotide changes up to position 
114 was non-synonymous change.  The nucleotide change (G to A) in position 451, which 
resulted in amino acid change (G to R) in position 151, was observed in some of viruses at 
P1 and all viruses at P3, P7, P10 and P13 of all lines.  Line A showed three more 
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accumulative nucleotide changes, while line B and C showed 6 and 8 more accumulative 
nucleotide changes, which resulted in amino acid changes at position 11 (C to Y) and 34 (D 
to S) in line B, and 19 (C to Y), 94 (V to A) and 121 (T to I) in line C. The amino acid 
change at position 34 (D to N) (49) no longer observed in lines B and C after third passage.  
ORF6.     The number of NVs observed was 3, 8, and 8, yielding AVs of 3, 1 and 7 in 
lines A, B and C, respectively. The nucleotide changes at position 46 (G to C) and 47 (A to 
G) were observed from passage 3 in all three lines leading to an accumulative amino acid 
change at position 16 (E to Q or G). No other accumulative change in line A or B was 
observed, whereas additional three accumulative changes were in line C, resulting in amino 
acid substitutions at position 13 (T to A, K or T), 63 (A to V) and 163 (K to R).  
ORF7.     The least mutation rate of ORF 7 reflected the least number of NVs or AVs 
among the 7 ORFs.  Nonetheless, 3, 5 and 5 NVs emerged, producing 2, 3 and 2 AVs.  All 
observed nucleotide or amino acid changes were random without accumulation.  
Analysis of collective sequence of all structure protein genes (ORFs 2 to 7).     
Sequences of all ORFs were collated into one continuous collective sequence (3188 bp) for 
each plaque cloned virus isolate and compared to that of the CC-01.  The analysis with linear 
regression model showed that:  a) increase in mutation rate of the line A was significantly 
higher (p<0.001) than that of lines B and C; and b) increase in the mutation rate of line B was 
not significantly different from that of line C (p>0.9).  Mutation rates of the structural protein 
genes (ORFs 2-7) in lines A, B and C over time followed: YA=0.094X - 0.0052, YB=0.0805X 
+ 0.0191 and YC=0.0807X – 0.012, respectively, where X represents the number of passage 
(Fig. 5). 
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Sequential pig-to-pig passages of the CC-01 for 720 days produced a total of 86 NVs 
which had at least one nucleotide changed from the CC-01 at P1, 3, 7, 10 and 13.  
Phylogenetic analysis showed that three different branches were formed along with pig line. 
The formation of the independent phylogenetic branches started with viruses of passage 3, 
creating three distinct evolutionary paths made up with all viruses from each of independent 
lines at passage 3, 7, 10 and 13 in chronological order (Fig. 6).  
Susceptibility of mutants to neutralizing activity of porcine polyclonal antibody.     
Mean RI of plaque-cloned viruses from line C at P3, P7, and P13 were not significantly 
different (p >0.1) from that of CC-01.  In contrast, mean RIs of viruses from line A at P7 and 
line B at P7, P13 were significantly different (p<0.0001) from that of the CC-01 although 
mean RIs of line A at P3 and line B at P3 were not significantly (p >0.1) less than that of CC-
01.  There was no considerable difference in the mean RI of the viruses from line B at 
between P7 and P13 or the viruses in line C at between P7 and P13 (Figure 7).  
The difference in deduced amino acid sequences between viruses resistant and 
susceptible to the neutralizing activity of the anti-CC-01 polyclonal pig antibody was 
recognized.  Five positions (78, 84, 130, 188 and 191) in ORF2, five positions (87, 93, 134, 
140 and 143) in ORF3, one position (45) in ORF4 and one position (34) in ORF5 were 
distinctly different from those of the CC-01 (Table 3).  Nonetheless, there was no changes in 
potential glycosylation sites in ORF 5, which were postulated to be mainly responsible for 
the change in viral structure and corresponding antigenicity.  
 
Discussion 
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In this study, structural protein genes (ORFs 2-7) of viruses (n=195), which were isolated 
from pigs after certain passages (P1, P3, P7, P10 and P13) during pig-to-pig sequential 
passages of a plaque-clone strain (CC-01) for a total of 727 days, were analyzed and 
compared to the virus in the inoculum in order to characterize the evolutionary biology of 
PRRSV in vivo.  Previously our laboratory showed, via pig-to-pig passages of the CC-01 for 
a total of 367 days, that PRRSV (particularly ORF5) can continuously mutate in infected pigs 
while house-keeping gene or internal protein gene, such as ORF1b (polymerase) and ORF7 
(nucleocapsid), remains relatively conserved (6).  That study also demonstrated that 
dominant ORF5 NV and AV were different at each passage with the emergence of new 
genotypes over times.  The present study further evidenced that PRRSV continues to evolve 
via introduction of random mutations during in vivo replication.  All structural genes of 
PRRSV (ORFs 2 to 7) were concurrently subjected to continuous molecular evolution at 
varying mutation rates, which created multiple genotypes.  As a result, PRRSV existed as 
multiple variant populations (i.e., quasi-species) in individual pigs during pig-to-pig 
passages; the dominant genotypes differed from one pig to another even within the same pig 
line.  Presence of multiple strains in a farm (10, 29, 44, 60) has been common phenomenon 
in PRRS affected farms, which is supposedly an aftermath of viral mutation of a single strain 
during circulation in a farm or external introduction of new strains.  Therefore, the 
appearance or disappearance of multiple variants at each passage within or among pigs 
demonstrated how a single strain might be developed into multiple strains during circulation 
in pigs after introduction to a farm.  
Commonly, ORFs encoding envelope-associated proteins (GP2a, 3, 4 and 5) showed a 
higher mutation rate than ORFs 6 or 7 that encode internal structural proteins (M and N) of 
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PRRSV (Fig. 2).  Although many field studies reported that ORF5 is the most variable region 
among the 7 ORFs, it is interesting that ORFs 2a, 2b and 3 had a mutation rate higher than or 
similar to ORF5 in this study.  Nevertheless, regression coefficient (r2) for nucleotide and 
amino acid mutation rates of ORF5 was higher than those of the other ORFs (ORFs 2 and 3), 
suggesting the consistent and continuous mutation occurs in ORF5 after 13th passages so that 
ORF5 become the most variable region as reported by field-based molecular epidemiology 
studies (22, 23, 31).  Unexpectedly, ORF2b showed exceptionally high in mutation rates at 
both nucleotide and amino acid levels.  However, as shown in the study by Cha et al. (2006) 
in which ORF2b had the genetic variability similar to ORF6 among field isolates, further 
passages of the virus in pigs may appear to produce much less mutation rates in ORF2b than 
other ORFs (i.e. ORFs 2a, 3, 4 and 5).  
The following 3 different observations strongly support that a single strain (CC-01) of 
PRRSV evolved into three distinct virus genogroups along with three independent pig lines 
(i.e., Line A, B and C).  First, mutation rates among seven ORFs varied within each of the 
lines at nucleotide level: 3 > 2 > 5 > 2b > 4 > 6 > 7 (p<0.05) in line A; 2b > 2 = 5 > 3 > 4 = 6 
= 7 (p<0.05) in line B; and 5> 2 = 2b > 4 > 3 = 6 = 7 (p<0.05) in line C.  At deduced amino 
acid level, the rates were 3 > 2 > 2b > 4 > 5 > 6 > 7 (p<0.05) in line A; 2b > 3 > 2 = 5 > 4 = 6 
= 7 (p<0.05) in line B; and 2 = 2b > 5 > 4 > 3 = 6 = 7 (p<0.05) in line C.  Second, 
accumulative changes in nucleotide sequence (data not shown) or amino acid sequence (Fig. 
4) were different among the three lines, with respect to position and number of the change.  
Third, phylogenetic analyses using ORF5 (4) or ORFs 2-7 (Fig. 6) resulted in three 
independent clades, which started from viruses at early passage (P2 or P3) of each of the 
three independent lines.  Such distinct evolutionary paths could be indicative of host 
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influence on genetic changes of the virus.  The potential host influence on virus evolution 
remains however to be further studied using a large number of pigs (i.e., population). 
Mutation rate is generally influenced by replication frequency, determining mutant 
spectrum or resulting in the emergence of distinct viral population.  Hanada et al. (2004) 
have reported that replication frequency is mostly associated with the synonymous 
substitution rates under the similar replication error rate, and that PRRSV with exceptionally 
high replication frequency has the highest synonymous substitution rate (6.2×10-2/site/year) 
among RNA viruses.  In our study, varying levels of viremia appeared among pigs infected 
with the same amount of inoculum in the first passage as well as among pigs infected with 
tissue homogenates in the subsequent passages that may contain different level of viral titers.  
Since the viremia represented level of replication of the inoculated virus in host, the different 
level of viremia may affect on overall mutation rate and mutant spectrum.  On the other hand, 
hosts can select a specific viral population.  Gay et al (2006) reported that passage of 
avirulent strain of coxsackievirus B3 in old mice resulted in the selection of a pathogenic 
subpopulation that existed as minor population in the inoculum, while passages in adult host 
did not revert the virus to a pathogenic strain (i.e., phenotypic change).  Host factor(s) may 
also be involved in “competitive exclusion” (8, 11) that lead to the selection of different viral 
populations among host.  This mechanism was believed to exclude one of two clones of 
vesicular stomatitis virus that had the same degree of fitness during passages in BHK-21 cells 
(8).  The same mechanism may also be applicable to PRRSV.  Lager et al (2003) observed 
that one or two isolates were obtained from gilts that were challenged with 20 different type 
2 PRRSV isolates regardless of vaccination status.  However, the possibility could not be 
excluded that the observation resulted from different viral titers in the inoculum and uneven 
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degree of fitness among the viruses (subpopulations) to the host.  Nevertheless, the present 
study revealed that one subpopulation outcompeted other subpopulations and became the 
major population during replication in pigs.  Collectively, it is plausible that a high degree of 
genetic variability among PRRS viruses is attributed to: a) high replication frequency of 
PRRSV in nature which generates numerous errors during RNA replication and b) population 
selection (mainly negative selection) in individual host, besides accumulation of point 
mutations.  
The mutation types of transition and non-synonymous change were prevalent in 
glycoproteins, such as GPs 2, 3 and 5, while synonymous change was the main type for some 
lines at certain passages (Table 2).  Overall, synonymous changes tended to increase in all 
ORFs during passages, implying that “purifying selection” may have been involved to 
suppress expansion of viral diversity.  On the other hand, analyses of non-synonymous 
change revealed accumulative changes in amino acid variants emerged from P3 and/or P7 
and/or P10 throughout all structural proteins (Fig. 4), which maintained the same change of 
amino acid up to P13, indicating “positive selection” in viral mutants that has those changes.  
The positively selected amino acids were dominant in GP2a, 3 and 5 and were located in 
different positions among the three lines, contributing to the generation of genetic 
distinctness among viruses within the three lines.  However, it remains to be determined if 
the prevalence of positive selection in glycoproteins, which surface PRRS virons, may be 
driven by immune pressure and fitness as previously proposed for other viruses, such as 
capsid protein of dengue virus (2) and hemagglutinin of influenza (3).  
Forsberg et al (2001) suggested a useful tool of ORF3 as a molecular clock for PRRSV 
evolution through analyses for ORF3 sequences of type I PRRSV field isolates obtained 
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between 1991 and 1999.  In our study, mutation rates of individual ORFs varied among hosts, 
implying that use of single ORF may give rise to inaccurate assessment of PRRSV mutation.  
In contrast, mutation rates assessed using all 7 ORFs’ sequences (3188bp) did not show 
significant difference between lines B and C (p>0.05), although the mutation rate in the line 
A was higher than that in the other two lines (p<0.0001) which might be attributed to the 
difference in length of in vivo replication (Fig. 5).  This result suggested that the collective 
sequence of ORFs 2-7 may be able to better serve as “molecular clock”, which is useful for 
evolutionary or molecular epidemiological study.   
Danish researchers reported that revertant viruses originated from the vaccine virus (i.e., 
RespPRRS®) had changes in amino acid at position 151 (G to R) on ORF5 and position 16 (E 
to Q or G) on ORF6 (53).  The same amino acid change at the position 151 on ORF5 was 
reported in viruses obtained from P2 in the previous study (6).  In the present study, such an 
amino acid change in ORF5 was consistently shown at P10 and P13. Amino acid change also 
appeared at position 16 (E to Q or G) on ORF6 from P3 to P13.  Although it remains to be 
determined if these specific changes affect the virulence or in vivo replication of PRRSV, 
viremia data and clinical observations (6) suggest that these changes are possibly a marker 
for cell adaptation or virulence since the duration and level of viremia appears to be the most 
important criteria for determining the virulence of PRRSV besides lesions and clinical signs 
(e.g. abortion) (18, 27).  
Virus neutralization is closely associated with delay or restriction of clinical signs by, or 
complete protection from numerous viral diseases, such as bovine rotavirus diarrhea (25), 
murine hepatitis virus (26), porcine respiratory coronavirus (50), Ebola virus (55), HIV (51), 
porcine circovirus (33).  In case of PRRSV, virus-specific antibodies protected sow and 
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young pigs from viremia, transmission, abortion and clinical diseases (30, 41) even though 
the antibody-mediated protection mechanisms may differ among age groups as pigs of young 
age appear to need higher amount of neutralizing antibodies to be fully protected (30).  In 
contrast, the emergence of mutants which are capable of escaping from the neutralizing 
activity by antibodies is common in some viruses such as hepatitis B virus (15, 54) and HIV 
(37).  In the present study, the emergence of PRRS viruses resistant to the neutralizing 
activity of antisera raised against the inoculum PRRSV (CC-01) during pig-to-pig passages 
of the CC-01 (Fig. 7).  The resistance to neutralizing antibodies observed in this study would 
be indicative of that those viruses may be capable of escaping from immune-mediate 
antiviral activity in the host, leading to failure of complete clearance of mutants or highly 
diversified viruses by neutralizing antibody and continuous circulation in individual animals 
or a population.   
The resistance to neutralizing antibody may be rendered by modified antigenic structure 
that resulted from changes of amino acid residues.  Amino acid position 36 to 52 comprising 
ectodomain (45), 130 to 201 (47) and 28 to 30 or 37 to 39 (42) in PRRSV of North American 
genotype have been reported be highly immunogenic epitopes inducing neutralizing antibody.  
Our study, however, did not demonstrate accumulative or major changes in these sites even 
though potential escape mutants were observed, suggesting that the resistance to 
neutralization might be attributed to changes in other regions that have not been reported to 
be responsible for neutralization activity.  The common amino acid substitution among 
plaque-cloned viruses from lines A and B which were resistant to neutralization was 
observed at position 93 (M to V), in addition to other various changes, in ORF3. The ability 
of ORF3 protein to induce neutralizing antibody has not been demonstrated in pigs and mice 
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exposed to PRRSV (17, 59).  Nonetheless, partial protection from reproductive losses due to 
PRRSV infection was demonstrated in pregnant animals immunized with ORF3 recombinant 
baculoviruses (46).  Although it remains to be further determined if GP3 plays a role in 
protective immunity against PRRSV, data from the present study suggests that the amino 
acid changes in ORF3 is a possible factor responsible for the partial resistance to 
neutralization.  The amino acid change (D to N or S) at position 34 of ORF5 can be another 
factor.  The change (D to N) that was shown in P3 of line B was determined not to affect the 
neutralizing activity of PRRSV antiserum in vitro (49).  Our in vitro VN test with the viruses 
that had the same change at the same position also showed no significance of the change with 
respect to the resistance to virus neutralization.  On the other hand, substation of D with S at 
position 34 of ORF5 may have the potential to determine antigenic structure affecting virus 
neutralization by antibody since viruses obtained at P7 and P13 in line B with such a change 
showed significantly low susceptibility to neutralization (Table 3 and Figure 7).   
In summary, our study clearly demonstrated that PRRSV continuously evolves during 
replication in pigs and genetic changes occur in all genes encoding for structural proteins at 
varying rates of mutation.  Genetic changes certainly resulted in amino acid substitutions 
which are likely responsible for antigenic modifications which is associated with increasing 
resistance to neutralizing antibody raised against the parental virus.  Continuous variations 
and resulting genetic and antigenic diversity of PRRSV present in individual pig and a 
population would be a mechanism for the persistence of PRRSV in swine population despite 
huge efforts to control the disease, and should be taken into consideration for designing an 
effective strategy for control and prevention.  
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Table 1. Oligonucleotide primers used for PCR and sequencing. 
Primer Sequence Location (nucleotide) 
  PR11933F      5’-AAA CGG TGA GGA CTG GGA GGA TTA-3’ 11933-11956 
  PR12202F      5’-CCG GTT GGC TGG TGG TCT-3’ 12202-12219 
  PR12712F      5’-CAT TCC TCC ATA TTT TCC TCT GTT-3’ 12712-12735 
  PR13254F      5’-TTC TTT TCC TCG TGG TTG GTT TTA-3’ 13254-13277 
  PR13342R      5’-CGC TGC GGT GGT GTT GGT CTT A-3’ 13342-13321 
  PR12809R      5’-TCG AAA GAA AAA TTG CCC CTA ACC-3’ 12809-12786 
  PR12478R      5’-ATC CAA ACT ACT AAT GCG AGA CAG-3’ 12478-12455 
  PR13863R      5’-CAA AAC AGA ACG GCA CGA TAC ACC-3’ 13863-13840 
  P6F      5’-GCG GTC GCC TGT CAT CAT AG-3’ 14252-14271 
  P6R      5’-GGC TGG CCA TCC CCC TTC TTT CT-3’ 14941-14919 
  P7F      5’-TCG TGT TGG GTG GCA GAA AAG C -3’ 14816-14837 
  P7R      5’-GCC ATT CAC CAC ACA TTC TTC C-3’ 15300-15279 
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Table 2. Mutation types among PRRS viruses emerged during pig-to-pig sequential passages of a plaque-cloned virus (CC-01) of 
PRRSV VR-2332 
a Transition,  b Transversion, c Synonymous,  d Non-synonymous 
e
 A total of 15 plaque-cloned viruses were collected from each line at each passage  
f
 Line A could not be maintained after P7 because viral infectivity could not be demonstrated in samples collected from pigs at the end of P7.   
 
 
 
Mean (SEM) no. of nucleotide substitutions per plaque-cloned virus in the following passagee 
P1  P3  P7  P10f  P13 ORF  
A B C  A B C  A B C  B C  B       C 
        TSa 0.07 (0.07) 0.00   0.13 (0.09)  2.00 (0.24) 5.67 (0.19) 1.00 (0.00)    4.47 (0.19)    7.13 (0.09) 3.00 (0.00)  10.1 (0.13) 4.2 (0.24)  10.6 (0.16)      6.53 (0.13) 
TVb 0.00 0.00 0.00  1.00 (0.00) 0.00 1.00 (0.00)  2.00 (0.00) 1.00 (0.00) 2.00 (0.00)  1.00 (0.00) 1.47 (0.13)  1.00 (0.00)      2.53 (0.13) 
Sc 0.00 0.00 0.00   0.07 (0.07)  2.07 (0.07) 1.00 (0.00)   1.47 (0.19) 4.00 (0.00) 2.00 (0.00)   6.07 (0.07) 2.00 (0.00)  6.6 (0.16)      3.53 (0.13) 
2 
NSd 0.07 (0.07) 0.00   0.13 (0.09)  2.87 (0.22) 3.60 (0.21) 1.00 (0.00)  5.00 (0.19)   4.13 (0.19) 3.00 (0.00)  5.00 (0.00) 3.67 (0.13)  5.00 (0.00)      5.53 (0.13) 
TS 0.00 0.00   0.07 (0.07)  0.20 (0.11) 2.00 (0.00) 0.00  0.07 (0.07) 2.00 (0.00) 0.00  3.00 (0.00) 0.07 (0.07)  3.00 (0.00)      1.53 (0.13) 
TV 0.00 0.00 0.00  1.00 (0.00) 0.00 1.00 (0.00)  1.00 (0.00) 1.00 (0.00) 1.00 (0.00)  1.00 (0.00) 1.00 (0.00)  1.00 (0.00)      1.00 (0.00) 
S 0.00 0.00 0.00  0.20 (0.11) 0.00 0.00  0.00 0.00 0.00  1.00 (0.00) 0.00  1.00 (0.00)       1.00 (0.00) 
2b 
     NS 0.00 0.00   0.07 (0.07)  1.00 (0.00) 2.00 (0.00) 1.00 (0.00)  1.07 (0.07) 3.00 (0.00) 1.00 (0.00)  3.00 (0.00) 1.07 (0.07)  3.00 (0.00)       1.53 (0.13) 
TS 0.00 0.07 (0.07)   0.13 (0.13)   4.33 (0.13) 2.80 (0.11) 0.20 (0.11)  7.00 (0.20)   5.07 (0.07) 1.00 (0.00)   7.13 (0.09)   5.47 (0.47)  7.2 (0.14) 5.00 (0.00) 
TV 0.00 0.00 0.00  0.07 (0.07) 0.00 0.00  1.00 (0.00) 2.00 (0.00) 0.07 (0.07)  3.00 (0.00) 1.00 (0.00)  3.00 (0.00) 1.00 (0.00) 
S 0.00 0.00 0.00  1.4 (0.13) 0.80 (0.11)  0.07 (0.07)  1.67 (0.25) 3.00 (0.00) 0.07 (0.07)  4.00 (0.00)   1.87 (0.17)  2.20 (0.14) 2.00 (0.00) 
3 
NS 0.00 0.07 (0.07)   0.13 (0.13)  3.00 (0.00) 2.00 (0.00)  0.13 (0.09)   6.47 (0.13) 4.00 (0.00) 1.00 (0.00)   6.13 (0.09) 4.60 (0.40)  8.00 (0.00) 4.00 (0.00) 
TS 0.07 (0.07) 0.13 (0.09)   0.07 (0.07)  2.00 (0.00) 0.07 (0.07) 1.00 (0.00)  2.80 (0.11) 1.00 (0.00) 2.00 (0.00)   2.27 (0.12)   4.40 (0.21)  2.13 (0.13)        4.07 (0.27) 
TV 0.00 0.13 (0.09)   0.07 (0.07)  0.00 0.00 0.00  0.00 0.00 0.07 (0.07)  1.00 (0.00)   0.40 (0.13)  1.00 (0.00) 1.00 (0.00) 
S 0.00 0.07 (0.07) 0.00  1.00 (0.00) 0.07 (0.07) 1.00 (0.00)  1.53 (0.13) 0.00 1.00 (0.00)  1.27 (0.12)   1.40 (0.13)  2.07 (0.07) 3.00 (0.00) 
4 
NS 0.07 (0.07) 0.2 (0.11)   0.13 (0.09)  1.00 (0.00) 0.00 0.00  1.27 (0.12) 1.00 (0.00) 1.07 (0.07)  2.00 (0.00)    3.40 (0.21)  1.07 (0.07)        2.07 (0.27) 
TS   0.80 (0.17) 0.20 (0.11)   0.60 (0.16)  3.02 (0.07) 3.13 (0.09)  3.53 (0.13)   4.40 (0.16)    4.13 (0.09) 3.07(0.07)  5.00 (0.00)   6.73 (0.15)  8.93 (0.07)     7.73 (0.15) 
TV 0.00 0.00 0.00  0.00 0.00 0.00  0.00   1.00 (0.00) 0.00   1.00 (0.00)   1.00 (0.00)  1.00 (0.00)     1.00 (0.00) 
S 0.07 (0.07) 0.13 (0.09) 0.00  2.07 (0.07) 0.07 (0.07)  0.53 (0.13)      3.07 (0.07)   1.00 (0.00) 0.07 (0.07)  2.00 (0.00) 3.67 (0.13)  4.33 (0.13)     4.67 (0.16) 
5 
NS 0.73 (0.15) 0.07 (0.07) 0.60 (0.16)  1.00 (0.00) 3.07 (0.07) 3.00 (0.00)  1.13 (0.13)    4.13 (0.09) 3.00 (0.00)  4.00 (0.00)    4.07 (0.07)  5.63 (0.13)     4.07 (0.07) 
TS 0.00 0.00   0.07 (0.07)  0.00 0.27 (0.12)   1.07 (0.07)   0.33 (0.13)  1.33 (0.33) 6.00(0.00)  2.07 (0.07)   1.93 (0.27)  2.00 (0.00)        5.20 (0.26) 
TV 0.00 0.00 0.00  1.00 (0.00) 1.00 (0.00) 0.00  1.00 (0.00)   0.93 (0.07) 0.00  1.00 (0.00)   1.00 (0.00)  1.00 (0.00)        0.60 (0.13) 
S 0.00 0.00 0.00  0.00 0.27 (0.12)   0.07 (0.07)  0.00   1.13 (0.13) 3.00 (0.00)  2.07 (0.07) 0.00  2.00 (0.00)        1.20 (0.26) 
6 
NS 0.00 0.00   0.07 (0.07)  1.00 (0.00) 1.00 (0.00) 1.00 (0.00)  1.33 (0.13)   1.13 (0.13) 3.00 (0.00)  1.00 (0.00)    2.93 (0.27)  1.00 (0.00)        4.60 (0.13) 
TS 0.00 0.00   0.07 (0.07)  0.07 (0.07) 1.00 (0.00)   0.53 (0.13)    0.40 (0.13) 0.00 1.00 (0.00)  1.00 (0.00)    1.07 (0.07)  2.00 (0.00) 3.00 (0.00) 
TV 0.00 0.00   0.07 (0.07)  0.00 0.00 0.00  0.00 0.00 0.00  0.00 0.00  0.00 0.00 
S 0.00 0.00   0.07 (0.07)  0.00 0.00   0.53 (0.13)  0.00 0.00 1.00 (0.00)  1.00 (0.00)    1.07 (0.07)  1.00 (0.00) 1.00 (0.00) 
7 
NS 0.00 0.00   0.07 (0.07)  0.07 (0.07) 1.00 (0.00) 0.00    0.40 (0.13) 0.00 0.00  0.00 0.00  1.00 (0.00) 2.00 (0.00) 
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Table 3. Deduced amino acid residues observed in structural genes (ORFs 2, 3, 4 and 5) 
between plaque-cloned virus isolates resistant and susceptible to the neutralizing activity of 
pig polyclonal antibody raised against the inoculum PRRSV (CC-01)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
 “-” means that there was no amino acid sequence difference from CC-01 
b The substitution in the amino acid position was shown in all 15 plaque-cloned viruses.  
 
 
 
 
 
 
 
 
 
 
Lines and Passages 
Line A  Line B  Line C ORF 
Amino 
acids 
Position 
CC-01 
P3 P7  P3 P7 P13  P 3, 7 and 13 
2 78 F -a  Yb  - - -  - 
 84 V - A  - - -  - 
 130 V - A  - - -  - 
 188 N - -  - D D  - 
 191 F - -  - S S  - 
3 87 H - -  - Q Q  - 
 93 M - V  - V V  - 
 134 R - Q  - - -  - 
 140 K - T  - - -  - 
 143 L - F  - - -  - 
4 45 A - -  - V V  - 
5 34 D - -  N S S  - 
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Fig. 1. Dynamics of PRRSV quasispecies in individual open reading frames during pig-to-pig sequential passages of the PRRSV 
CC-01 strain. The variants with black color (dominant populations) or grey color (minor populations) were determined by 
frequency of nucleotide (panel A) and amino acid (panel B) variants among 15 plaque-cloned viral isolates from each pig (A, B or 
C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORF2a ORF2b ORF3 ORF4 ORF5 ORF6 ORF7 
(A) 
(B) 
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Fig. 2. Estimated accumulative mutation rate of ORF 2a, 2b, 3, 4, 5, 6 and 7 over time during pig-to-pig sequencing passage of a 
plaque-cloned strain (CC-01) of PRRSV. Each symbol represents the mean of mutation rates in each ORF among plaque-cloned 
viral isolates (n=15) at each given passage in comparison to the inoculum virus (P0). Lines are regression of observations. Error 
bars are the standard errors of the mean.  Mean nucleotide mutation rates (%) of individual ORFs followed: Y2a=0.1106X + 0.0218 
(r2=0.83), Y2b=0.1114X + 0.0289 (r2=0.64), Y3=0.0958X - 0.0052 (r2=0.73), Y4=0.0634X - 0.0079 (r2=0.79), Y5=0.1104X + 
0.0382 (r2=0.92), Y6=0.0688X + 0.0042 (r2=0.63), and Y7=0.0341X + 0.0124 (r2=0.59).  Mean amino acid mutation rates (%) of 
individual ORFs followed: Y2a=0.1768X + 0.1269 (r2=0.79), Y2b=0.2567X + 0.2843 (r2=0.56), Y3=0.1634X + 0.0347 (r2=0.49), 
Y4=0.0968X - 0.0029 (r2=0.56), Y5=0.1494X + 0.2390 (r2=0.73), Y6=0.1259X + 0.0402 (r2=0.55), and Y7=0.0391X + 0.0402 
(r2=0.19).  X represents number of passage. 
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Fig. 3. Mutation rates for PRRSV ORFs 2a, 2b, 3, 4, 5, 6 and 7 during sequential pig-to-pig passages (P) in 3 independent pig lines 
(A, B and C). The mutation rates were calculated as the proportions of substitutions in each plaque cloned virus and are 
represented as the mean percent change on the nucleotide (A) and amino acid (B) levels. Each symbol represents the mean of 
mutation rates for 15 cloned isolates.  
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Fig. 4. Positions and frequency of non-
synonymous mutations in ORFs 2 to 7 of 
PRRSV during pig-to-pig sequential 
passages in 3 independent pig lines (A, 
B, C). Asterisk indicates amino acid 
substitutions remained until the last 
passage (13) once occurred in a previous 
passage (3, 7 or 10). Frequency is a ratio 
between the number of amino acid 
variants with changes at the specific 
position of amino acid sequence and the 
total number of amino acid variants of 
each ORF.  
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Fig. 5. Accumulative mutation rates in full-length sequence of all structural protein open-
reading frames 2-7 (3188bp) of PRRSV during sequential pig-to-pig passages (P) in 3 
independent pig lines (A, B and C). Each symbol represents the mean of mutation rates 
among 15 plaque-cloned viral isolates collected from each pig at each given passage in 
comparison to the inoculum virus (P0). Lines are regression of observations. Error bars are 
the standard errors of the mean. 
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Fig. 6. Phylogenetic relationship of 86 nucleotide variants (NVs) identified during sequential 
pig-to-pig passages of PRRSV (CC-01) based on full-length sequence of structural protein 
open reading frames 2 to 7 (3188 bp) 
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Fig. 7. Change in the susceptibility of viruses collected during pig-to-pig passages (P) of the 
PRRSV CC-01 strain to the neutralizing activity of polyclonal antibody raised against the 
inoculum PRRSV (CC-01) as determined by in vitro one-way serum-virus neutralization test.  
Mean reduction index (RI) was calculated from 15 plaque-cloned viruses at given passage 
per each line (A, B or C) represented by different color bar in comparison to P0 that 
represents 15 plaque-cloned viruses of the CC-01 inoculum. Asterisk (*) represents the mean 
RI that was significantly (p<0.0001) lower than P0.   
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Abstract 
 
Restriction fragment length polymorphism (RFLP) analysis is one of the tools 
commonly used in molecular epidemiology of porcine reproductive and respiratory syndrome 
viruses (PRRSVs).  As PRRSVs are genetically variable, the stability of RFLP pattern of 
PRRSV during in vivo replication was evaluated by carrying out 13 sequential pig-to-pig 
passages (P1 to P13) of PRRSV VR-2332 in 3 independent pig lines for a total of 727 days.  
P1 were inoculated with a homogenous inoculum (CC-01) prepared through a series of 
plaque purification and P2 to P13 inoculated with a tissue filtrate from the corresponding pig 
in the previous passage.  Fifteen viral plaque clones were directly isolated from CC-01 and 
day 7 serum of each pig of each passage, sequenced for ORF5, and compared to CC-01 to 
assess mutation rates and RFLP patterns (MluI-HincII-SacII) over time.  Among 495 viral 
clones recovered during passages, 398 clones including CC-01 had 2-5-2 pattern; however, 
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the remaining 97 viral clones showed different patterns [2-6-2 (P2), 1-5-2 (P3), 2-5-4 (P7), 2-
1-2 (P10)], suggesting that the RFLP pattern can be changed.  Importantly, the MluI site that 
was reported to be present only in one of PRRS MLV vaccines (Ingelvac®) and its parental 
strain (VR-2332) can disappear during in vivo replication.  Furthermore, sequence homology 
between CC-01 and clones with 2-5-2 pattern or clones with other patterns ranged 0.05 to 
1.58% and 0.5 to 1.45%, respectively, suggesting that RFLP analysis cannot accurately 
predict genetic relatedness between PRRSVs.  Collectively, precaution should be taken when 
molecular epidemiology of PRRSVs will be done only using RFLP analysis. 
 
Introduction 
 
Porcine reproductive and respiratory syndrome (PRRS) is a plague causing significant 
economic loss to pig production throughout the world. The PRRS virus, the causative agent, 
is an RNA virus belonging to the family Arteriviridae (4, 22) and has shown several 
outstanding characteristics that are strong impediments to effective disease control. Those 
characteristics are well reviewed in the 2003 PRRS compendium (28). One of those is that 
PRRS virus continues to change, as evidenced by the high degrees of genetic and antigenic 
variability that exist among field isolates (2, 8, 10, 11, 17, 18). Such a high degree of 
heterogeneity among PRRS viruses prompted the development of molecular tools such as 
restriction fragment length polymorphism (RFLP) analysis (25), sequencing (2, 8, 10, 11, 13, 
14, 17, 21), and heteroduplex mobility assay (12) for use in further characterizing the 
genotypes of PRRS viruses and tracing virus movements within or among herds. All of these 
methods target open reading frame 5 (ORF5) of PRRS virus, which encodes the major 
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envelope (gp5) protein (15, 16, 19), since ORF5 has shown the highest genetic variability 
among PRRS viruses compared to the variabilities of other genes (2, 10). 
Among the molecular tools available, RFLP analysis is a rapid and relatively 
inexpensive nucleic acid-based differential test; hence, the technique has been used in 
numerous field-based molecular epidemiological surveys of PRRS viruses reported 
previously (3, 6, 9, 24).  RFLP analysis of PRRS virus starts with PCR amplification of 
ORF5, followed by digestion of the PCR product with the three restriction enzymes MluI, 
HincII, and SacII. Then, a three-digit code, based on the pattern of cutting by each enzyme, 
in the order MluI, HincII, and SacII, is assigned to the virus tested. If necessary, additional 
restriction enzymes can be added for further characterization of the virus. The foundation for 
the popular use of RFLP analysis is that the RFLP pattern of a PRRS virus is relatively stable 
during infection, although the potential for change was suggested (25, 26). However, field 
observations demonstrated the emergence of new RFLP patterns and the disappearance of 
existing RFLP patterns over a period of time (3). Furthermore, a high level of genetic 
variability was shown to exist among field isolates of PRRS virus with the same RFLP 
pattern of cutting (27). These observations raised concern over the usefulness of RFLP 
analysis for tracking virus movements and predicting genetic relatedness among PRRS 
viruses. The study described here was conducted to evaluate the stability of the RFLP pattern 
of a PRRS virus during in vivo replications. 
 
Materials and Methods 
 
Virus. The North American prototype PRRS virus, ATCC VR-2332 (American Type 
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Culture Collection [ATCC], Manassas, Va.) was used in the study. To produce a highly 
homogeneous challenge virus, ATCC VR-2332 was subjected to three rounds of plaquing on 
MARC-145 cells. Following the third round of plaquing, one virus clone, designated VR-
2332-CC-01 (hereafter referred to as CC-01), was selected and propagated once on MARC-
145 cells to obtain an amount sufficient to inoculate the pigs in passage 1 (P1). Surplus CC-
01 was divided into aliquots and stored at -80°C for future use. Fifteen viral clones were 
obtained by plaque cloning from CC-01, and the ORF5 sequence was determined to assess 
the variability of the virus population within the inoculum and provide a baseline for 
comparison. The CC-01 inoculum was determined to be homogeneous, as 15 viral plaque 
clones isolated from the inoculum shared 100% sequence homology (5). 
Experimental design. The experiment began by inoculating PRRS virus-naïve pigs with 
highly homologous clone CC-01. Three independent lines of pigs (lines A, B, and C) were 
established for in vivo virus replication, and the pigs were monitored over 13 animal 
passages (P1 to P13), representing a total of 727 days of in vivo replication. Pigs in a fourth 
line (line D) served both as mock-infected negative controls and as environmental sentinels. 
Pigs 1A, 1B, and 1C were inoculated with CC-01, and during P2 to P13 pigs were inoculated 
with a tissue filtrate from the corresponding pig in the previous passage. The time between 
consecutive passages was 60 days. At each passage, serum samples were periodically 
collected from all pigs and were used to monitor viremia and the antibody response to PRRS 
virus. In addition, 15 viral plaque clones were directly isolated from the day 7 serum of each 
pig of each passage and sequenced for genetic characterization of ORF5. The RFLP pattern 
of each viral clone obtained by digestion with three restriction enzymes (MluI, HincII, and 
SacII) was initially predicted from sequence data based on the previously published coding 
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system (25). Viral clones with distinct patterns were again examined by RFLP analysis, as 
originally reported, to confirm the patterns. 
Animal and animal care. Crossbred pigs were obtained from a closed specific pathogen-
free herd known to be free of PRRS virus. Pigs were weaned at 10 to 14 days of age and 
were housed in groups in HEPA-filtered isolation units for several days prior to exposure to 
the virus and were then housed individually in the isolation units from the time of exposure 
until the end of the observation period. Throughout the study, the animals were housed and 
cared for in compliance with the requirements given in the Guide for the Care and Use of 
Agricultural Animals in Agricultural Research and Teaching (7). 
Sequencing and RFLP analysis. Total RNA was extracted from each virus clone by 
using the QIAamp® viral RNA mini kit (Qiagen, Inc., Valencia, Calif.) by following the 
protocol recommended by the manufacturer. The entire ORF5 of PRRS virus was amplified 
by reverse transcription-PCR from 10 ul of RNA extracted by using a OneStep® reverse 
transcription-PCR kit (Qiagen) and primers primers P5F (5-CCTGAGACCATGAGGTGGG-
3) and P5R (5-TTTAGGGCATATATCATCACTGG-3). The primers were developed by 
using the sequence information for PRRS virus strain ATCC VR-2332 (GenBank accession 
no.PRU87392) and were designed to amplify the entire ORF5 region as well as the flanking 
ORF4 and ORF6 regions. Reverse transcription was performed for 30 min at 50°C. Reverse 
transcriptase was inactivated, and Taq polymerase was activated by raising the temperature 
to 95°C for 15 min. PCR amplification was done with 35 cycles of denaturation at 94°C for 
15 s, annealing at 50°C for 30 s, and extension at 72°C for 30 s. After the last cycle, the 
extension period was maintained at 72°C for another 2 min. PCR products (764 bp) were 
purified with either a QIAquick® PCR purification kit or a QIAquick 96 PCR purification kit 
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(Qiagen) by following the procedures recommended by the manufacturer. The final purified 
products (30 ng/ml each) and primers P5F and P5R (5 pmol each) were submitted to the Iowa 
State University Nucleic Acid Facility, where sequencing was performed. For RFLP analysis, 
each purified product was incubated at 37°C for 2 h with MluI, HincII, or SacII (New 
England Biolabs, Inc., Beverly, Mass.). The digested materials were then electrophoresed in 
a 1.5% agarose gel, stained with ethidium bromide, and visualized under UV light. The 
RFLP pattern of each viral clone was determined on the basis of the molecular masses of the 
resulting products according to the coding system proposed by Wesley et al. (25). 
Analysis of data. The sequences of the viral clones were analyzed with DNASTAR 
software (DNASTAR Inc., Madison, Wis.) and were compared to the sequence of CC-01 to 
evaluate the degree of mutation over time. Sequence alignment was done with the Clustal W 
program (23). The nucleotide sequences of ATCC VR-2332 (20) and the Ingelvac® PRRS 
(Boehringer-Ingelheim Vetmedica, Inc., St. Joseph, Mo.) vaccine strain (1) were obtained 
from GenBank and included in the analyses. The mutation rates were calculated as the 
proportion of substitutions and were expressed as the mean percent change in the sequence 
compared with the sequence of plaque-cloned viruses. 
 
Results 
 
PRRS viruses in line A could not be passed to subsequent pigs after P7, while the 
viruses in lines B and C were successfully passed to subsequent pigs until the end of the 
study (i.e., P13). A total of 495 viral clones (15 clones per pig line at each passage) were 
recovered from a total of 33 pigs (i.e., line A, n= 7 pigs; line B, n= 13 pigs; and line C, n = 
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13 pigs) over 13 passages (i.e., 727 days of in vivo replication) and sequenced. In agreement 
with a previous report (5), the ORF5 nucleotide sequence of CC-01 continued to change over 
time, and different lines (i.e., lines A, B, and C) showed different mutation rates, as 
illustrated in Fig. 1. The ORF5 sequence of the inoculum virus, CC-01, annually deviated, on 
average, 0.75, 0.79, and 0.73% in lines A, B, and C, respectively, under the conditions 
present in this study. While some nucleotide substitutions (at positions 32, 56, 100, 101, 207, 
281, 390, 399, 451, 453, and 513) remained throughout the study, once they occurred, most 
other changes randomly appeared, disappeared, and reappeared during the study. Over time 
the mutation rates (Y values) of ORF5 of CC-01 in lines A, B, and C were YA =0.112x + 
0.082 (r2 = 0.807), YB= 0.104x + 0.114 (r2= 0.89), and YC = 0.114x + 0.083 (r2 = 0.772), 
respectively, where x represents the number of passages. It is interesting that the regression 
coefficient (r2) value for line C was lower than those for lines A and B because line C 
showed a “yo-yo” phenomenon in the mutation rate; i.e., between passages there were 
increases and decreases in mutations instead of a consistent increase.  
During the study, a total of 86 nucleotide variants (NVs) were derived from CC-01, 
and these corresponded to 39 amino acid variants. The phylogenetic relationship among the 
86 NVs is illustrated in Fig. 2, demonstrating that the phylogenetic distance of each NV from 
CC-01 is correlated with the chronological order of their appearance during the study. That is, 
NVs appearing in an earlier passage showed a shorter phylogenetic distance (i.e., fewer 
genetic changes) from the inoculum virus. The CC-01 genotype completely disappeared after 
P1. At each passage, a particular NV became the dominant genotype among plaque-cloned 
virus isolates. Interestingly, most of the NVs observed went through a negative selection (i.e., 
disappeared) in the subsequent passage. However, a few NVs (e.g., NV-01, NV-23, NV-34, 
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NV-37, NV-40, and NV-63) remained for several subsequent passages once they initially 
appeared.  
The predicted RFLP patterns of the viral clones are summarized in Table 1. Among 
the clones, 398 clones (80.4%) were predicted to have pattern 2-5-2, which is the same as the 
RFLP pattern of the inoculum virus (CC-01). The remaining 97 viral clones were predicted 
to have RFLP patterns different from that of the initial inoculum. The appearance of different 
RFLP patterns varied between passages and among pig lines, suggesting that mutational 
changes in PRRS viral ORF5 are likely random and independent. Despite the incidence of 
randomness and independence, the complete conversion and reversion of the RFLP patterns 
among all 15 plaque-cloned viruses were observed between P11 and P12 and between P7 and 
P8 in lines B and C, respectively. The biological significance of this phenomenon was not, 
however, apparent with respect to the clinical responses, including viremia and antibody 
production (data not shown).  
During the study period (727 days), four RFLP patterns distinct from 2-5-2 were 
observed: 2-6-2 (P2), 1-5-2 (P3), 2-5-4 (P7), and 2-1-2 (P10). Such predicted patterns were 
confirmed to be the same as those obtained by the actual RFLP analysis (Fig. 3), 
demonstrating that the RFLP pattern of each virus predicted from its nucleotide sequence 
was accurate. While most of the RFLP patterns different from pattern 2-5-2 were short-lived 
(i.e., they appeared in only one passage and disappeared in the subsequent passage), pattern 
2-1-2 became predominant (75 of 97 clones) after nine passages of CC-01. In particular, the 
RFLP patterns of all viral clones from line C became 2-1-2 (Table 1). 
 Although the sequences of all three restriction enzyme sites used to characterize the 
PRRS virus ORF5 changed during the study period, the HincII sites appeared to be more 
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vulnerable to mutational changes than the other two restriction enzyme sites. More 
importantly, a clone without the MluI site (position 196) that was reported to be present only 
in Ingelvac® PRRS vaccine virus and its parental strain (ATCC VR-2332) but not in wild 
types (25) appeared during the long-term in vivo replication of CC-01, which was derived 
from ATCC VR-2332.  
Phylogenetically, viral clones with different RFLP patterns, particularly clones with 
pattern 2-1-2, formed their own cluster which was separated from clusters among viral clones 
with RFLP pattern 2-5-2 (Fig. 2). However, the overall sequence homology did not provide a 
clear-cut demarcation between these two groups. The nucleotide sequence divergence 
between variant viral clones with RFLP pattern 2-5-2 and CC-01 ranged from 0.05 to 1.58%, 
whereas the sequence discrepancy between viral clones with RFLP patterns other than 2-5-2 
and CC-01 ranged from 0.5 to 1.45%. Furthermore, it was observed that virus clones with 
pattern 2-5-2 that had completely disappeared in the preceding passage reemerged in the 
successive passage (Table 1); however, their ORF5 genetic makeup was different from that 
of virus clones with pattern 2-5-2 in an earlier passage. 
 
Discussion 
 
The study described here was conducted to evaluate whether the ORF5 RFLP pattern 
of a PRRS virus is stable during replication in pigs and how well RFLP analysis of ORF5 can 
predict the genetic relatedness among PRRS viruses. These questions were important, since 
RFLP analysis has commonly been used to study the molecular epidemiology of PRRS 
viruses in the field not only because of its rapid turnaround and inexpensive nature but also 
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because of an assumption that the RFLP pattern of a PRRS virus is stable (25, 26). In 
contrast to that assumption, the results of this study demonstrated that the ORF5 RFLP 
pattern of PRRS virus can be changed during in vivo replication and that the change is 
somewhat unpredictable and inconsistent due to conversion and reversion. The study also 
demonstrated that the predictive value of a RFLP pattern for genetic similarity or relatedness 
between PRRS viruses is questionable because of observed continuous genetic changes in 
ORF5 during the study period (Fig. 1). Although this may not be an unexpected result, since 
PRRS virus is an RNA virus for which genetic instability is common, to our knowledge this 
is the first report to prove the instability of the ORF5 RFLP pattern of a PRRS virus in pigs 
under experimental conditions, thus challenging the reliability of RFLP analysis for rapid 
genetic characterization.  
Several RFLP patterns that differed from that of the inoculum emerged during the 
727-day study period (Table 1). All of those patterns have been seen among field isolates 
implicated in clinical outbreaks of PRRS after the vaccine (Ingelvac® PRRS) was introduced 
to the market (K.-J. Yoon, unpublished data), and some of those were seen as intermediate 
patterns between the vaccine strain and the wild types even before the vaccine was available 
(26). As genetic changes in ORF5 were mostly random, no directional change in the RFLP 
pattern was observed between passages and among pig lines. Furthermore, alteration of the 
RFLP pattern was not permanent and many times disappeared in a successive passage, 
although one particular RFLP pattern (pattern 2-1-2) became dominant after nine passages of 
clone CC-01 (pattern 2-5-2) in pigs. This observation, along with the fact that pattern 2-5-2 
was still dominant overall, suggests that there is a purifying process which prevents a radial 
expansion of mutants until a certain variant(s) among quasispecies acquires a better fitness 
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for the host, although the better adaptation of certain genotypes to the cell culture system 
used in this study certainly could account for it. Furthermore, complete conversion and 
reversion of an RFLP pattern between passages could have been attributed to the number (i.e., 
n = 15) of plaque-cloned isolates from each pig. Although that number was statistically 
determined at the 95% confidence level for the detection of one variant in a population with 
10% deviation, it would be possible that minor variants may be detected if the number of 
plaque-cloned viruses were increased.  
The disappearance of the MluI site from ORF5 of CC-01, which was derived from 
ATCC VR-2332, during in vivo replication was an unexpected observation. More 
surprisingly, the virus clone without the MluI site (i.e., pattern 1-5-2) emerged at the early 
stage in sequential passages, while such a virus clone shared 99.7% sequence homology with 
CC-01. Previous reports (25, 26) strongly suggested that not all wild-type PRRS viruses have 
an MluI site in ORF5, unlike the Ingelvac® PRRS vaccine virus and parental strain ATCC 
VR-2332. Consequently, if PRRS viruses were to be evaluated only by RFLP analysis, some 
viruses without an MluI site could erroneously be categorized into the wrong group, i.e., as 
the wild type instead of the vaccine type. In fact, the loss of the MluI site appears to occur 
during natural infection, as field isolates of PRRS virus which have pattern 1-5-2 and which 
share a relatively high degree of sequence homology (97.0 to 99.3%) with ATCC VR-2332 
or the Ingelvac® PRRS vaccine strain have been identified (Yoon, unpublished).  
In summary, our observations demonstrate that the RFLP pattern of a PRRS virus can 
be changed during its replication in pigs and that RFLP analysis may not accurately predict 
genetic similarity or relatedness between or among PRRS viruses. These facts should be 
taken into consideration when molecular characterization or the epidemiology of PRRS 
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viruses is determined only by RFLP analysis. 
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 Table 1. Restriction fragment length polymorphisms (RFLPs) of open-reading frame 5 of 
PRRS virus that was plaque-cloned from VR-2332, North American prototype during a long-
term in vivo replication.  RFLP pattern of each virus clone was predicted from its nucleotide 
sequence. 
RFLP pattern Passage Line No. cloned 
viruses 2-5-2 2-6-2 1-5-2 2-5-4 2-1-2 
A 15 15a     
B 15 15     1 
C 15 15     
A 15 15     
B 15 9 6    2 
C 15 15     
A 15 15     
B 15 14  1   3 
C 15 15     
A 15 15     
B 15 15     4 
C 15 15     
A 15 15     
B 15 15     5 
C 15 15     
A 15 15     
B 15 15     6 
C 15 15     
A 15 15     
B 15 15     7 
C 15    15  
B 15 15     8 C 15 15     
B 15 15     9 C 15 15     
B 15 15     10 C 15     15 
B 15     15 11 C 15     15 
B 15 15     12 C 15     15 
B 15 15     13 C 15     15 
Total 495 398 6 1 15 75 
aNumber of clones with given RFLP pattern 
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Fig. 1. Change of nucleotide sequence in ORF5 during sequential pig passages of a plaque-
cloned PRRSV (CC-01) derived from VR-2332.  Each symbol represents the mean of 
mutation rate among 15 plaque-cloned isolates obtained from each pig’ serum collected at 
day 7 post inoculation of each passage.  Mutation rate at each given time was calculated as 
the proportion of nucleotide substitutions in ORF5 sequence of each cloned virus in 
comparison to the sequence of the inoculum (CC-01).  Error bars are the standard errors of 
the mean.   
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Fig. 2. Phylogenetic relationship of plaque-cloned PRRS virus isolates representing different 
nucleotide variants (NVs) and RFLP patterns appeared during 727-day replication in pigs 
based on ORF5 nucleotide sequence.  CC-01 is the inoculum virus.  Different nucleotide 
variants are designated with different numbers.  The number in the parenthesis is the number 
of passage in which the given NV appeared first.  NVs without specific RFLP pattern have 2-
5-2 pattern. 
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Fig. 3. Photograph of 1.5% agarose gel with ORF5 cDNA of selected plaque-cloned PRRS 
virus isolates with representative predicted RFLP patterns observed during 727-day 
replication in pigs after digestion with selected restriction enzymes (lane 1: Mlu I; lane 2: 
Hinc II; lane 3: Sac II).  PCR product of each virus was digested, electrophoresed along with 
DNA ladder (lane M) and stained with ethidium bromide.  
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Abstract 
 
In vivo recombination of PRRSV was examined by simultaneously inoculating pigs 
with divergent type II strains (13B6 and 13C8).  Pigs were randomly divided into three 
different treatment groups (two single infection groups and one mixed infection group), and 
viruses were passaged through multiple naïve hosts within each group.  In the first passage, 
three pigs each were inoculated with 13B, 13C8, or both viruses and kept individually in 
HEPA-filtered isolation units for 60 days post inoculation (dpi).  One pig served as negative 
sentinel control.  In the first passage, all dually infected pigs were bled at 7, 14, 21, 28, 35 
and 60 dpi, and singly infected pigs were bled at 21 dpi.  At 60 dpi various specimens were 
collected from each pig and used to initiate the second passage by inoculating three more 
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naïve pigs.  In subsequent passages, all pigs were bled at 21 dpi.  A total of three pig-to-pig 
passages were performed, and 760 plaque-cloned viral isolates (approx. 20 clones/pig at each 
sampling time) were obtained from sera.  For each clone, ORF2 to ORF7 was sequenced and 
analyzed for recombination.  Recombinants emerged in all dually infected pigs in the first 
passage, and a total of five different types of recombinants were observed throughout the 
study.  Interestingly, recombinants that emerged in the first passage were often replaced with 
novel recombinants arising in the second passage.  Cross-over sites were located throughout 
the structural proteins, with a slight preference for ORF 5.  This study is the first direct 
evidence that recombination occurs during PRRSV in vivo replication, and further suggests 
that recombination can occur virtually anywhere in the structural protein genes of PRRSV.  
Recombination in PRRSV may provide the virus with a mechanism for rapidly producing 
divergent variants that could partially explain why controlling the disease is such a challenge.   
 
Introduction 
 
  Since porcine reproductive and respiratory syndrome (PRRS) first appeared in the 
United States as ‘Mystery Swine Disease’ in the mid 1980s (17), the catastrophic and 
uncontrollable disease it causes has plagued the swine industry in the US and throughout the 
world.  The causative agent, PRRS virus (PRRSV), belongs to the family Arteriviridae in the 
order of Nidovriales along with equine arteritis virus (EAV), lactate dehydrogenase elevating 
virus (LDV) of mice, and simian hemorrhagic fever virus (SHFV) (2, 42).  The PRRSV is 
enveloped and contains a polyadenylated, single-stranded, non-segmented, positive-sense 
RNA genome of 15 kb in length and encoding nine open reading frames (ORFs).  ORF1a and 
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ORF1b are postulated to encode the viral replicase complex and various proteinases (8, 32, 
60).  The rest of the ORFs (ORFs 2a to 7) encode structural proteins: glycoprotein (GP) 2a, 
2b (E), GP3, GP4, GP5, matrix (M) protein, and nucleocapsid (N) protein (33, 46, 56).    
  PRRS viruses are divided into two genotypes, type I (European) and type II (North 
American), showing a high degree of antigenic and genetic diversity between them (13, 21, 
31).   Numerous studies have described substantial genetic or antigenic variation within each 
genotype as well (5, 17, 26, 30, 40, 41, 47, 57, 58). 
 Genomic recombination is one of the most efficient ways to generate diversity, and 
since it is more frequent in RNA viruses, it could give them an advantage over DNA viruses.  
There are two overarching modes of recombination in RNA viruses: homologous and non-
homologous, although some (39) have distinguished three classes: class 1 (similarity-
essential recombination), class 2 (similarity-nonessential recombination) and class 3 
(similarity-assisted recombination).  The mechanisms of viral recombination have been well 
studied using experimental systems involving the turnip crinkle virus (1), tombusvirus (55), 
and brome mosaic virus (BMV) (38).   Most mechanisms of RNA recombination involve 
replicase-mediated template switching following pausing and termination of RNA 
polymerization (37).   Recombination has been well documented in a variety of RNA viruses 
(23, 24, 43, 44, 49, 54). 
  Recombination among PRRSV was postulated in a report studying the genetic 
diversity among PRRS viruses from Midwestern US swine populations(18) and demonstrated 
in the ORF3 and 4 regions in MA-104 cells concurrently infected with the RespPRRS® and 
Prime Pac®PRRS vaccine strains, as well as in the ORF5 region in a field isolate (59).   
Recombination in European strains was also observed in ORF4 and mainly ORF5 when 
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Marc-145 cells were infected with Lelystad and Danish 111/92 viruses (52).  Among other 
members of Arteirviridae, recombination of LDV was demonstrated by inoculating two 
different strains into mice (27), and EAV was shown to undergo recombination during 
replication (35).   
Despite previous reports of recombinant PRRSV, there is no direct evidence of 
recombination during in vivo replication in the natural host.  This study was conducted to 
demonstrate recombination in pigs simultaneously inoculated with two different viruses by 
finding statistical evidence for recombination among these strains in the ORFs 2-7 sequences 
isolated from dually infected pigs.  
 
Materials and Methods 
 
   Viruses, cells and media.  MARC-145 cells, a clone of the African monkey kidney cell 
line MA-104 that is considered highly permissive to PRRSV (22) were cultured and 
maintained in Dulbecco’s modified Eagle’s medium (DMEM; Sigma Chemical Co., St Louis, 
MO, USA) supplemented with 10% fetal bovine serum (HyClone Laboratories, Inc., Logan, 
Utah. USA), and gentamicin (Sigma) and amphotericin B (Sigma) at a concentration of 50µg 
and 0.25µg, respectively, per 1 ml of the medium (hereafter DMEM growth medium). 
Two PRRS viruses designated 13B and 13C were used for the study.  The viruses 
were obtained from a previous study (4).  Highly homologous challenge viruses were made 
by the method previously described (6).  In brief, the viruses were isolated by plaque cloning 
three times in MARC-145 cells inoculated with 7 days post-inoculation (DPI) sera of pigs, 
which were infected with tissue homogenates of pigs at 12th passage.  Following the third 
 104 
round of plaque cloning, the viruses were propagated two times in Marc-145 cell and divided 
into aliquots and stored at -80oC for future inoculation into pigs.  Twenty viral clones were 
obtained by plaque cloning from each virus and sequenced from ORF 2 to 7 to assess the 
homogeneity of the virus population within the inoculum and to provide a baseline for 
sequence comparison.   
   Passage experiments.  Ten pigs were divided into 4 groups: two single infection groups (3 
pigs per each group), one dual infection group (3 pigs) and one control group (1 pig).  The 
control group pig served both as a mock-infected negative control and as an environmental 
sentinel.  Three independent lines (A, B and C) within each group except control group were 
established for in vivo virus replication, and the pigs were monitored for genetic changes in 
the viruses and animal response to infection over 3 animal passages (P1 to P3).  In P1, the six 
pigs of the two single infection groups were inoculated intranasally and intramuscularly with 
PRRSV 13B or 13C (102 TCID50 per pig).  For the dual infection group, aliquots containing 
102 TCID50 viruses from each of the two strains were mixed and inoculated into each pig 
with the same routes as single infection groups.  Animals were housed in HEPA-filtered 
isolation units (Barrier systems, Inc., Tom River, N.J.) to prevent exposure to extraneous 
viruses and cross contamination among groups.  For 60 dpi, pigs were observed daily for 
clinical symptom and sera were collected periodically for virological and serological assays.  
Sera were collected at 7, 14, 21, 28, 35 and 60 dpi from the dual infection group in P1, and 
21 dpi from all other pigs and passages.  At 60 dpi, the animals were euthanized, and serum, 
lymph nodes (submandibular, tracheobronchial, suprainquinal, mesenteric), samples of other 
tissues (tonsil, liver, lung, peyers patches, small intestine, kidney, brain, meat, spleen, heart, 
patotid), and bronchoalveolar lavage fluid were collected from each pig.  For each 
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subsequent passage after P1, ten PRRSV-free pigs were randomly assigned to the four groups 
and inoculated as described above, except that tissue homogenate filtrate prepared from the 
postmortem samples collected from the corresponding pig in the previous passage was used 
in place of the cell culture-derived PRRSV inoculum to keep the independent three lines and 
avoid any selective pressure from cell culture on viruses.  
   Animals and animal care.  Throughout the study, animals were housed and cared for in 
compliance with the requirements given in the Guide for the Care and Use of Agricultural 
Animals in Agricultural Research and Teaching.  Crossbred pigs were obtained from a closed 
specific-pathogen free herd known to be free of PRRSV. Pigs were weaned at 10 to 14 days 
of age, and housed in groups in HEPA-filtered isolation units for several days prior to 
exposure to the virus and were then housed individually in the isolation units from the time 
of exposure until the end of the observation period.  
   Virus titration.  A microtitration infectivity assay was performed to assess the virus titer 
of the original inoculum, as well as the levels of PRRSV in serum samples collected over 
time from pigs in P1 through P3.  Briefly, samples were 10-fold serially diluted (i.e., 100 to 
10-6) in the DMEM growth medium.  One hundred microliters of each dilution were added to 
each of 3 wells of a 96-well microtitration plate (Corning) containing 24-hour old confluent 
MARC-145 cell monolayers.  Inoculated cells were incubated at 37°C in a humidified 5% 
CO2 incubator.  Each sample was run in duplicate.  The cells were monitored daily for 
cytopathic effects (CPE) for up to 7 days.  If CPE were not evident, the cells were fixed with 
cold aqueous 80% acetone solution, dried and stained with fluorescein isothiocyanate 
conjugated MAb SDOW17 (Rural Technologies, Brookings, S.Dak.) which is specific for the 
N protein of PRRSV, and antigen-antibody complexes were visualized with fluorescence 
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microscopy.  The presence of PRRSV in the inoculated cells was determined based on the 
observation of virus-specific CPE and/or fluorescence reaction.  Virus titers were determined 
by the Reed and Muench method, and were expressed as TCID50 per milliliter. 
   RT-PCR and sequencing.  ORFs 2-7 (3188bp) were sequenced for 760 plaque-cloned 
viruses.  Viral RNA for RT-PCR amplification and sequencing was extracted from each 
plaque-cloned viral isolate with a QIAamp viral RNA kit (Qiagen Inc., Valencia, Calif.) by 
following the protocols recommended by the manufacturer. Viral RNA was collected and 
stored at -80oC until used.   
For ORFs 2-7 RT-PCR, 5µl of extracted RNA template was added to a tube 
containing 25µl of 2X Reaction Mix (0.4mM of each dNTP, 2.4mM MgSO4), 1µl of 
SuperscriptTM III RT/Platinum® Taq High Fidelity Enzyme Mix, and 17 µl of RNase-free 
H2O (SuperScriptTMIII One-Step system with Platinum Taq High Fidelity; Invitrogen, 
Carlsbad, Calif.); 1µl (10pmol) of primer PR11933F; 1µl (10pmol) of primer 7R (Table 1).  
The RT-PCR was performed with a thermal cycler (GeneAmp PCR system 2400; Applied 
Biosystems, Foster City, Calif.) at 50°C for 30min and 94°C for 2min; then, 40 cycles of 
denaturation at 94°C for 15 s, annealing at 55°C for 30s and extension at 68°C for 3min 
followed.  After the last cycle, the extension period was maintained at 68°C for 5min.  To 
confirm the positive reaction, 2 µl of the final products was separated by electrophoresis in a 
1% agarose gel (Amresco Inc., Solon, Ohio) containing 0.1% ethidium bromide in Tris-
borate-EDTA buffer. The positive products were visualized and photographed under UV 
light.  The positive products were purified with either QIAquick or 96-well PCR purification 
kits (Qiagen) by following the procedures recommended by the manufacturer, then all final 
products were stored at 4°C until used.  
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Sequencing of ORFs 2-7 was performed at the Iowa State University Nucleic Acid 
Facility (Ames, IA) by using the appropriate amount of purified PCR product (30 µg/ul) and 
5 pmol of each primer in Table 1.  
   Sequence comparison, statistics and phylogenetic analysis.  The sequence data were 
analyzed by Lasergene® software (DNASTAR© Inc., Madison, WI, USA) and compared to 
inoculums (13B and 13C) to evaluate the degree of mutation over time.  Sequence alignment 
was done using Clustal W (51).  The mutation rates for individual plaque-cloned viral 
isolates were calculated as the proportion of total nucleotide or amino acid substitutions in 
comparison to the sequence of 13B or 13C and were expressed as mean percent change in all 
plaque-cloned viruses per sampling time or group.   
Unrooted phylogenetic trees were generated using the distance-based neighbor-
joining method of MEGA software version 3.1 (http://www.megasoftware.net/).  Confidence 
values for each branch were calculated on 1000 bootstrap replicates of the alignment. 
Differences of mean mutational change, linear regression curve and regressional 
coefficient value (r2) were analyzed by one-way ANOVA test.  The graphs were prepared 
using SigmaPlot (ver. 8.0) (Systat Software, Inc., Point Richmond, CA, USA)  
   Recombination analysis.  All ORF 2-7 sequences were individually aligned with the two 
consensus sequences representing each inoculum (13B and 13C) and the consensus of the 
original ancestral strain CC-01 that produced 13B and 13C (ref).  Each four-sequence 
alignment was screened for possible recombination using all three statistics (Max Chi square, 
Phi, and Nearest Neighbor Score) computed in PhiPack.  For each sequence with [some 
evidence of recombination], cBrother (12), using Markov Chain Monte Carlo (MCMC), 
estimated the recombinant structure, including cross-over points and parental strain (13B or 
 108 
13C) of each region, using a dual multiple change point model for recombination among 
sequences (34,48).  A sample of 3000 iterations from two independent MCMC chains started 
from random nonrecombinant states was obtained.  Initial burnin was 7,000,000, and the 
subsample rate was 1,000.  We deduced the recombinant structure as the 5’ to 3’ sequence of 
parental strains that achieved 90% or higher posterior support along the alignment.  Several 
statistical tests were performed to check that these chains had converged to the stationary 
distribution and the results were reliable.  The Gelman-Rubin statistic (15) was computed on 
the number of cross-overs obtained from the two chains.  Also, for each cross-over point in 
the inferred recombinant structure, data on its location were collected and then compared 
with chain inferences using the Gelman-Rubin statistic and the Wilcoxon test of medians 
(45). 
Once the MCMC samples were verified, the posterior distribution was summarized in 
several ways.  The hypothesis of recombination for each tested sequence was summarized 
using the log10 Bayes factor (BF) (48)  
                                                                        
where X was the data, and the hypothesis of recombination implies the test sequence is 
involved in at least one crossover event.  The BF is estimated as the ratio of posterior odds to 
prior odds in favor of recombination.  By default, prior odds are 1 in cBrother, so the log10 
BF reduces to log10(# samples with > 1 crossover) − log10(# samples with 0 crossovers).  The 
posterior median and 95% Bayesian credible intervals were used to summarize the posterior 
distribution of each cross-over point location.  The posterior support for a cross-over point is 
the proportion of times the designated cross-over point occurred in the posterior sample.  
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Results 
 
 Pigs were housed in individual isolation units equipped with a HEPA filter to prevent 
cross contamination following inoculation with cell culture-derived virus or tissue 
homogenate filtrates.  During the study period, all pigs did not show apparent or consistent 
clinical signs compatible with those usually observed during clinical outbreaks of PRRS in 
the field.  All pigs in lines A, B and C of all infection groups were viremic through all 
passages except for one pig in line C at the third passage in the 13B single infection group 
(Fig. 1).  Lack of viremia in this animal indicated that the third passage was not successful.  
The two viruses 13B and 13C showed different patterns of replication in the host during the 
first passage.  13C viruses achieved significantly higher level of viremia early in infection.  
13C viruses also dominated early time points in the dual infection group.  All pigs developed 
antibodies against PRRS viruses, and showed similar humoral immune responses (data not 
shown).     
   Genetic characterization of the 13B and 13C inocula.  Twenty clones of each 
inoculating virus were sequenced for ORFs 2-7 (3188bp).  For both strains, there were six 
variants, each with a single synonymous mutation, suggesting the inoculating viruses are 
highly homogenous.  Nucleotide sequence divergence between the two viruses was 2.1 % 
based on the ORF 2-7 consensus sequences.  
   Random mutational change in single infection groups.   The sequences from all single 
infection groups and line A of the dual infection group, which produced no recombinants 
before 21 dpi of the first passage and had 13B genetic features, were compared.  Continuous 
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random nucleotide mutations were introduced throughout ORFs 2-7, and the mutation rates 
were increased over passages.  The rates of viruses in each animal at each passage were 
calculated and compared among individual animals (Fig. 2a).  However, mutational kinetic 
based on lines was different among individual lines or between infection groups as shown by 
linear regression: in 13B infection group, Y13B-A (line A) = -0.007 + 0.0309X (r2=0.435), 
Y13B-B (line B) =0.006 + 0.0159X (r2=0.175), Y13B-C (line C) =0.003 + 0.0196X (r2=0.178); in 
13C infection group, Y13C-A(line A) =-0.030 + 0.1518X (r2=0.922), Y13C-B (line B) =-0.016 + 
0.0753X (r2=0.895), Y13C-C (line C) =-0.015 + 0.1005X (r2=0.879); in dual infection group, 
Ydual-A=-0.027 + 0.085X (r2=0.874) (X represents passage number).  Increase in the 
mutational change rates among the seven lines of three groups was placed in order: 13C-
A>13C-C>13C-B=Dual-A>13B-A=13B-C=13B-B (p<0.05).   Mutational change rates were 
examined based on groups (Fig. 2b).  13C group at 2nd and 3rd passages showed significantly 
higher rates than did 13B group at all passages and 13C group at the first passage.  Increase 
in mutational change rates over passage was shown as linear regression:  Y13B=0.0227X, 
Y13C=-0.020 + 0.1093X, Ydual-A=-0.027 + 0.085X (r2=0.874) (X represents passage number).  
Increase in mutational change rates were placed in order: 13C>Dual-A>13B (p<0.05).  
Overall, viruses from pigs infected with 13B showed lower nucleotide mutational change 
rates than 13C. Interestingly, mutational change rates and increase of mutational change rates 
over passages of line A of dual infection group were significantly higher than that of 13B 
group in any individual or group.    
`   Genetic exchange and continuous mutation in dual infection group.   To determine 
when recombinants were generated in the dual infection group, plaque-cloned viruses (20 
viruses per each serum sample) were isolated by inoculating the serum obtained at 7, 14, 21, 
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28 and 35 dpi from the first passage into MARC-145.  Comparison of ORFs 2-7 revealed the 
change of viral populations in sera and generation of recombinants over time.  We next 
determined the time of appearance of each recombinant and assessed whether any 
recombinant appeared in more than one dual infection line.  At 7 dpi, all plaque-cloned 
viruses from all pigs were most closely related to parental strain 13C, however, plaque-
cloned viruses similar to 13B appeared at 14 dpi in lines A and C and later came to dominate 
viral populations in these lines (Table 2).  
Recombinants emerged as early as 14 dpi, but only in the dual infection group (Table 
2).  In the first passage of line A, RECOM 1 appeared as two of the 20 clones at 14 dpi, but 
was not sampled at or after 21 dpi.  No other recombinants appeared in this line.  Line B was 
dominated by RECOMB 2 in all 20 clones examined at 14, 21 and 28 dpi of passage one.  
Passage to the second pig, however, inaugurated a novel recombinant, RECOMB 4, that then 
dominated throughout the experiment in this line. RECOM 3 appeared as one of the 20 
clones sampled from line C at both 21 and 28 dpi of passage one, but again, passage two 
marked the domination of a novel recombinant, RECOMB 5, that persisted through passage 
three.  
   Recombination analysis and cross-over points.  cBrother confirmed the recombination 
by comparing the parental strains with the recombinants that was detected by sequence 
comparison and Simplot assay (Fig. 4a).   
The BFs of all tested sequences were infinite, indicating overwhelming support for 
recombination (data not shown).  The inferred recombinant structures are shown in Fig. 4b, 
along with 95% Bayesian credible intervals for all cross-over points (Fig. 4b).  Statistical 
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support for each cross-over point exceeded 98%, except for the second cross-over of 
RECOM 2, which received only 71% posterior support.  
   Phylogenetic analysis.  Phylogenetic analysis was performed with all 760 plaque-cloned 
viruses, including sequences of the two inocula (Fig. 5).  Viruses isolated from each passage 
of each single infection group formed independent clades, within which viruses were located 
in chronological order.  All recombinants formed separate clades, again in chronological 
order.  Nonrecombinant viruses from line A of the dual infection group formed a separate 
clade, close to 13B clades from the inoculum and single infection group.  Most first passage 
viruses from the 13C infection group and nearly all viruses from the 13B infection group did 
not form distinct clades and were close to their corresponding parental clade. 
 
Discussion 
 
13B and 13C viruses used as inoculums in this study were obtained by passing a 
plaque-cloned virus originated from VR-2332, a prototype of North American genotype, 
thirteen times in pigs (4, 6) and three times repeated plaque-cloning in a cell line, Marc-145.  
Thus, they had the same replication history, in terms of number of passages and type of host.  
The two inoculum viruses, 13B and 13C, were highly homologous, which was supported by 
sequences of 20 plaque-cloned viruses from each of 13B and 13C viruses.  Nevertheless, 
fitness to natural host of the two viruses was significantly different at the first passage as 
evident with viremia level (Fig. 1), which may be due to the population selection by plaque-
cloning during preparation of inoculum.  Since RNA viruses are composed of multiple viral 
populations, “quasispecies”, that may have diverse fitness and phenotypic variants, single 
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plaque cloning may choose a specific population.  Repeated passages by plaque cloning put 
the viral population under the purifying selection, and make it distant from the original 
viruses regarding genetic as well as phenotypic features like fitness (9, 10, 11).   
Mutational change rates were also significantly lower in 13B infection group than 
13C infection group.  Viral mutation frequency or rate can be affected by viral replication 
frequency (16), replication error rate of viruses (16, 53), host type (e.g., cell culture or natural 
host) for replication (50), unknown host factors (14), and recombination within quasispecies 
(7, 36).  The higher mutation frequency in 13C may be due to preeminent viral replication 
frequency and more diverse mutant spectrum than the 13B in the inoculums used for the 
animal infection.  Hanada et al. (2004) reported that PRRSV has the highest synonymous 
substitution rate (6.2×10-2/site/year) among viruses, replication frequency is mostly 
associated with the synonymous substitution rates under the similar replication error rate. As 
shown in viremia level of each infection group in the first passage, 13C virus had superior 
replication frequency in pigs as compared to 13B virus, which might render better recurrence 
of mutation in 13C.  On the other hand, mutant spectrum of 13C virus in inoculum is 
possibly broader than that of 13B.  Charpentier et al. (2006) reported that extensive 
recombination within quasispecies generated further diversity in HIV-1.  The sequence of 
ORFs 2-7 of viral populations in each virus indicated similar level of mutant spectrum among 
the inoculums.  However, since the viral populations were obtained by isolation in cell 
culture, viral populations that were not identified, but, maintain replication ability in natural 
host may exist.  In other words, unbalanced mutant spectrum between two viruses may lead 
to the difference in mutation frequency during generation of novel mutants by recombination.  
The two potential factors were reflected on the observation that the number of mutants of 
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13C group (14.6 on average) was larger than that of 13B group (11.3 on average) at 21DPI of 
the first passage.  Another observation supported the beneficial effect of mutant spectrum on 
mutation frequency.  Line A of dual infection group that had genetic features of 13B was 
significantly (p<0.05) higher than any line of 13B infection group in mutational change rates 
and increase of mutational change rates (Fig. 2a and 2b).  However, generation of diversity in 
line A of dual infection group may indicate different mechanism.  
Mutational change rates were significantly different among individuals infected with 
a single virus, but linear regression slope of ORFs 2-7 (1 through 13 passages) indicating 
increase in mutational change rates were not statistically different (3).  The previous study 
results were echoed by this study showing significant differences (p<0.05) of mutational 
change rates within infected animals of single infection groups (Fig. 2a and 2b).  However, 
increase in mutational change rates cannot be compared due to the limited numbers of 
passages performed in this study  
PRRS viruses undergo independent evolution in isolated hosts, producing genetically 
different viral populations among individual animals infected with a single strain of viruses 
(3).  Under the current study, phylogenetic analysis of ORFs 2-7 sequences also revealed 
distinct development of evolution among individual animals and between two viral groups 
(Fig. 5), in which modification of biological feature (e.g. fitness and tropism) or/and 
antigenic change (susceptibility to neutralizing antibody) may be outcomes as shown in 
previous studies (3, 6).  As expected by the unusual mutational rates in the group, line A of 
dual infection group was developing its clade, becoming distant from viruses in 13B group 
Recombinants emerged in blood during in vivo replication and survived in the 
subsequent passages.  Recombinants arose early in the infection (14 days p.i.) (RECOM1 and 
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2) and lasted up to 28 DPI (RECOM2 and 3), while one of the recombinants (RECOM1) 
showed up at 14 days p.i. and disappeared shortly thereafter.  Recombinants existed in blood 
as dominant (20 out of 20) (RECOM2, 4, and 5) or minor (2 out of 20 [RECOM1] and 1 out 
of 20 [RECOM3]) population.  Observation of new recombinants in the subsequent passages 
(2nd and 3rd passages), which had different pattern of recombination from the corresponding 
animals at the first passage, was not however expected.  To examine the origin of the new 
recombinants, we attempted to amplify ORF 5 region from all tissues and organs of 9 pigs 
euthanized at the first passage that were used for the next passage.  The amplification was 
successful in lymph nodes (tonsil, suprainquinal lymph node, submandibular lymph node, 
tracheal lymph node and mesenteric lymph node) and the amplicons were determined for 
master sequence.  Sequence analysis showed that same patterns of recombinants in lymph 
nodes as those that were shown in serum of the second or third passage were not observed. 
And viral populations of non-recombinants or recombinants were different among lymph 
nodes within individuals (data not shown).  These results generated two speculations about 
generation of the new recombinants; 1) Genetic exchange among different type of viral 
recombinants present in inoculum may continue to ensue during infection in the next host, 
producing the new type of recombinants. 2)  The new recombinants coexisted as minor 
population or at undetectable level with other patterns of recombinants in the inoculum and 
may be preferentially selected during infection.  The explicit process for the generation of the 
novel recombinants remains to be elucidated.  However, it seems that mixing of tissues and 
organs for inoculation contributed to continuous emergence of emergence of novel viral 
population including recombinants at the subsequent passage, since various tissue and organs 
(mainly lymph nodes) harbored distinct viral populations (data not shown).  
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Previous studies demonstrated intra-genotypic recombination during PRRS virus 
replication in cells.  Recombination rates of PRRS viruses had been estimated at 2-10% in 
1182 bp fragment (59) and 0.1-2.5% in 621bp fragment (52).  Meanwhile, among other 
viruses belonging to Nidovirales, recombination rates were estimated at 5% in 1276 bp 
fragment in LDV (27) and 1% in 1300 bp fragment in MHV.  Our study showed emergence 
of recombinants in all pigs of dual infection group, and dominance and evolution of 
recombinants in viral population.  A direct comparison of recombination frequency with the 
previous studies is not appropriate because of obvious differences in experimental designs, 
such as host for replication, test samples, and test region for recombination analysis.    
However, this study signified the potential of significant circulation of recombinants in the 
field.  
Cross-over sites were found throughout the structural proteins genes, although none 
occurred in ORF2.  Because there were so few recombinants, it was impossible to test for a 
nonuniform distribution of cross-over sites, but three recombinants, RECOM2, RECOM3, 
and RECOM4 have cross-overs near the ORF4-ORF5 boundary. This result was in 
agreement with observation by Molenkamp et al (2000) where it was reported that 
recombination frequency was much higher at 3’ proximal region than at the 5’ proximal 
region of EAV genome, and speculated that the preference may be led by two mechanisms in 
genome replication, discontinuous subgenomic mRNA and strand transfer mechanism.  Since 
PRRSV takes advantage of the same mechanisms for replication, our result was not 
surprising.  However, there was no specific preference in leader-body junction for 
recombination, implying that strand transfer mechanism involving the junction may not be 
influential in the event.  Kapur et al (1996) reported that ORF6 was the most conserved gene 
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among the structural protein genes, and could not find any evidence of recombination in 
ORF6.   In contrast, our study revealed that ORF6 also could be a target for recombination.  
However, the recombination frequency of the region could not be assessed because of limited 
number of recombination event.  
Despite PRRSV recombination observed in the previous studies (18, 52, 59), it has 
been difficult to describe emergence of PRRSV recombinants during infection in the field.  
This was mainly because the studies investigated recombination using molecular cloned 
samples and recombinants were generated during in vitro replication.  In contrast, our study 
demonstrated recombination with live viruses harboring recombinant genome generated 
during replication in natural host under experimental conditions.  Even more, demonstration 
of obviously live recombinants generated from natural host was unprecedented among 
members of the genus Arterivirus.  High frequency of recombination and survival of 
recombinants during passages are strongly supportive of generation and circulation of 
recombinants in the field.  Further studies using multiple field strains need to be done in 
order to provide direct evidence of recombinants circulating in the field. 
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TABLE 1. Primers used for PCR and sequencing 
Primer Sequence Location (nucleotide) 
  PR11933F      5’-AAA CGG TGA GGA CTG GGA GGA TTA-3’ 11933-11956 
  PR12202F      5’-CCG GTT GGC TGG TGG TCT-3’ 12202-12219 
  PR12712F      5’-CAT TCC TCC ATA TTT TCC TCT GTT-3’ 12712-12735 
  PR13254F      5’-TTC TTT TCC TCG TGG TTG GTT TTA-3’ 13254-13277 
  PR13342R      5’-CGC TGC GGT GGT GTT GGT CTT A-3’ 13342-13321 
  PR12809R      5’-TCG AAA GAA AAA TTG CCC CTA ACC-3’ 12809-12786 
  PR12478R      5’-ATC CAA ACT ACT AAT GCG AGA CAG-3’ 12478-12455 
  PR13863R      5’-CAA AAC AGA ACG GCA CGA TAC ACC-3’ 13863-13840 
  P5F      5’-CCT GAG ACC ATG AGG TGG G-3’ 13696–13714 
  P5R      5’-TTT AGG GCA TAT ATC ATC ACT GG-3’ 14459–14437 
  P6F      5’-GCG GTC GCC TGT CAT CAT AG-3’ 14252-14271 
  P6R      5’-GGC TGG CCA TCC CCC TTC TTT CT-3’ 14941-14919 
  P7F      5’-TCG TGT TGG GTG GCA GAA AAG C -3’ 14816-14837 
  P7R      5’-GCC ATT CAC CAC ACA TTC TTC C-3’ 15300-15279 
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TABLE 2. Emergence of recombinants and change of viral population during in vivo 
replication based on ORFs 2-7 (3188bp) 
 
a Number of plaque-cloned viruses that have genetic elements of either of parental strains, or recombinants 
b
 RECOM1, c RECOM2, d RECOM3 , e RECOM4 , f RECOM5  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Passage 1  Passage 2  Passage 3  
7DPI 14DPI 21DPI 28DPI 21DPI 21DPI 
Mixed 
infection 
13B 13C RE 13B 13C RE 13B 13C RE 13B 13C RE 13B 13C RE 13B 13C RE 
Line A 0a 20 0 11 7 2b 20 0 0 20 0 0 20 0 0 20 0 0 
Line B 0 20 0 0 0 20c 0 0 20c 0 0 20c 0 0 20e 0 0 20e 
Line C 0 20 0 7 13 0 10 9 1d 17 2 1d 0 0 20f 0 0 20f 
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FIG 1. Infectious viral titers of sera (7, 14, 21, 28, 35 and 60 dpi) collected from pigs in three infection groups 
(13B, 13C and dual infection) during sequential passages. Mean and standard error were indicated. 
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FIG 2.  Distribution and average of mutational change rates of ORF 2-7 sequences of a) individual (of single 
infection groups and line A of dual infection group) animals during serial passages, and b) infection group (13B, 
13C) and line A of dual infection group.  One-way ANOVA test of the data (p<0.05) marked different letter (A-
K) on the data, showing there was no significance (p>0.05) on difference of data under the same letter.  
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FIG 3.  Genomic structure of structural protein genes (ORFs 2-7) of recombinants.  Simplot (window : 200, 
step: 20) was performed to show similarity between recombinants and the two parental strains (13B and 
13C).  
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FIG 4.  (a) Strong evidence of recombination was confirmed on ORFs 2-7 sequences of the viruses that 
were proposed by sequence comparison and simplot, and (b) cross-over points were located by using 
cBrother (Fang et al., 2007).  (a) indicates the statistical distribution of the most closely related sequences to 
the recombinant at each site.  The number (0.0 to 1.0) on the left shows posterior probability that the 
recombinant is most closely related to 13C or 13B.  (b) indicates the statistical distribution of the crossover 
points.  Thus, each crossover point distribution is summarized as its median (vertical lines) and 95% 
confidence set (gray area). 
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FIG 5. Phylogenetic analysis using ORFs 2-7 sequences of 760 viruses isolated from sera throughout the 
study. Reliability of the tree was assessed by bootstrap analysis with 1000 replications. 
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CHAPTER 6. OCCURRENCE AND FREQUENCY OF RECOMBINATION IN 
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Abstract 
 
ORFs 2-7 sequences of 37 type II PRRS field isolates and 3 vaccine strains, and 
ORFs 2-5 sequences of 5 field isolates were analyzed for recombination.  Four of these 
isolates (VR-2332, JA142, SDSU73 and MN184) were chosen as reference strains 
because of their ancestral relationship to the epidemic and/or genetically distinct features.  
Remaining isolates were tested for unstable phylogenetic relationships along the genome 
with respect to these four reference strains.  Seventeen out of the 38 tested viruses 
(44.7%) showed highly supported, but incongruent branching patterns among ORFs 2 
through 5, strongly suggesting pervasive genetic shuffling.  A fine-scale analysis 
confirmed recombination in 15 of these viruses and found two additional highly 
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supported recombinants.  Cross-over sites were observed throughout the structural protein 
genes, but most of ORF2, and particularly the 5’ end, all of ORF7 and ORFs 4 and 5 
experienced higher frequencies of recombination.  The non-overlapped portion of ORF3, 
5’ end of ORF4 and most of ORF6 experienced low rates of recombination. Some of the 
rate non-uniformity may be the consequence of circulating recombinants that have spread 
through the sampled population.  Recombination appears to be a major mechanism for 
creating diversity among PRRS viruses in the field, and may greatly affect the 
development of effective vaccines as well as future epidemiological and evolutionary 
studies using sequence analysis of the structural protein genes. 
 
Introduction 
 
Porcine reproductive and respiratory syndrome (PRRS) is a disease characterized 
by clinical manifestation of reproductive failure, respiratory distress and/or systemic 
infection.  It was reported simultaneously in North America, Europe and Asia (5, 8, 22, 
29, 50, 58) and is now endemic throughout the world, causing huge economic loss in 
swine industry.  
PRRSV belongs to the family Arteriviridae, which also contains equine arteritis 
virus (EAV), lactate dehydrogenase elevating virus of mice (LDV), and simian 
hemorrhagic fever virus (SHFV), in the order of Nidovirales (9, 47).  Currently PRRS 
viruses are classified into two genotypes, North American (type I) and European (type II) 
genotypes (47), which share less than 60% nucleotide similarity based on ORF5 or full 
genomic sequence (3, 42, 47) and have distinct antigenicity (34, 64). 
Evolution of PRRSV has occurred through continuous mutation during in vivo 
replication (6), probably via its error-prone RNA polymerase.  Recombination event was 
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proposed in a genetic analysis of ten PRRS viruses originated in Midwestern United 
States (21), in which most of structural protein genes (ORFs 2, 3, 4, 5 and 7) except for 
ORF6 had evidence of recombination.  Recombination in type II viruses was 
demonstrated in ORFs 3 and 4 using MA-104 cells concurrently infected with two 
vaccine strains, RespPRRS® and Prime Pac®PRRS, and within ORF5 of one field isolate 
(66).  Type 1 viruses also underwent recombination between ORFs 4 and 5 during 
concurrent infection of porcine alveolar macrophages (PAM) cells with Lelystad and 
Danish 111/92 strains (62).  Among other arteriviruses, recombination has been 
demonstrated in LDV (28) and EAV (40). 
Recombination has been used to generate novel strains by increasing genetic 
diversity in a variety of HIV virus (7). Also, the event disrupts the molecular clock, and 
may interfere with estimation of virus origins (52). When recombination occurs, 
phylogenetic analysis using a single gene or a small portion of the genome may lead to 
wrong conclusions about the epidemiology or evolution of a virus (18). 
The genetic diversity of type I and II PRRS viruses in the field has been well 
documented.  Continuous genetic changes result in emergence of novel strains in swine 
populations, leading to expanding genetic variability (33, 48, 57), existence of multiple 
strains in the same farm (11), and concerns about vaccine efficacy (26).  The mechanisms 
that generate such diversity and evolution in the field remain to be fully elucidated, but 
recombination is well-known to generate novel strains in a variety of RNA viruses (7).   
Our recent study (4) demonstrated recombination during viral replication in pigs 
under experimental conditions.  In that study, all three dual infection experiments 
produced recombinants, implying that recombination is a frequent occurrence.  The 
present study was conducted to investigate the occurrence of recombination in the 
structural proteins of type II field isolates and to locate cross-over points.  The results 
 133 
indicate a high prevalence of recombinants and hold crucial implications for strategic 
control of PRRS in the field.  
 
Materials and Methods 
 
    Viruses, cells and media.  A total of 45 PRRS viruses (42 field isolates and 3 vaccine 
viruses) were used for this study (Table 3).  Among them, 22 viruses were isolated from 
clinical samples submitted to ISU/VDL during 2000-2002.  Virus isolation was attempted 
by inoculating the samples into MARC-145 cells, a clone of the African monkey kidney 
cell line MA-104 that is considered highly permissive to PRRSV (24).  
Four field viruses (VR-2332, JA142, SDSU73 and MN184) were used as 
reference in phylogenetic analysis.  One field strain (17198) was isolated from an 
Oklahoma herd showing severe PRRS in 1997 (20).  SDSU73 was isolated from an Iowa 
sow herd that experienced abortions in 1996 (35), and Abst-1 was obtained by 52 
passages of SDSU73 in cell line (21).  MN184 was isolated in 2001 from pigs showing 
severe PRRS and mortality in Minnesota (17).   
MARC-145 cells were cultured and maintained in Dulbecco’s modified Eagle’s 
medium (DMEM; Sigma Chemical Co., St Louis, MO, USA) supplemented with 10% 
fetal bovine serum (HyClone Laboratories, Inc., Logan, Utah. USA), and gentamicin 
(Sigma) and amphotericin B (Sigma) at a concentration of 50µg and 0.25µg, respectively, 
per 1 ml of the medium.  
   RT-PCR and sequencing.    A total of 26 strains including 22 field isolates from the 
state of Iowa, 17198, SDSU73, and Abst-1and MN184 were sequenced in the structural 
protein genes, ORFs 2-7 (3188bp).  Viral RNA for RT-PCR amplification was extracted 
from each field isolate with a QIAamp viral RNA kit (Qiagen Inc., Valencia, Calif.) by 
 134 
following the protocols recommended by the manufacturer. Viral RNA was collected and 
stored at -80oC until used.   For ORFs 2-7 RT-PCR, 5µl of extracted RNA template was 
added to a tube containing 25µl of 2X Reaction Mix (0.4mM of each dNTP, 2.4mM 
MgSO4), 1µl of SuperscriptTM III RT/Platinum® Taq High Fidelity Enzyme Mix, and 17 
µl of RNase-free H2O (SuperScriptTMIII One-Step system with Platinum Taq High 
Fidelity; Invitrogen, Carlsbad, Calif.); 1µl (10pmol) of primer PR11933F; 1µl (10pmol) 
of primer 7R (Table 1).  The RT-PCR was performed with a thermal cycler (GeneAmp 
PCR system 2400; Applied Biosystems, Foster City, Calif.) at 50 oC for 30min and 94 oC 
for 2min; then, 40 cycles of denaturation at 94 oC for 15 s, annealing at 55 oC for 30sec 
and extension at 68 oC for 3min followed. After the last cycle, the extension period was 
maintained at 68 oC for 5min.  To confirm a positive reaction, 2 µl of the final products 
was separated by electrophoresis in a 1% agarose gel (Amresco Inc., Solon, Ohio) 
containing 0.1% ethidium bromide in Tris-borate-EDTA buffer.  The positive products 
were visualized and photographed under UV light.  The positive products were purified 
with either QIAquick or 96-well PCR purification kits (Qiagen) by following the 
procedures recommended by the manufacturer, then all final products were stored at 4 oC 
until used.  
   Sequencing of ORFs 2-7 was performed at the Iowa State University Nucleic Acid 
Facility (Ames) by using the appropriate amount of purified PCR product (30 µg/ul) and 
5 pmol of each primer in Table 1.  
   Sequence alignment, comparison and phylogenetic analysis.  The sequence data of 
the field viruses were analyzed by Lasergene® software (DNASTAR© Inc., Madison, WI, 
USA).  ORFs 2-7 sequences of five recombinants (RECOM1, RECOM2, RECOM3, 
RECOM4 and RECOM5) were obtained from dual infection in pigs (4).  ORFs 2-5 
sequences of 5 field isolates, and ORFs 2-7 sequences of 16 field isolates including two 
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field isolates (VR-2332 and JA142) and two vaccine viruses (ATP and Ingelvac® PRRS 
MLV) were collected from GenBank (http://www.ncbi.nlm.nih.gov).  Sequence 
alignment was done using ClustalW (61).  Unrooted phylogenetic trees were generated 
using the distance-based neighbor-joining method of MEGA software version 3.1.  
Bootstrap values were calculated on 1000 replicates of the alignment.  
   Statistical tests for Recombination.  Each of the 41 test sequences was aligned with 
the four chosen representative sequences.  Alignments were trimmed of gaps on both ends. 
cBrother (12) was used to infer both topology change-points, representing cross-over 
points, and parameter change-points, representing spatial changes in the evolutionary 
processes.  All default settings were used except we allowed test sequences to be assigned 
ancestral parents (allow_ancient_ancestry: true).  For example, a test sequence might 
have combination parent (JA142, MN184), indicating that the ancestor of JA142 and 
MN184, or some descendent of this ancestor is the immediate ancestor of the test 
sequence.  Default run settings permitted the possibility of recombination among the 
reference sequences, but phylogenetic analysis suggested these sequences were not 
recombinant (data not shown), and we only report on recombination involving the test 
sequences. 
 cBrother’s multiple change point model for recombination detection (39, 59) is 
implemented in a Bayesian context via Markov Chain Monte Carlo (MCMC).  For 
posterior inference, we obtained a sample of 3000 iterations from three independent 
MCMC chains started from random nonrecombinant states.  Initial burnin was 100,000 
and subsample rate was 1,000.  Several statistical tests were performed to check that these 
chains had converged to the stationary distribution.  We computed the Gelman-Rubin 
statistic (15) on the number of crossover points involving the test sequence.  We also 
performed a test of proportions (54) on the posterior support for recombination for all 
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pairs of chains.  Finally, we deduced the recombinant structure as the 5’ to 3’ sequence of 
parents that achieve 90% or higher posterior support along the alignment.  For each 
crossover point in this structure, we collected data on the location of the inferred 
crossover point and then computed the Gelman-Rubin statistic across all chains and the 
Wilcoxon test of medians for all pairs of chains.  If any GR statistic exceeded 1.1 (22) or 
p-value fell below 0.05, the MCMC run was continued with subsample rate increased by 
1000 to collect another sample of size 1000 from each chain. 
The hypothesis that the test sequence was recombinant is summarized 
using the log10 Bayes factor for recombination (59), 
                                                                        
where X is the alignment data and the hypothesis of recombination implies the test 
sequence is involved in at least one crossover event.  The Bayes factor is estimated as the 
ratio of posterior odds to prior odds in favor of recombination.  By default, prior odds are 
1 in cBrother, so the log10 BF reduces to log10(# samples with > 1 cross-over) − log10(# 
samples with 0 cross-overs).  Statistics about each cross-over point were also collected.  
The posterior median and 95% Bayesian credible intervals were used to summarize the 
posterior distribution of each cross-over point location.  The posterior support for a cross-
over point is the fraction of posterior samples having the specified 
cross-over point with the specified left and right parents.  We report statistics on only 
those cross-over points that received more than 50% posterior support.  Some regions 
contained very strong evidence of a cross-over point, but were not reported because the 
parentage of the test sequence was unclear on the left, right or both sides of the cross-over 
point.  It is possible that these ambiguous regions would be resolved if additional or 
different reference sequences were used. 
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 The recombination rate at each position along the alignment was computed as the 
posterior probability that the position was a crossover point in the test sequence, averaged 
over the 38 test sequences.   
 
Results 
 
Impact of recombination on phylogenetic analysis.  Previously, we demonstrated 
emergence of recombinants during replication of two type II viruses in pigs (4).  
Recombination was observed throughout all structural protein genes (ORFs 2-7), and a 
total of five patterns of recombination (designated as RECOM1, 2, 3, 4 and 5) were found 
in viruses isolated from sera of pigs under dual infection.  The mosaic structure results in 
incongruent classification of the test viruses for different genomic regions (Fig. 1).  In one 
instance, RECOM1 had 13B genetic elements in ORF2 and partial region of ORF3, while 
the rest of structural protein genes were composed of 13C genetic elements.  Phylogenetic 
analysis showed that the virus was classified into 13B group in ORF2 that contained 13B 
and 13B originated viruses, and formed another branch apart from 13B group in ORF3 
that had mixed genetic elements.  The rest of the genes belonging to 13C group were 
composed of 13C and 13C originated viruses.  RECOM2 belonged to 13C group in ORFs 
2, 3 and 4, while classified into 13B group in ORFs 5 and 6, and formed partial branch in 
ORF 7.  RECOM3 and 4 were classified into 13C group in ORFs 2, 3, 4 and formed 
independent group in ORF5, and belonged to 13B group in ORFs 6 and 7.  RECOM5 was 
classified into 13C group in the structural protein genes except for ORF6, in which the 
virus did not belong to either group.  Overall, emergence of recombinants followed by 
recombination generated inconsistent classification of viruses according to regions where 
the recombination occurred.   
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   Nucleotide sequence similarities and phylogenetic analysis of field isolates.  Four 
PRRS viruses, VR-2332 (type II prototype), JA142, MN184 and SDSU73 were 
designated as representative viruses of type II in this study.  ORFs 2-7 of these viruses 
where genetically distinct, share nucleotide sequence similarities of 89.6-95.5%, 87.8-
94.6%, 88.8-95.2%, 86.6-92.5%, 90.7-97.3% and 90.9-94.6% in ORFs 2, 3, 4, 5, 6, and 7, 
respectively.   
A phylogenetic analysis was separately performed for ORFs 2, 3, 4 and 5 of all 
45 study viruses.  The structure of the phylogenetic trees was not identical across all four 
ORFs.  The analysis for ORFs 6 and 7 was not performed because these sequences were 
not available in GenBank for some isolates.  Clades containing each of the representative 
viruses were identified and designated as V group (VR-2332), J group (JA142), M group 
(MN142), and S group (SDSU73).  There were also a few distinct clades not contained 
within one of these four groups, and they were designated as O group representing 
outliers (Fig. 2).  Caution was also taken to monitor changes in the identity of the O group 
from ORF to ORF.  Relatively high pairwise nucleotide sequence similarities were 
observed among the viruses within each of the four groups, excluding O (Table 2).   
Classification of 17 out of 38 field viruses was incongruent among ORFs 2, 3, 4, 
and 5, suggesting possible recombination in these sequences with respect to the 
representative groups V, J, M, and S.  Table 3 summarizes the field isolates belonging to 
each of the four groups in each ORF.  Among 22 field isolates from ISUVDL and one 
field isolate (11715), four field isolates (3628, 12817, 11715 and 4519) were classified 
into S group in ORFs 2-4, but formed O group in ORF5.  Two field isolates (5966 and 
43087) were classified into S group in ORFs 2 and 3, J group in ORF4 and O group in 
ORF5.  A field isolate (21599) was classified into S in ORFs 2 and 5, but J group in 
ORFs 3 and 4.  Isolates 19248 and 17198 belonged to the same clade as SDSU73 in ORFs 
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3 and 4, and belonged to group O in ORFs 2 and 5.  Isolate 18087 was classified into J 
group in ORF4, while other regions belonged to group V.  Among field isolates obtained 
from GenBank, AY032626 and AY262352 were observed in in group O in ORF2, and 
were classified into the J and S groups in ORFs 3 to 5, respectively.  U34298 belonged to 
group M only in ORF4, and AF035409 and AF121131 were classified into group M in 
ORFs 4 and 5.  LMY, a Korean isolate, was classified into group M in ORFs 3 and 4, 
while other regions had no genetic relatedness with the representative strains.  
   Assessment of recombination and cross-over sites.   A multiple change point model 
used for detecting sporadic recombination (39, 59) and implemented in cBrother (12) was 
used to find the cross-over points anywhere within the region covered by ORFs 2 through 
7.  The method examines one test sequence at a time, comparing the phylogenetic 
relationship of the test sequence to representative sequences.  The Bayes Factor (BF) 
summarizes the support in favor of the hypothesis of recombination for each test 
sequence (60), and we interpreted log10BF above 1 as strong evidence of recombination 
(24).  A total of 17 viruses of the 38 test viruses (44.7%) were determined as 
recombinants with respect to the representative sequences (VR-2332, JA142, MN184, 
and SDSU73) (Table 3).  Some recombinants (e.g. 11715, 21599, 4519) appeared to 
involve three or more distinct parental sequences, suggesting that recombinants can 
undergo subsequent recombination. 
Fig. 3 summarizes cross-over points that had high statistical support, meaning the 
posterior probability of a cross-over point with matching left and right clade assignments 
in the vicinity of the reported posterior median exceeded 0.5.  The posterior median 
location, limits of the 95% Bayesian confidence interval, the left and right representatives, 
the posterior support, as well as the Gelman-Rubin convergence statistic (15) are reported.  
We observed several sequences with cross-over points in similar locations: U34297, 
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19248, 43087, 18087, 5966, U34299 and AY032626 in nucleotide position (np) 40-49; 
AY262352, 43087, and 5966 in np 685-688; AF066384, AF184212 and 18087 in np 
1177-1178; 4519, 12817,and 5966 in np 1546-1551; 18087 and 21599 in np 1729-1735; 
3628 and 11715 in np 1656-1658; 3628, 21599, and 11715 in np 1952-2023; 4519, 12817, 
11715, 3628, AY262352, and 19748 in np 2846-2874; 19248, AY032626, AY262352, 
and 4519 in np 3108-3116.  Some of these sequences shared the same clade assignment 
on the both sides of cross-over points.  For example, the MN184 to VR-2332 cross-over 
point around position 2873 was found in four separate field isolates (4519, 12817, 11715 
and 3628).  Field isolates 3628 and 11715 harbored a VR-2332 to MN184 cross-over 
point near position 2022, while field isolates 3628 and 11715 also shared a SDSU73 to 
VR-2332 cross-over point near position 1655.  A nearby cross-over point involving the 
same parents in field isolate 18087 may indicate a different recombination event, but joint 
analysis of both recombinants would be required to draw a solid conclusion.  The rest of 
the cross-over points were observed only once, however some of the cross-over points 
involving distinct clades were still remarkably similar in location.  For example, U34297, 
isolate 19248, and AY032626 share a cross-over point near np 45, all with distinct clade 
assignments.   
   Spatial variation in recombination rate.  We estimated the recombination rate at each 
position along the alignment by combining results from all 41 test sequences (Fig. 4).  In 
this analysis, we assumed all sequences are independent, each providing equal 
information about the prevalence of recombination along the ORFs 2 through 7.  
Recombination rate was estimated to be highest in ORF2, particularly the 5’ end, the 3’ 
end of ORF7, and in ORFs 4 and 5.  Inflation of recombination rate near the alignment 
ends is often caused by increased uncertainty about phylogeny, and should be interpreted 
with caution.  Interestingly, the non-overlapped portion of ORF3 and most of ORF6 
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experienced low rates of recombination.  Using the median location to represent all 40 
highly supported cross-over points, the distribution of points was not uniform (p-value: 
0.05).  This significant non-uniform distribution persisted even when eliminating all 
cross-over points within 200 nucleotides of the 5’ or 3’ boundary to avoid boundary 
effects. 
     
Discussion 
    
This study provides the first estimate of recombination frequency and cross-over 
points based on multiple field isolates of PRRSV.  Cross-over points were found 
throughout the structural gene ORFs 2 through 7, but there was some evidence that the 
distribution of cross-overs was non-uniform.  Several field isolates shared similar cross-
over points, indicating either hotspots for recombination or the spread of recombinant 
products in natural populations.        
For this study, 23 field isolates were sequenced in ORFs 2 through 7, and viral 
sequences of 17 (ORFs 2-7 sequence) and 5 (ORF 2-5) field isolates were collected from 
GenBank.  As the first step to investigate recombination among field isolates, four viruses 
(VR-2332, JA142, SDSU73 and MN184) were designated as representative strains.  
Three of these four viruses, all but MN184, were chosen because they are ancestral to the 
current epidemic by virtue of their isolation in the 1990s.  In addition, all four viruses are 
genetically distinct from each other, and maintain a stable phylogenetic relationship with 
each other throughout the ORFs studied (data not shown).   
Phylogenetic analysis is a popular method for detecting recombination in viral 
genomes, and numerous studies have identified recombinant viruses (10, 29, 30, 54).  A 
total of 17 viruses out of 38 PRRS field isolates (44.7%) showed inconsistent 
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relationships when comparing phylogenies of all field isolates from ORFs 2 through 7.  
Application of the multiple change-point model confirmed 15 of these as strongly 
supported recombinants with respect to the four representative strains.  In addition, the 
method found two highly supported recombinants, AF066384 and AF184212, among 
those classified everywhere as belonging to the “Other” group in the ORF-by-ORF 
analyses.  The two recombinants left unconfirmed by change-point analysis, AF035409 
and AF121131, had ambiguous support for recombination.  These sequences, which were 
classified as belonging to group O in ORFs 2 and 3 and MN184 elsewhere, were mostly 
MN184-like in the change-point analysis.  The discrepancy resulted because the change-
point analysis did not define the “Other group,” and inclusion of additional parental types 
in the analysis could reveal these sequences as recombinant in the change-point analysis.  
In addition, field isolate 18087’s ORF4 located in clade JA142 in phylogenetic analysis, 
but was found to have a short SDSU73-like in cBrother.  Phylogenetic placement of 
regions covering multiple segments of a recombinant tends to be somewhat intermediate 
between the two parents, which likely explains this discrepancy.   
The high fraction of recombinants estimated in this study may underestimate the 
true circulation rate of recombinants in the field.  Our study detected recombinants only 
with regard to the chosen representative strains.  Inclusion of additional parental strains 
could detect even more recombinants.  For example, when using three representative 
strains, excluding MN184, the change-point analysis found only 13 recombinants rather 
than 17, and the ORF analysis indicated 12 recombinants rather than 17. 
The prevalence of highly supported regions descendent from ancestors of the four 
selected strains (Table 3b) in the change-point analysis as well as the abundance of 
“Other” group sequences may support the existence of additional ancestral strains, which 
remain unsampled or only persist to the present day as partial fragments in surviving 
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recombinants.  The divergence time of PRRS subtypes has been controversial, with 
different estimates depending on technique (13, 14, 17, 21, 49), and there is no 
information about a precursor PRRSV or the early ancestors arising as the virus adapted 
to replicate in swine.  Before causing manifest disease in swine and becoming prevalent 
in swine industry during the mid 1980s to early 1990s, PRRS viruses likely spent a 
significant time adapting to the host, and probably did so simultaneously in the relatively 
isolated swine populations, e.g. North America and Europe (49).  Divergent strains of 
PRRSV descendent from these early ancestors could be circulating in unrecognized 
reservoirs to this day, maintaining pools of genetically distinct virus through relative 
genetic isolation.  MN184 may be a good example of this hypothesis.  Though the isolate 
was only detected in 2001 in Minnesota, it was strikingly distinct from other viruses of 
type II, with the shortest full-length genome among PRRSV and the least nucleotide 
sequence similarity to type I viruses (16).  Recently, studies on the genetic variability of 
type I viruses have disclosed exceptionally diverse strains in Lithuania and Poland (56, 
57), Belarus (56), Denmark (14) and Italy (14), which clustered differently from field 
isolates from the UK, France, the Netherlands, Germany and Spain.  These viruses were 
speculated to be the ancestral type of the present-day European strain (Lelystad)-like 
viruses circulating in the latter countries (14, 27, 33, 57).  Stadejek et al (2006) posited 
that historical or political changes and livestock trade may have permitted the 
contamination of herds in these countries from unknown reservoirs. 
The high level of recombination found in this study was anticipated because 
previous studies had demonstrated intra-genotypic recombination during PRRS virus 
replication in cells or host.  We observed that recombinants emerged in all of three in vivo 
dual infection experiments (4).  Recombination rates of PRRS viruses have been 
estimated at 2-10% in an 1182 bp fragment (66) and 0.1-2.5% in a 621 bp fragment (62).  
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Extrapolating these results to a length of 3188 bp (ORF 2-7), the recombination rate 
would be between 13% and 30%.   
The degree of homology at cross-over sites likely has a dramatic impact on the 
frequency of recombination.  Nucleotide sequence divergences between PRRS sequences 
known to recombine, 13B and 13C viruses used in the dual infection study (4), 
RespPRRS® and Prime Pac®PRRS in MA-104 (66), and Lelystad and Danish 111/92 
viruses in PAM cells (62), were 2.1 (2.8) %, 6.7 (9.1) % and ND (7.6) %, based on ORFs 
2-7 (ORF5) sequence, respectively, where ND indicates “not done”.  Typical ORF 5 
nucleotide divergence is somewhat higher, 12% among type I viruses (48) and 16% 
among type II viruses (3).  The average pairwise distance in our study was 7% (range 0% 
to 11%) in all ORFs and 9% (range 0% to 14%) in ORF5, perhaps a little lower than 
previously reported, but within the range expected to yield recombination.  On the other 
hand, many of these recombination events could have occurred long ago among viruses of 
unknown diversity. 
Cross-over points distributed throughout the structural protein genes, focusing on 
ORF2, particularly the 5’ end, ORFs 4 and 5 and the 3’ end of ORF7 (Figure 3 and 4), 
which was largely in agreement with another recombination study (4) where cross-over 
points were found throughout ORFs 2-7, focusing on the ORF5 region.  Replication and 
transcription mechanisms of arteriviruses may be associated with the observation, since 
the subgenomic mRNA can serve donor or acceptor strand (40).  However, the high 
frequency of recombination in ORF2 and low frequency in ORF6 suggested other factors, 
such as secondary structure elements or heteroduplex formation (43, 44).  Kapur et al 
(1996) reported that ORF6 was the most conserved of all the structural protein genes 
among 10 field isolates, and could not find any evidence of recombination in ORF6.  In 
another recombination study (4) and here, we demonstrated direct evidence of 
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recombination within ORF6, even if it was infrequent (Fig. 3 and 4).  In addition, the non-
overlapped region of ORF3 was newly proposed as the region of rare recombination.  
The cross-over points (Fig. 3) likely marked hot-spots for PRRSV genetic 
exchange, because viruses that showed cross-over points at same or similar regions had 
different chronological as well as geographical isolation history indicating independent 
recombination.  In particular, the same representative strains were located at both sides of 
some cross-over points, suggesting there may be a preference of donor and acceptor 
strains at specific position.  However, further studies with more numbers of field isolates 
are required to substantiate this possibility. 
Contribution of recombination to viral diversity has been demonstrated in both 
genotype and phenotype.  HIV-1 can overcome the bottleneck caused by drug treatment 
by recombination among viral groups with distinct drug mutants in a host (7) (41, 51).  
Recombination with host genes is another mechanism that increases the diversity of RNA 
viruses.  Tomato bushy stunt virus recombined with a host transgene to restore its 
pathogenicity (1), and bovine viral diarrhea virus adopted a host gene into its genome to 
change its biological characteristics (38).  The presence of recombination in PRRSV 
structural genes is also likely to introduce novel variants that could have a selective 
advantage in natural hosts.  There are sites in these genes that experience nonsynonymous 
changes at a disproportionate rate (data not shown), but lack of data prevented us from 
establishing a significant relationship between recombination rate and selection. 
No recombinants in this study showed any deletion or addition in their genome, 
which may be an indication of imprecise recombination.  Deletions were observed in an 
in vitro recombination study (62), suggesting the possibility of inaccurate recombination 
in PRRSV (44), although homologous recombination events of class 1 or 3 (46) are 
through to dominate in PRRSV.  In fact, it has been suggested that most deletions or 
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insertions in ORFs 2-7 may adversely affect PRRSV viability, although a few field 
isolates were found to have deletions in ORF5 (3, 60).  
In this study, the evidence of high recombination frequency in field isolates could 
reveal potential problems for controlling PRRSV in the swine industry.  Recombination 
may 1) expedite genetic/phenotypic diversification and along with random mutations, 
challenge vaccine efficacy, 2) act as an efficient way for low virulent strains to acquire or 
increase virulence by trading virulence factors with high virulent strains, and 3) lead to 
wrong conclusions in epidemiological or evolutionary studies.  Collectively, it is 
suggested that recombination in PRRSV should be seriously considered when attempts 
are made to control the disease using vaccines and in interpreting the genetic data from 
field isolates. 
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TABLE 1. Primers used for RT-PCR and sequencing. 
  Primer      Sequence Location (nucleotide) 
  PR11933F      5’-AAA CGG TGA GGA CTG GGA GGA TTA-3’ 11933-11956 
  PR12202F      5’-CCG GTT GGC TGG TGG TCT-3’ 12202-12219 
  PR12712F      5’-CAT TCC TCC ATA TTT TCC TCT GTT-3’ 12712-12735 
  PR13254F      5’-TTC TTT TCC TCG TGG TTG GTT TTA-3’ 13254-13277 
  PR13342R      5’-CGC TGC GGT GGT GTT GGT CTT A-3’ 13342-13321 
  PR12809R      5’-TCG AAA GAA AAA TTG CCC CTA ACC-3’ 12809-12786 
  PR12478R      5’-ATC CAA ACT ACT AAT GCG AGA CAG-3’ 12478-12455 
  PR13863R      5’-CAA AAC AGA ACG GCA CGA TAC ACC-3’ 13863-13840 
  P5F      5’-CCT GAG ACC ATG AGG TGG G-3’ 13696–13714 
  P5R      5’-TTT AGG GCA TAT ATC ATC ACT GG-3’ 14459–14437 
  P6F      5’-GCG GTC GCC TGT CAT CAT AG-3’ 14252-14271 
  P6R      5’-GGC TGG CCA TCC CCC TTC TTT CT-3’ 14941-14919 
  P7F      5’-TCG TGT TGG GTG GCA GAA AAG C -3’ 14816-14837 
  P7R      5’-GCC ATT CAC CAC ACA TTC TTC C-3’ 15300-15279 
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TABLE 2. Nucleotide sequence similarities among field isolates within groups (J, S, V 
and M) or all field isolates in ORFs 2, 3, 4 and 5. 
 
       1
 range of nucleotide similarity (%) 
       2
 not available 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORF (open reading frame)  
Group 
      2       3       4       5 
All    88.1-1001    87.1-100    87.3-100    85.6-99.8 
J    99.6-99.7    94.4-99.5    92.6-100    98.8-99.5 
S    93.8-99.6    91.6-99.3    95.3-99.1    91.2-98.8 
V    95.1-100    92.5-100    93.1-100    92.2-99.8 
M    NA2    89.5    89-99.3    86.6-99.7 
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TABLE 3.  Classification of viruses in the available structural protein genes using a) full 
phylogenies for each ORF and b) phylogenetic change-point analysis (cBrother). a) V, 
J,M,S and O indicates the ORF sequence clusters in the VR-2332, JA142, MN184, 
SDSU73 groups and other groups, respectively. b) When log10 BF (Bayers factor) is 
greater than 1 or inf, there is strong evidence of recombination.  If log10 BF is below -1 or 
–inf, there is strong evidence that the sequence is not recombinant.  The graphic presents 
the recombinant structure, showing which representative parental sequence is assigned to 
each region.  Only regions where the parent is assigned with > 90% posterior support are 
colored.  White indicates no reference sequence exceeded 90%.  Mixed parentage ( ) 
means the most highly supported parentage in the region is the descendent of an ancestral 
sequence, either MV (also SJ, since the trees are unrooted), MS (VJ), or MJ (SV).  The 
descendents of JA142 ( ), VR-2332 ( ), MN184 ( ) and SDSU73 ( ) were also 
colored in the region.  U34296, U34297, U34298, U34299 and U34300 were available 
only for ORF2-5.  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
a) ORF Analysis  b) Change-Point Analysis  
Isolates (GenBank 
Acession No.) 
 
Isolation 
Year 
 
Country 
 
ORF2 
 
ORF3 
 
ORF4 
 
ORF5 
  
log10BF 
 
Inferred Structure 
(ORF2-7) 
VR2332 (U87392) 1990 USA V V V V  - 
 
MLV (AF066183)  USA V V V V  -0.45 
 
JA142 (AY424271) 1995 USA J J J J  - 
 
ATP (DQ988080)  USA J J J J  -1.04 
 
SDSU73 1996 USA S S S S  - 
 
Abst-1  USA S S S S  -0.98 
 
MN184 2001 USA M M M M  - 
 
17198 1997 USA O S J O  
 1.97  
3628 2000 USA S S S O  inf  
4485 2000 USA V V V V  -0.44 
 
5966 2000 USA S S J O  
 2.87  
9530 2000 USA V V V V  -0.46 
 
11715 2000 USA S S S O  inf  
21599 2000 USA S J J S  inf  
41628 2000 USA J J J J  -0.95 
 
43087 2000 USA S S J O  
 2.78  
44688 2000 USA V V V V  -0.47 
 
4190 2001 USA V V V V  -0.47 
 
4519 2001 USA S S S O  inf  
12439 2001 USA V V V V  -0.42 
 
12817 2001 USA S S S O  inf  
16727 2001 USA V V V V  -0.42 
 
18087 2001 USA V V J V  inf  
19248 2001 USA O S J O  inf  
64955 2001 USA V V V V  -0.44 
 
67516 2001 USA V V V V  -0.44 
 
1403 2002 USA V V V V  -0.25 
 
1488 2002 USA V V V V  -0.45 
 
2341 2002 USA J J J J  -0.98 
 
3233 2002 USA V V V V  -0.30 
 
AF035409  Taiwan O O M M   0.54 
 
AF066384  USA O O O O  
 1.93  
AF121131  Taiwan O O M M   0.48 
 
AF184212  Singapore O O O O  inf  
AF325691  USA S S S S  -0.95 
 
AF331831  China V V V V  -0.45 
 
AY032626  China O J J S  
 3.00  
AY262352  China O J J S  inf  
LMY 2002 Korea O M M O  inf  
NC001961 1998 USA V V V V  -0.49 
 
U34296  USA V V V V  -0.28 
 
U34297  USA V V V V   0.88 
 
U34298  USA O O M O  inf  
U34299  USA V V O O  
 1.73  
U34300  USA V V V V  -0.48 
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FIG 1. Genomic structure of structural protein genes (ORFs 2-7) of five recombinants and impact on unrooted phylogenetic tree analyses.  
Thirteen master sequences of 20 plaque cloned isolates isolated from each animal in single infection groups and one pig of mixed infection 
group (which did show any recombination in the region) at first and second passages, and two original viruses (13B and 13C) were added to 
these analyses.  Reliability of the tree was assessed by bootstrap analysis with 1000 replications.  The five recombinants (R1, R2, R3, R4 and 
R5) were marked by the full name on phylogenetic tree.  13B and 13C indicates groups that contain original virus (13B or 13C) and viruses 
which were isolated from pigs infected with either of viruses.  
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FIG 2. Structure of groups observed in unrooted phylogenetic tree analysis.  Reliability of the 
trees were assessed by bootstrap analysis with 1000 replications.  Groups were made based 
on bootstrap values (≥80), which were marked as closed circles. The V, J, S, and M groups 
were designated, according to whether they included the standard viruses, VR-2332, JA142, 
SDSU73 and MN184, respectively. 
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FIG 3. Highly supported cross-over points with posterior support greater than 0.5.  Each 
cross-over point is labeled with the containing field isolate, e.g. 3628, posterior median 
(black vertical line), which is also labeled, and the match support in parenthesis. The 95% 
Bayesian credible set (hatch shading) indicates where the cross-over point has 95% chance of 
being, and the colored rectangles indicate the clade assignments on each side of the crossover 
point. 
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FIG 4. Spatial variation in recombination rate.  An estimate of the recombination rate at each 
position of ORFs 2 through ORF 7 is shown in the plot.  A map of the ORFs is shown above.  
Gray boxes mark putative leader sequences.  A smoothed recombination rate is shown as a 
dotted line. 
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CHAPTER 7. GENERAL DISCUSSION 
 
Previous studies on the genetic variability among field isolates of PRRSV have 
implied potential contribution of common genetic change mechanisms, such as random point 
mutation and recombination, to continuous generation of genetic diversity among PRRSV, as 
expected for other RNA viruses.  However, limited information from the studies failed to 
provide direct and concrete evidence to define evolutionary features of PRRSV, raising the 
necessity of further studying PRRSV evolution for better understanding of disease ecology.   
The present studies were conducted to examine and characterize molecular evolution 
of PRRSV in three different ways: 1) sequential pig-to-pig passage with a single strain; 2) 
sequential pig-to-pig passage with two different strains; 3) sequence analysis of field isolates 
for recombination.  A few experimental strategies were adopted in the present studies, which 
were more advantageous in attaining powerful evidence of evolutionary characteristics of 
PRRSV, making the present studies be differentiated from the previous studies.  First, the 
present studies were performed during in vivo replication of the virus excluding bias induced 
by host difference.  Second, all structural protein genes were subjected to sequence analysis, 
which enabled us to find more diverse features of PRRSV evolution, making the results of 
analysis engaged in practical application.  Third, biological clones were used for the analysis, 
which confers the outcome with more direct impact on evidence since the sequence 
information was originated from viable virus.  Finally, using multiple field isolates provided 
decisive evidence for a role of evolutionary mechanism(s) in generation of PRRSV diversity 
in the field. 
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Sequential pig-to-pig passages with a single strain 
In principle, infidelity of RdRp introduced continuous point mutation into PRRSV 
genomes during replication.  Sequential pig-to-pig passages incessantly introduced random 
point mutations to structural protein genes, which produced multiple NVs or AVs based on 
individual genes (ORFs 2, 2b, 3, 4, 5, 6 and 7) or a collective gene (ORFs 2-7) at every 
passage.  The variants were shown to undergo negative selection, as new variants that were 
emerged in each passage disappeared in the following passage.  Generation of mutation was 
not even among the 7 structural protein genes.  Commonly, glycosylated protein genes (e.g. 
ORFs 2a, 3, 4 and 5) revealed higher variability with relatively large number of mutants and 
mutation rates, while ORF7 had the least mutation.  Mutation was cumulative, which was 
observed from the second passage as shown in ORF5 sequence analysis during P1 through 
P13.  Mutation rates of individual ORFs were different among hosts (i.e. the three 
independent lines). Collective sequence analysis of ORFs 2-7 resulted in constant increase in 
mutation among hosts, suggesting the usefulness of sequencing as a “molecular clock” in 
molecular epidemiological or ecological studies.  Sequence comparison and phylogenetic 
analysis based on ORF5 or ORFs 2-7 sequence indicated that the three independent lines 
developed distinct genetic evolutionary path, being differentiated from each other.  In 
addition, it can be suggested that unknown host factors may affect such distinct evolution of 
PRRSV.  That is, a viral population seems to be selected at the first passage, and the chosen 
population continued to be developed into independent clade among hosts in the subsequent 
passages. Genetic diversity resulted in antigenic changes, which was demonstrated by 
increased resistance to neutralizing activity of porcine polyclonal antibody raised against the 
original inoculum virus among viruses isolated from P7 and P13.  Furthermore, mutation of 
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ORF5 sequence was reflected on the instability of RFLP pattern of virus, having an adverse 
affect on epidemiological studies of PRRSV using this technique.  Overall, the study results 
demonstrated negative impact of continuous genetic change on cross protection and 
diagnostics.  
 
Sequential pig-to-pig passages with two different strains 
Even if potential recombination among PRRSV was postulated and demonstrated 
under in vitro experimental conditions by previous studies, our study was the first evidence 
of recombination between PRRS viruses during in vivo replication.  In ORFs 2-7 sequence 
analysis, a total of five types of recombinants emerged during the study period.  
Recombinants were observed in all animals of dual infection group, while recombinants in 
one animal disappeared in the subsequent passages.  Recombination event appeared to be 
taken place early during replication in pigs as recombinants were generated in early period of 
concurrent infection (between 7DPI and 14 DPI).  Different types of recombinants among 
hosts indicated randomness in generation of recombination as well as selection process of 
viral subpopulation led to disappearance of recombinants (line A) or appearance as dominant 
population (line B and C) during passages.  Importantly, the fact that two recombinants were 
newly emerged in the subsequent passages indicates that recombination can occur among 
subpopulations of virus (quasispecies).  Recombination was found to occur throughout the 
structural protein genes (ORFs 2-7) although proximity to 3’end of the viral genome seemed 
to be the major target for cross over.  
Besides recombination, this study also demonstrated that concurrent infection with 
more than one strain may end up with competitive selection of a certain virus, which may 
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harbor enhanced genetic diversity.  Meanwhile, ORF5 region were amplified from various 
organs of pigs in dual infection group at the first passage, and sequence analysis showed that 
different viral populations existed in various organs within the same animal, and were 
different from viruses in serum.  This observation underscored organ tropisms of a certain 
viral subpopulation, suggesting that organ-specific selection of viral population may 
contribute to further genetic diversity of PRRSV and persistent infection of the virus.  
 
Sequence analysis of field isolates for recombination 
Induction of recombination by artificial infection in pigs may not mirror 
recombination event under natural setting.  So, investigation of recombination among the 
field isolates was attempted to address the occurrence and frequency of PRRSV 
recombination in the field.  As an inventive approach, 4 representative strains were 
designated, and 38 test viruses obtained from the field were examined for recombination in 
related to the representative strains.  Recombination analysis was performed using two 
independent methods: phylogenetic analysis and c-Brother (statistical approach).  The 
experimental scheme resulted in 44.7 % of recombinants among all tested viruses.  The fact 
that two methods, which were useful and popular methodologies for recombination study, 
produced similar results, making results of the study credible.  Cross-over sites had 
propensity to be found on the proximity to 3’ end of viral genome with less occasion in OR 6 
and part of ORF3.  More importantly, it was suggested that recombination may be positively 
correlated with viral diversity particularly induced by non-synonymous changes.  This study 
is the direct evidence of recombination among PRRS viruses occurring in the field and also 
the first report demonstrating universality and features of recombination in field isolates.    
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Future studies 
Even if evolutionary processes for genetic and antigenic diversity among PRRS 
viruses were well defined with firm proof in the present studies, unidentified 
fashion/mechanism may be involved in the generation.  For example, horses with long-term 
infection by EAV consistently shed mutants (Balasuriya et al., 1999; Hedges et al., 1999).  
Although persistent infection of PRRSV is well known, there is no information how 
persistent infection of the virus in swine herd may influence on the genetic diversity of 
PRRSV.  To address this ecological question, an experiment needs to be conducted, 
mimicking field situation, in terms of route of viral infection, number of animals for infection 
and viral transmission mode in a swine herd (i.e., population).  Host immune systems 
(humoral or cell mediated immunity) may work in the selection of minor population 
(subpopulation) resulting in production of a novel viral population with high genetic diversity.  
During serial passages of FMDV in the presence of polyclonal antibodies against VP1, 
mutant population emerged and became a dominant population.  Crucial amino acid changes 
for immune escape of the virus were observed on VP1 of the mutants, while not the viruses 
passed without the antibodies (Borrego et al., 1993).  Since extraneous field isolates 
introduced into a farm may not be able to be cleared by the existing host immune systems 
conferred by vaccination or a certain wild-type virus (Yoon et al., 1997), whether the viruses 
may undergo higher genetic changes under host immune pressure is hugely worthy of being 
investigated.   
Infection dose may affect on the extent of genetic diversity, since the dose is 
associated with level of replication of the virus and severity of clinical manifestation in hosts 
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(Yoon et al., 1999).  Hanada et al. (2004) reported that RNA viruses possess various 
synonymous substitution rate, and replication frequency is mostly associated with the rate of 
synonymous substitutions under the similar replication error rate.  Therefore, infection dose 
should be positively associated with genetic diversity.  
Our present studies demonstrated recombination of PRRS viruses by inoculating two 
different strains into pigs simultaneously.  However, infection of a pig by multiple strains 
may occur in a different way in the field.  Therefore, it remains to be further investigated 
how recombination may appear dissimilarly in the experiment simulating field situation.  As 
an example of experimental design, pigs are infected with one strain, and then with another 
strain that is genetically distinct from the other strain at different time points after initial 
exposure.  The variation in the time point of second infection would create diverse chance for 
mixing between two different strains, which may result in distinct view of recombination 
from our present studies.  Meanwhile, we can assume that as demonstrated in random point 
mutation, recombination also may modify phenotypic features.  The phenotypic alteration by 
recombination may become a supportive explanation about rapid generation of antigenic or 
pathogenic variation in the field isolates.  Nonetheless, it remains to be studied in the future.  
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